STUDYID|DOMAIN|USUBJID|PPSEQ|PPTESTCD|PPTEST|PPCAT|PPSCAT|PPORRES|PPORRESU|PPSTRESC|PPSTRESN|PPSTRESU|PPSPEC|TAETORD|EPOCH|PPDTC|PPDY|PPRFTDTC|PPSTINT|PPENINT
e|PP|35f5401f-575a-44dc-9141-8084716a5b70|1|RAAUCIFO|Ratio AUC Infinity Obs|[?]|COMPARTMENTAL|[?]|pmol/L/(mg/kg)|[?]|1|day*ug/mL/g|CARDIAC MUSCLE TISSUE|1|SCREENING|2020-10-17|7|2021-01-05|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8a863a88-67d8-4e50-bafa-c3146591f046|1|TAUHL|Half-Life TAU|[?]|COMPARTMENTAL|[?]|IU/h|[?]|1|h*mmol/L/(mg/g)|SPERMATOZOON|7|FOLLOW-UP|2020-12-31|12|2021-02-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f8e8acef-d26d-40c0-9bf0-fe7ac24c9fea|1|RNCLTAUS|Renal CL for Dose Int Norm by SA|[?]|NON-COMPARTMENTAL|[?]|h*mol/L/(mg/g)|[?]|1|fg/mL/(mg/m2)|PLATELET POOR PLASMA|6|TREATMENT|2020-08-02|9|2020-08-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0558cb35-f542-4f9a-a7e7-18b1d71be69c|1|SWING|Swing|[?]|COMPARTMENTAL|[?]|fg/mL/m2|[?]|1|day*pmol/L/(mg/g)|SEBUM|7|TREATMENT|2020-12-15|5|2021-01-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a9cf4d21-c2a8-4f32-b932-f05d2d317400|1|RAAUCLST|Ratio AUC to Last Nonzero Conc|[?]|COMPARTMENTAL|[?]|L/(mg/kg)|[?]|1|fg/mL/kg|WHITE MATTER TISSUE|6|TREATMENT|2020-09-03|72|2020-08-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0389257f-50de-4a05-8f2a-69c068374337|1|NRENLCLW|Nonrenal CL Norm by WT|[?]|COMPARTMENTAL|[?]|day*mmol/L/(mg/g)|[?]|1|h*ug/mL/(mg/kg)|SMEGMA|3|TREATMENT|2020-10-26|28|2020-10-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|279ca0c7-7c4e-4cd7-a3b6-87bc5c037352|1|CLST|Last Nonzero Conc|[?]|NON-COMPARTMENTAL|[?]|h2*umol/L|[?]|1|min*fg/mL/(kg/m2)|TISSUE|1|SCREENING|2021-02-28|85|2021-02-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ca4e757f-268f-4f3f-b0d0-950bf9c26b08|1|CTROUGH|Conc Trough|[?]|COMPARTMENTAL|[?]|mIU/mL/(mg/day)|[?]|1|h*mmol/L/g|EPITHELIAL CELL|2|TREATMENT|2021-02-15|65|2021-02-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ad402b62-0625-431b-9bd7-ffd6124610f3|1|CLSTW|Last Nonzero Conc Norm by WT|[?]|COMPARTMENTAL|[?]|(L/min)/(ug/m2)|[?]|1|(mL/h)/kg|PLATELET POOR PLASMA|5|TREATMENT|2020-10-26|41|2020-12-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d76b0f55-541c-491d-9162-4c133c9509f1|1|AURCALLD|AURC All Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|day*mol/L/(mg/g/day)|[?]|1|ngEq/mL|SWABBED MATERIAL|3|TREATMENT|2020-06-26|43|2020-06-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|146059d8-5652-41cd-b484-c6e5d8ea540f|1|CLFO|Total CL Obs by F|[?]|NON-COMPARTMENTAL|[?]|h*fg/mL|[?]|1|pmol/L/(mg/kg/day)|HAIR FOLLICLE|4|TREATMENT|2020-08-24|8|2020-10-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3d5f1964-b65c-4a0a-bb5b-1689308754d8|1|VZTAUD|Vz for Dose Int Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|h*Bq/g|[?]|1|GBq/ug|SYNOVIAL FLUID|3|WASHOUT|2020-12-14|50|2020-12-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|129dc836-068a-463e-b789-a0d05c60605d|1|LAMZUL|Lambda z Upper Limit|[?]|COMPARTMENTAL|[?]|h*pg/mL/(kg/m2)|[?]|1|mol/L/(ug/day)|SERUM|2|TREATMENT|2020-07-06|10|2020-08-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9ef8a6d4-8326-4050-be85-e9f8983f55c1|1|CAVINTDW|CAVGINT Norm by Dose/WT|[?]|COMPARTMENTAL|[?]|mol/L/ug|[?]|1|h*mg/mL/(kg/m2)|MONOCYTE|1|WASHOUT|2020-12-27|60|2020-10-31|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b91c4469-b3be-467f-8512-b73cf561e168|1|ERINT|Excret Rate from T1 to T2|[?]|COMPARTMENTAL|[?]|day*mol/L/(mg/g)|[?]|1|uIU/mL/(kg/m2)|SKIN TISSUE|4|SCREENING|2020-05-25|17|2020-06-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3637e1e0-8c0c-45cc-b139-e812a589f940|1|AUCPBEP|AUC %Back Extrapolation Pred|[?]|NON-COMPARTMENTAL|[?]|mg/mL/(mg/m2)|[?]|1|day*fg/mL|PROSTATIC FLUID|7|SCREENING|2020-10-21|62|2020-10-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|23385974-5fcd-4c36-b9fa-2fbb3841f182|1|LAMZLL|Lambda z Lower Limit|[?]|NON-COMPARTMENTAL|[?]|(L/min)/(ug/m2/day)|[?]|1|IU/mL/kg|STRIATED MUSCLE TISSUE|5|WASHOUT|2020-12-01|14|2020-12-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b76a836f-57ee-4e3d-89c4-31fdef04e5fe|1|VSSPF|Vol Dist Steady State Pred by F|[?]|COMPARTMENTAL|[?]|IU/mL/ug|[?]|1|h*ng/mL/kg|PLASMA ULTRAFILTRATE|6|TREATMENT|2021-01-28|63|2021-02-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f1327e16-08c6-4ef0-852e-13c095a94c00|1|LAMZ|Lambda z|[?]|COMPARTMENTAL|[?]|(L/day)/(mg/m2/day)|[?]|1|h*g/mL/(mg/kg)|PROSTATIC FLUID|4|TREATMENT|2020-06-17|32|2020-07-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|52de3d1f-e750-49f3-9cfa-09ac97a5dd4b|1|RCPCTAU|Pct Rec Over Dosing Interval|[?]|COMPARTMENTAL|[?]|h*ugEq/mL/mgEq|[?]|1|g/mL/(mg/m2)|PLEURAL TISSUE|3|FOLLOW-UP|2021-02-01|27|2021-01-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e8065021-c163-41c8-8a76-5f0c1c3a06c4|1|CAVINTDW|CAVGINT Norm by Dose/WT|[?]|COMPARTMENTAL|[?]|ng/mL/(mg/kg/day)|[?]|1|min*mg/mL/(mg/g/day)|MONOCYTE|3|TREATMENT|2021-03-03|95|2020-12-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|854a9218-995e-47f4-87ab-e58d20f56d19|1|MRAUCLST|Metabolite Ratio AUC Last Nonzero Conc|[?]|NON-COMPARTMENTAL|[?]|day*ng/mL/kg|[?]|1|IU/h|MENSTRUAL BLOOD|6|TREATMENT|2020-11-21|8|2020-11-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7865f4e0-11d8-45f7-b0d1-0fd7bb4c1311|1|MRTEVIFP|MRT Extravasc Infinity Pred|[?]|COMPARTMENTAL|[?]|(L/h)/g|[?]|1|nmol/L/(mg/day)|TUMOR TISSUE|4|SCREENING|2020-07-24|43|2020-08-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|08944dcd-a62d-4932-bb15-a8f15cc73229|1|RCPCIFOW|Pct Rec Infinity Obs Norm by WT|[?]|NON-COMPARTMENTAL|[?]|IU/mL/kg|[?]|1|nmol|SALIVA|2|TREATMENT|2021-02-15|64|2021-03-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1d7df560-695a-41fe-9226-4cc206b05f48|1|VZOD|Vz Obs Norm by Dose|[?]|COMPARTMENTAL|[?]|(L/h)/(mg/kg/day)|[?]|1|(mL/day)/kg|PLASMA|4|WASHOUT|2020-12-18|19|2021-01-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|12c802a8-862c-45a4-b12c-a6f920772534|1|CLFPD|Total CL Pred by F Norm by Dose|[?]|COMPARTMENTAL|[?]|h*mol/L|[?]|1|day*mol/L/g|INTERSTITIAL FLUID|5|TREATMENT|2020-07-18|41|2020-06-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1ac2ce3b-f73f-4a46-a8fe-ea44dfc635a3|1|RCAMIFPW|Amt Rec Infinity Pred Norm by WT|[?]|NON-COMPARTMENTAL|[?]|h*ug/mL/(kg/m2)|[?]|1|min|SKIN TISSUE|7|TREATMENT|2020-11-25|12|2020-12-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6c1628af-ea1b-40ea-80fd-667bcfc29a4b|1|CTROUGHS|Conc Trough by SA|[?]|COMPARTMENTAL|[?]|umol/L/m2|[?]|1|day*umol/L/(mg/g)|SPERMATOZOON|7|TREATMENT|2020-11-13|99|2020-10-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|96114171-59a0-4543-b3ec-c7796ae8ee92|1|AURCLSTB|AURC Dosing to Last Conc Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|umol/L/m2|[?]|1|min*mol/L/(mg/g)|SKIN TISSUE|4|TREATMENT|2020-12-15|31|2020-12-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0070d42d-c864-4a83-a3c9-4c8ca7de51de|1|RCAMIFPS|Amt Rec Infinity Pred Norm by SA|[?]|COMPARTMENTAL|[?]|min*fg/mL/g|[?]|1|nmol/L/(mg/kg/day)|WHITE MATTER TISSUE|4|TREATMENT|2020-09-03|29|2020-08-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a2ec3389-6f5f-44a3-a6dd-f6177a805791|1|AURCIFO|AURC Infinity Obs|[?]|COMPARTMENTAL|[?]|mmol/min|[?]|1|IU/mL/(mg/m2)|SALIVA|1|WASHOUT|2020-11-20|44|2020-10-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|cc562042-9641-460d-862e-d6923dd4207d|1|RCPCIFOS|Pct Rec Infinity Obs Norm by SA|[?]|COMPARTMENTAL|[?]|h*g/mL/(mg/g)|[?]|1|day*nmol/L/m2|PLATELET|1|FOLLOW-UP|2020-06-10|24|2020-08-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d0a4f2af-eb3c-4f04-b16d-b3ef5a8d0646|1|CLST|Last Nonzero Conc|[?]|COMPARTMENTAL|[?]|mIU/mL/(mg/m2)|[?]|1|h*ng/mL/(mg/g)|SALIVA|5|WASHOUT|2020-10-27|99|2020-09-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d90f2824-692e-403f-b1ca-5b6462c93a75|1|ERLSTD|Last Meas Excretion Rate Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|h*nmol/L/(kg/m2)|[?]|1|mL/h|ARTERIAL CORD BLOOD|7|TREATMENT|2020-07-13|8|2020-09-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ee0e55e1-6107-4a3c-85b4-cb48300153e8|1|CLFTAUS|Total CL by F for Dose Int Norm by SA|[?]|NON-COMPARTMENTAL|[?]|h*pg/mL/(kg/m2)|[?]|1|(mL/h)/m2|HAIR FOLLICLE|5|TREATMENT|2020-05-23|8|2020-08-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6aa37bb3-85aa-427f-9e56-a776257f1548|1|AUCIFOUB|AUC Infinity Obs, Unbound Drug|[?]|COMPARTMENTAL|[?]|nmol/L/(mg/day)|[?]|1|(L/h)/m2|EPIDERMAL TISSUE|2|SCREENING|2021-01-09|66|2020-12-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|592c5ea9-d4ca-4c3a-a836-6d88f2b93303|1|RCAMLST|Amt Rec to Last Nonzero Conc|[?]|COMPARTMENTAL|[?]|(L/min)/(kg/m2)|[?]|1|nmol/kg|SWABBED MATERIAL|7|TREATMENT|2020-06-02|25|2020-06-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|940d4614-b41a-44d3-b878-6e19ee22f24b|1|CLPD|Total CL Pred Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|%|[?]|1|day*fg/mL/g|ARTERIALIZED CAPILLARY BLOOD|2|TREATMENT|2020-08-18|53|2020-08-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e2edd4f0-926b-4514-bf3f-7449f248343f|1|MRTIVLST|MRT Intravasc to Last Nonzero Conc|[?]|NON-COMPARTMENTAL|[?]|h*mmol/L/(mg/g/day)|[?]|1|pg/mL|LAVAGE FLUID|5|WASHOUT|2020-11-07|16|2020-11-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|215d711d-c98a-4f7b-ba41-d2c06ad70ddd|1|AUMCIFOS|AUMC Infinity Obs Norm by SA|[?]|NON-COMPARTMENTAL|[?]|day*mg/mL/(mg/g)|[?]|1|h*pg/mL/(mg/kg/day)|DIALYSIS FLUID, PERITONEAL|2|WASHOUT|2020-07-03|15|2020-07-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|493a53ef-01ab-470c-9bbe-7c2aa48b946b|1|CONC|Concentration|[?]|NON-COMPARTMENTAL|[?]|mmol/L|[?]|1|(mL/min)/m2|LAVAGE FLUID|6|TREATMENT|2020-08-16|44|2020-09-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ba33de14-b676-4389-a863-a7fa3edb8543|1|AUMCIFPS|AUMC Infinity Pred Norm by SA|[?]|COMPARTMENTAL|[?]|fg/mL/(ug/m2/day)|[?]|1|day*mmol/L/m2|PLATELET POOR PLASMA|6|FOLLOW-UP|2020-12-01|38|2020-12-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|24801f05-79be-433d-8124-85580bc14c4f|1|LAMZLTAU|Lambda z Lower Limit TAU|[?]|COMPARTMENTAL|[?]|nmol/L/(mg/kg)|[?]|1|mL/(ug/kg)|CAPILLARY BLOOD|6|SCREENING|2020-12-04|96|2020-09-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|02df80f9-2337-4abd-9452-41cd83dec8ba|1|AUMCIFOS|AUMC Infinity Obs Norm by SA|[?]|COMPARTMENTAL|[?]|h*ng/mL/(mg/kg/day)|[?]|1|(L/day)/(ug/kg/day)|VITREOUS HUMOR|7|SCREENING|2020-08-19|25|2020-08-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d9eea93b-f9f9-466c-aa8a-a250baff18ef|1|CLFPW|Total CL Pred by F Norm by WT|[?]|COMPARTMENTAL|[?]|h*fg/mL/m2|[?]|1|pg/h|BASAL TEAR|6|WASHOUT|2020-07-29|5|2020-09-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|35a59f6a-2712-4d1b-a954-f1418d4b9168|1|RAAUCINT|Ratio AUC from T1 to T2|[?]|NON-COMPARTMENTAL|[?]|day*fg/mL/m2|[?]|1|h*Bq/mL|SUPERNATANT, CEREBROSPINAL FLUID|6|TREATMENT|2021-02-01|98|2020-12-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ecfa7c81-fd68-4b8c-8305-65e1ecbff67f|1|KDIST|K Slope of Distribution|[?]|COMPARTMENTAL|[?]|(mL/h)/m2|[?]|1|fg/mL/(ug/m2)|GASTRIC CONTENTS|5|TREATMENT|2020-12-16|46|2021-01-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7fa3d0ff-fd49-4114-bebe-1c27765f01b8|1|AURCINT|AURC from T1 to T2|[?]|NON-COMPARTMENTAL|[?]|g/mL/(ug/day)|[?]|1|(L/min)/mg|SMOOTH MUSCLE TISSUE|2|WASHOUT|2020-07-12|70|2020-07-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d041952e-4aa6-4b37-9cec-127adce2eabb|1|VZOW|Vz Obs Norm by WT|[?]|NON-COMPARTMENTAL|[?]|nmol/L|[?]|1|g/mL/(kg/m2)|WHITE MATTER TISSUE|3|TREATMENT|2020-11-03|35|2020-10-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7f0ceec0-eda9-40ea-b2e8-90ba6bf3d115|1|CLFPW|Total CL Pred by F Norm by WT|[?]|COMPARTMENTAL|[?]|h*fg/mL/(mg/g/day)|[?]|1|mg/mL/(mg/kg/day)|CERUMEN|3|TREATMENT|2020-08-22|84|2020-09-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9fc393da-4665-4be5-a869-856c45ddcf13|1|ARAUCIFO|Accum Ratio AUC Infinity Obs|[?]|COMPARTMENTAL|[?]|h*umol/L/kg|[?]|1|h*nmol/L|TRANSUDATE|2|WASHOUT|2020-08-11|64|2020-08-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|cddc1541-4de9-45e7-bb61-15a2d5baca6f|1|VZFOB|Vz Obs by F Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|h*mmol/L/g|[?]|1|h*ng/mL/mg|SEMINAL FLUID|2|TREATMENT|2021-02-27|49|2021-03-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|303c6dbe-59f9-4016-baa1-8506c0c1ee09|1|VSSPW|Vol Dist Steady State Pred Norm by WT|[?]|NON-COMPARTMENTAL|[?]|pg/mg|[?]|1|h*pmol/L|SYNOVIAL FLUID|4|TREATMENT|2021-03-05|79|2021-01-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|fee3c810-3d76-4db4-9272-6b4e8fd14088|1|RNCLUB|Renal CL for Unbound Drug|[?]|COMPARTMENTAL|[?]|ng|[?]|1|pg/mg|PROSTATIC FLUID|7|TREATMENT|2021-02-11|68|2021-03-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d5125e6c-2ab6-4286-8ce0-0011f1e08fbb|1|RAAUC|Ratio AUC|[?]|NON-COMPARTMENTAL|[?]|ng/mL/(ug/day)|[?]|1|(mL/h)/(mg/day)|VENOUS PLASMA|4|TREATMENT|2020-08-13|46|2020-09-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2e6e4c1d-4976-4f32-bd2e-8db09440f7b3|1|ERTLST|Midpoint of Interval of Last Nonzero ER|[?]|COMPARTMENTAL|[?]|pg/mL/m2|[?]|1|IU/mL/(mg/kg/day)|CORD SERUM|4|FOLLOW-UP|2020-08-09|18|2020-08-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|47fad45a-9a4c-47ee-a863-089d979523b5|1|LAMZNTAU|Number of Points for Lambda z TAU|[?]|NON-COMPARTMENTAL|[?]|mIU/mL/(mg/day)|[?]|1|min*g/mL|RETICULOCYTES|5|TREATMENT|2020-10-30|33|2020-10-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|317b8b6d-9638-44a3-816f-7f3fca1e01a3|1|NRENALCL|Nonrenal CL|[?]|NON-COMPARTMENTAL|[?]|nmol/L/(kg/m2)|[?]|1|min*pmol/L/(kg/m2)|CALCULUS|4|WASHOUT|2020-05-22|9|2020-07-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3bad8e12-9a92-4227-a3f6-b3eac8fa57ec|1|V0B|Vol Dist Initial Norm by BMI|[?]|COMPARTMENTAL|[?]|mmol/L/(kg/m2)|[?]|1|(L/h)/(mg/day)|CARDIAC MUSCLE TISSUE|7|FOLLOW-UP|2020-07-08|8|2020-10-05|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e7cee930-54f6-482e-b782-01aed0f0db06|1|RAAUCALL|Ratio AUC All|[?]|COMPARTMENTAL|[?]|IU/mL/m2|[?]|1|min*mmol/L/g|PLASMA|3|TREATMENT|2021-03-05|67|2021-03-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4f0e0353-bd4b-45ee-9e21-40489b5f8d2f|1|LAMZUL|Lambda z Upper Limit|[?]|COMPARTMENTAL|[?]|mL/h|[?]|1|day*umol/L/(kg/m2)|URINE|5|WASHOUT|2021-01-19|8|2021-04-05|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f754ae7d-0776-41c0-988c-8cf2879d85da|1|RCPCIFOS|Pct Rec Infinity Obs Norm by SA|[?]|NON-COMPARTMENTAL|[?]|min*g/mL/(kg/m2)|[?]|1|h*pg/mL/(mg/kg)|SALIVA|5|FOLLOW-UP|2020-10-24|47|2020-10-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8a8d8c31-ae36-4a64-90da-ba5eb473e420|1|CONCDW|Concentration Norm by Dose/WT|[?]|COMPARTMENTAL|[?]|min*mg/mL/(mg/g/day)|[?]|1|(L/h)/(mg/day)|INFRANATANT, PLEURAL FLUID|6|TREATMENT|2020-07-02|17|2020-08-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|482e40c9-2908-4269-b93c-61c311e9fde3|1|CMAXS|Max Conc Norm by SA|[?]|NON-COMPARTMENTAL|[?]|L/(ug/m2)|[?]|1|h*pmol/L/g|TUMOR TISSUE|6|TREATMENT|2020-09-24|80|2020-09-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f7cfb281-0556-4316-9373-65edf63c4b23|1|AUCALLW|AUC All Norm by WT|[?]|COMPARTMENTAL|[?]|(L/day)/kg|[?]|1|min*nmol/L/(mg/g)|DIALYSIS FLUID, PERITONEAL|2|WASHOUT|2020-08-16|58|2020-09-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e0b03cb9-aa73-48c8-b05b-4a506ecf077b|1|RAAUCLST|Ratio AUC to Last Nonzero Conc|[?]|COMPARTMENTAL|[?]|pg/mL|[?]|1|ng/kg/min|ALVEOLAR AIR|7|TREATMENT|2021-03-19|78|2021-03-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9ed8a578-a82a-423a-81ca-ee87f98d62f7|1|RCAMTAUS|Amt Rec Over Dosing Interval Norm by SA|[?]|COMPARTMENTAL|[?]|min*nmol/L|[?]|1|g/mL|CARDIAC MUSCLE TISSUE|3|TREATMENT|2020-10-18|56|2020-08-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2214af46-1072-4328-bf3d-f4fe9cd97d9b|1|AUMCLSTD|AUMC to Last Nonzero Conc Norm by Dose|[?]|COMPARTMENTAL|[?]|uIU/mL|[?]|1|(L/day)/(ug/day)|MENSTRUAL BLOOD|2|SCREENING|2020-12-22|75|2020-12-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7e56eb43-62a6-45ac-9476-1d0655595a04|1|AUCALLS|AUC All Norm by SA|[?]|NON-COMPARTMENTAL|[?]|min*mg/mL|[?]|1|ng/mL/(ug/m2/day)|VENOUS CORD BLOOD|6|TREATMENT|2021-04-07|83|2021-04-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|73a8e85a-0b5f-496b-b164-afc4d1f02de2|1|CMAXB|Max Conc Norm by BMI|[?]|COMPARTMENTAL|[?]|RATIO|[?]|1|min*mol/L/(mg/g/day)|EXHALED BREATH CONDENSATE|5|WASHOUT|2020-09-07|80|2020-09-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|84f74359-c79b-4f1c-8119-a4993b071973|1|CMAXLN|Max Conc LN Transformed|[?]|COMPARTMENTAL|[?]|(L/h)/ug|[?]|1|mmol/L/(ug/m2)|KERATINOCYTE|5|FOLLOW-UP|2020-07-20|79|2020-05-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d6ff71b7-6a5f-415f-8267-15c9c1f5585c|1|ERLSTW|Last Meas Excretion Rate Norm by WT|[?]|NON-COMPARTMENTAL|[?]|day*mg/mL/(kg/m2)|[?]|1|(L/min)/(mg/day)|MIXED VENOUS BLOOD|4|TREATMENT|2021-01-08|73|2020-12-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|cd0c969e-61c6-4c65-ac19-4ee247f5009a|1|VZPD|Vz Pred Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|h*g/mL/g|[?]|1|mg/kg/day|ARTERIAL CORD BLOOD|6|TREATMENT|2020-11-19|81|2020-11-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1fff484d-0a68-42cd-8eff-bc4fe4da945c|1|AUCIFPUB|AUC Infinity Pred, Unbound Drug|[?]|NON-COMPARTMENTAL|[?]|L/(ug/kg)|[?]|1|(mL/min)/(mg/m2)|TISSUE|7|TREATMENT|2021-02-16|29|2021-02-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e2c20e9a-0ac5-4907-96de-472bee70bd79|1|AURCALL|AURC All|[?]|COMPARTMENTAL|[?]|mg/mL/(mg/m2/day)|[?]|1|min*fg/mL/(kg/m2)|BONE|2|WASHOUT|2021-01-03|40|2021-01-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6064ca8c-b723-4d05-914a-bb547d86fcc5|1|RCPCIFOS|Pct Rec Infinity Obs Norm by SA|[?]|NON-COMPARTMENTAL|[?]|day*pg/mL/(mg/g/day)|[?]|1|fg/mL/(mg/day)|NAIL|6|SCREENING|2020-06-04|12|2020-06-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8effbbff-acda-4718-89f1-e30a418f6bae|1|HDER|Hemodialysis Extraction Ratio|[?]|COMPARTMENTAL|[?]|day*umol/L/(mg/g/day)|[?]|1|mmol/L/(kg/m2)|CALCULUS|6|SCREENING|2020-11-25|29|2021-01-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|859b16a5-f6a2-40cc-8e01-18c112b1969e|1|AUMCIFPS|AUMC Infinity Pred Norm by SA|[?]|NON-COMPARTMENTAL|[?]|ug/h|[?]|1|h*mg/mL|LEUKOCYTE|5|TREATMENT|2020-09-08|31|2020-08-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|36b457ef-4cf6-4043-a836-49368ebf3f1c|1|AUCALLD|AUC All Norm by Dose|[?]|COMPARTMENTAL|[?]|(L/h)/(ug/kg)|[?]|1|uIU/mL/kg|DIALYSIS FLUID|2|TREATMENT|2020-09-05|30|2020-09-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|31f33e38-bba6-4c8a-b563-14afaabae5d7|1|CLOW|Total CL Obs Norm by WT|[?]|COMPARTMENTAL|[?]|(L/day)/(ug/kg)|[?]|1|mL/h|ISOLATE|5|TREATMENT|2020-07-20|29|2020-07-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6794dffe-333b-425b-8883-26f6e5ba0797|1|CLPD|Total CL Pred Norm by Dose|[?]|COMPARTMENTAL|[?]|mL/day|[?]|1|ng/mL/(mg/day)|NAIL|7|WASHOUT|2020-09-17|80|2020-08-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d7d9a12d-6bb1-44a2-a008-6a5bae013d40|1|AUMCPEP|AUMC % Extrapolation Pred|[?]|NON-COMPARTMENTAL|[?]|h*ng/mL/(mg/m2)|[?]|1|h*Bq/mL|SWABBED MATERIAL|6|TREATMENT|2020-08-14|78|2020-07-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|45897452-8f5a-458d-9a43-13237460ba48|1|ERINTW|Excret Rate from T1 to T2 Norm by WT|[?]|NON-COMPARTMENTAL|[?]|day*ug/mL|[?]|1|h*fg/mL/kg|SMOOTH MUSCLE TISSUE|4|TREATMENT|2020-11-28|27|2020-11-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|16eb981f-2118-4658-a83f-93d925c410c9|1|AUCINTW|AUC from T1 to T2 Norm by WT|[?]|COMPARTMENTAL|[?]|h2*mol/L|[?]|1|mol/L|FLUID|3|FOLLOW-UP|2020-12-17|11|2021-01-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3f3ade8a-e27b-4f20-8b4d-69c7bae520c1|1|RAAUCLSD|RatioAUC to Last Nonzero Conc NormByDose|[?]|NON-COMPARTMENTAL|[?]|day*g/mL/(kg/m2)|[?]|1|umol/L/(kg/m2)|BASAL TEAR|5|TREATMENT|2021-01-25|24|2021-03-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d99a6a66-accf-4a8e-b696-b6d5b4ce249c|1|VZFP|Vz Pred by F|[?]|COMPARTMENTAL|[?]|nmol/L/g|[?]|1|mol|EXPIRED AIR|6|TREATMENT|2021-02-20|32|2021-04-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|874f491c-5d55-4738-86b7-b1200b16d106|1|VZFP|Vz Pred by F|[?]|COMPARTMENTAL|[?]|h*umol/L/(mg/g/day)|[?]|1|pg/h|MIXED VENOUS BLOOD|3|SCREENING|2021-03-01|62|2021-02-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|281ccdef-794c-49ad-9616-6f6f68dd4543|1|CLFO|Total CL Obs by F|[?]|COMPARTMENTAL|[?]|MBq/uL|[?]|1|h*mmol/L|SOFT TISSUE|2|TREATMENT|2020-08-31|98|2020-08-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b1179e10-e8fe-472c-a511-d6d460571857|1|RNCLINTB|Renal CL from T1 to T2 Norm by BMI|[?]|COMPARTMENTAL|[?]|ug/h|[?]|1|mIU/mL/(kg/m2)|SERUM|7|FOLLOW-UP|2020-09-16|55|2020-08-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6362cf42-f286-4151-bdf7-38fcc5639eed|1|MRAUCTAU|Metabolite Ratio for AUC Dosing Interval|[?]|COMPARTMENTAL|[?]|pg/mg|[?]|1|mg/mL/(mg/m2)|SYNOVIAL FLUID|5|SCREENING|2020-09-25|28|2020-10-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8e28e3ab-0060-43f7-b033-c16bd77c0e29|1|RAAUCIFO|Ratio AUC Infinity Obs|[?]|NON-COMPARTMENTAL|[?]|L/h|[?]|1|h*fg/mL/(mg/g)|INFRANATANT, PLASMA|4|FOLLOW-UP|2021-02-16|88|2021-01-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d0f0a002-b5cd-468a-98ff-e0eeaa5969e7|1|CTROUGHB|Conc Trough by BMI|[?]|NON-COMPARTMENTAL|[?]|L/(mg/kg/day)|[?]|1|h*g/mL/(mg/g)|LEUKOCYTE|3|TREATMENT|2020-06-20|3|2020-06-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0c1fcd0e-847b-4bf1-82c1-5d749742cc5b|1|RCAMIFP|Amt Rec Infinity Pred|[?]|NON-COMPARTMENTAL|[?]|/min|[?]|1|ng/mL/(ug/m2)|MIXED VENOUS BLOOD|3|FOLLOW-UP|2020-08-24|73|2020-07-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|43880587-c397-402d-886b-9b666e3fe455|1|AUCINTD|AUC from T1 to T2 Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|mmol/L/ug|[?]|1|h*g/mL/(mg/kg/day)|TISSUE|2|TREATMENT|2020-08-04|24|2020-09-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|807f83d2-9364-4ee4-855d-304f3e252555|1|RCAMINTS|Amt Rec from T1 to T2 Norm by SA|[?]|NON-COMPARTMENTAL|[?]|g/mL/(ug/m2/day)|[?]|1|min*nmol/L/(mg/g)|AQUEOUS HUMOR|7|TREATMENT|2020-07-27|84|2020-07-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|45dd95cd-857f-4cbd-89d7-640a8ed74fd8|1|CMINB|Min Conc Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|mmol/L/(ug/m2/day)|[?]|1|min*ng/mL/kg|SPUTUM|3|TREATMENT|2021-02-07|70|2021-01-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|81c33633-6ade-45fe-a78e-0e853d8aa9c2|1|FB|Fraction Bound|[?]|COMPARTMENTAL|[?]|umol/L|[?]|1|nmol/L/(mg/kg/day)|EMOTIONAL TEAR|5|TREATMENT|2020-08-10|5|2020-09-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|62f3a2a8-f181-4d95-a9b3-a94cd71594a3|1|ARAUCIPD|Accum Ratio AUCIFP Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|/h|[?]|1|mL/(ug/kg)|ARTERIALIZED CAPILLARY BLOOD|6|TREATMENT|2020-09-27|67|2020-08-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7d6e9afe-919e-481a-87d5-bbaf7ca2ec6c|1|RENALCLW|Renal CL Norm by WT|[?]|COMPARTMENTAL|[?]|day*mg/mL|[?]|1|h*ug/mL/m2|INTERSTITIAL FLUID|2|TREATMENT|2020-09-04|13|2020-09-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|84ccf2f8-8b9d-486c-8aad-a11bc45ed4f5|1|RCAMINTS|Amt Rec from T1 to T2 Norm by SA|[?]|COMPARTMENTAL|[?]|(L/h)/(mg/day)|[?]|1|min*fg/mL/(kg/m2)|VENOUS BLOOD|3|TREATMENT|2021-02-20|34|2021-02-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|21740641-69bb-49a9-a86d-2444914f6d12|1|CLOB|Total CL Obs Norm by BMI|[?]|COMPARTMENTAL|[?]|IU/mL/(mg/m2)|[?]|1|day*mol/L/g|CORD BLOOD|2|TREATMENT|2020-07-15|69|2020-06-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c3984f41-30a0-49a4-a8bd-f36fad4621a8|1|RCPCIFOW|Pct Rec Infinity Obs Norm by WT|[?]|COMPARTMENTAL|[?]|(L/min)/m2|[?]|1|h*ug/mL/(mg/g/day)|SMOOTH MUSCLE TISSUE|5|WASHOUT|2020-08-19|72|2020-09-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1ae9a175-fd7a-4215-adc4-ce6bd220f94d|1|FLUCP|Fluctuation%|[?]|COMPARTMENTAL|[?]|nmol/L/(mg/m2)|[?]|1|mol/L/(ug/kg/day)|CAPILLARY BLOOD|4|TREATMENT|2021-02-20|40|2021-01-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0f85b859-187d-4c6b-8873-33c0f18d3e3c|1|RACTRGH|Ratio Conc Trough|[?]|COMPARTMENTAL|[?]|IU/mL/(ug/kg/day)|[?]|1|(L/h)/(mg/m2)|PLATELET|4|SCREENING|2020-08-17|34|2020-08-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5e383a9d-dc97-4352-8add-d55a1a566b9f|1|VSSPD|Vol Dist Steady State Pred Norm by Dose|[?]|COMPARTMENTAL|[?]|fg/mL/g|[?]|1|h*Bq/g|SEMEN|1|TREATMENT|2020-12-15|89|2020-12-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3eda746b-fb97-4950-a528-1d4ae5d3653a|1|AURCIFOS|AURC Infinity Obs Norm by SA|[?]|NON-COMPARTMENTAL|[?]|h*mg/mL|[?]|1|h*pg/mL/(mg/g/day)|TRANSUDATE|7|TREATMENT|2020-07-14|41|2020-07-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a3b72841-3401-4dcc-9d06-75438b408d0b|1|AUCIFOUB|AUC Infinity Obs, Unbound Drug|[?]|COMPARTMENTAL|[?]|IU/mL/(kg/m2)|[?]|1|mgEq|SMOOTH MUSCLE TISSUE|2|FOLLOW-UP|2020-11-02|7|2021-02-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4393406e-bda5-42e4-a752-a8121004b7ef|1|C0|Initial Conc|[?]|NON-COMPARTMENTAL|[?]|day*umol/L/(kg/m2)|[?]|1|g/mL/(kg/m2)|SOFT TISSUE|5|TREATMENT|2021-01-01|75|2020-11-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d70f5903-3d94-422b-8f69-212f015b54c9|1|VZP|Vz Pred|[?]|NON-COMPARTMENTAL|[?]|(L/min)/(mg/kg/day)|[?]|1|day*pmol/L/(kg/m2)|SWABBED MATERIAL|1|WASHOUT|2020-06-12|34|2020-07-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ef772266-faf1-4904-8ac3-19cbc3ea7d36|1|RCAMIFOS|Amt Rec Infinity Obs Norm by SA|[?]|COMPARTMENTAL|[?]|h*mmol/L/(mg/g/day)|[?]|1|day*mmol/L/(mg/g/day)|TUMOR TISSUE|4|TREATMENT|2021-02-02|37|2021-01-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c0f9c36c-1ae5-4f80-b936-0afe3f661746|1|V0S|Vol Dist Initial Norm by SA|[?]|COMPARTMENTAL|[?]|min*ug/mL/g|[?]|1|ugEq/mL|URINE SEDIMENT|4|TREATMENT|2020-07-26|22|2020-09-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f17b5630-e782-4135-8a50-4a9bb2fe63b1|1|AUMCLSTS|AUMC to Last Nonzero Conc Norm by SA|[?]|NON-COMPARTMENTAL|[?]|(L/min)/(mg/kg)|[?]|1|mmol/L/(mg/kg)|MONOCYTE|3|SCREENING|2021-02-20|93|2021-01-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8bdb40c9-1e44-45ae-bf08-81ea635fd762|1|AURCLSTD|AURC Dosing to Last Conc Norm by Dose|[?]|COMPARTMENTAL|[?]|day*ng/mL/(mg/g)|[?]|1|fg/mL/(mg/kg)|ARTERIALIZED CAPILLARY BLOOD|5|SCREENING|2021-02-04|43|2021-01-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c010dfcb-c1bb-4b4f-b58c-f4986ee86384|1|NRENALCL|Nonrenal CL|[?]|COMPARTMENTAL|[?]|min*ug/mL/m2|[?]|1|mg/kg|SMOOTH MUSCLE TISSUE|1|FOLLOW-UP|2021-02-21|46|2021-04-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|296f8314-5a07-47b5-8796-31afe709b379|1|RCAMINT|Amt Rec from T1 to T2|[?]|NON-COMPARTMENTAL|[?]|min*pmol/L/(kg/m2)|[?]|1|mol|VENOUS PLASMA|5|TREATMENT|2020-07-09|11|2020-07-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ae1e4047-f4d7-47fa-a5f6-974f9a9c2a48|1|RCPCIFP|Pct Rec Infinity Pred|[?]|COMPARTMENTAL|[?]|h*g/mL/(kg/m2)|[?]|1|min*mmol/L/m2|VENOUS BLOOD|5|SCREENING|2020-12-07|4|2021-02-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b06043ae-8251-4df8-ab6d-0ceb269c1a42|1|AUCIFPD|AUC Infinity Pred Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|h*ngEq/mL|[?]|1|h*mol/L/(mg/g)|CEREBROSPINAL FLUID|7|SCREENING|2021-02-09|25|2021-04-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d4fb5b9e-e244-4818-be3d-dbb57faacd43|1|RACONC|Ratio Concentration|[?]|NON-COMPARTMENTAL|[?]|day*fg/mL/(mg/g)|[?]|1|pg/day|MUSCLE TISSUE|5|TREATMENT|2021-01-20|84|2020-10-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7e6cbcf1-7175-4b46-b82f-32189cfcf6bb|1|RNCLINT|Renal CL from T1 to T2|[?]|COMPARTMENTAL|[?]|day*mg/mL/m2|[?]|1|min*umol/L|CARDIAC MUSCLE TISSUE|7|WASHOUT|2020-09-19|78|2020-07-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|26e6a3e9-7e84-4c99-b1b9-0608b6d73512|1|VZFOD|Vz Obs by F Norm by Dose|[?]|COMPARTMENTAL|[?]|h*pmol/L/g|[?]|1|h*DNA copies/ug|PLASMA ULTRAFILTRATE|5|TREATMENT|2021-03-28|83|2021-02-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b1215705-4c22-43bd-aa65-58bd8745f081|1|VSSOUB|Vol Dist Steady State Obs by UB|[?]|NON-COMPARTMENTAL|[?]|min*umol/L/kg|[?]|1|h*mol/L|SUPERNATANT, SERUM OR PLASMA|3|TREATMENT|2020-07-28|23|2020-07-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b99c6528-af4e-42f5-8d2d-18943b57d55a|1|AUCIFP|AUC Infinity Pred|[?]|COMPARTMENTAL|[?]|(L/day)/(mg/m2)|[?]|1|h2*umol/L|SUPERNATANT, SERUM OR PLASMA|5|TREATMENT|2020-10-20|5|2020-12-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6848e438-51ca-4a7d-8f81-26c375969a64|1|CTROUGHD|Conc Trough by Dose|[?]|NON-COMPARTMENTAL|[?]|h2*DNA copies/ug|[?]|1|(L/min)/g|SERUM OR PLASMA|3|FOLLOW-UP|2020-11-09|7|2020-11-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a6e11c33-7905-42d2-bda9-671d756d4c51|1|DISTHL|Half-Life Distribution|[?]|COMPARTMENTAL|[?]|ugEq|[?]|1|day*pmol/L|LAVAGE FLUID|4|WASHOUT|2020-08-19|23|2020-10-31|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|441d3bc1-c95e-4e52-bd1b-7713f3a2cd8c|1|AURCALLB|AURC All Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|h*mg/mL/(mg/g/day)|[?]|1|(mL/min)/(mg/m2/day)|SPERMATOZOON|5|FOLLOW-UP|2021-01-17|76|2021-01-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8ef37b54-b463-43a4-879f-3ad653c4fef4|1|VSSPF|Vol Dist Steady State Pred by F|[?]|NON-COMPARTMENTAL|[?]|mIU/mL/m2|[?]|1|kBq/uL|SEMEN|3|TREATMENT|2020-10-17|46|2020-11-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|cf10035c-4d44-4512-810b-c267d1c8821b|1|CTROUGH|Conc Trough|[?]|NON-COMPARTMENTAL|[?]|uIU/mL/(mg/day)|[?]|1|h*fg/mL/(mg/g/day)|SMOOTH MUSCLE TISSUE|7|TREATMENT|2020-05-22|5|2020-06-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f24e5ff9-ebe2-4dfe-88ed-1705eb410c9b|1|VSSPW|Vol Dist Steady State Pred Norm by WT|[?]|NON-COMPARTMENTAL|[?]|mg/mL|[?]|1|mmol/min|PROSTATIC FLUID|4|TREATMENT|2020-08-08|17|2020-10-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a1e0035a-3328-4966-8664-82e53a44eb59|1|RCPCTAUS|Pct Rec Over Dosing Interval Norm by SA|[?]|COMPARTMENTAL|[?]|mL/(ug/kg)|[?]|1|day*g/mL/(mg/g)|TUMOR TISSUE|4|TREATMENT|2020-11-07|99|2020-08-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|771377fd-724f-4056-b2ea-84e1adab1f47|1|HDCL|Hemodialysis Clearance|[?]|NON-COMPARTMENTAL|[?]|GBq|[?]|1|(L/min)/(kg/m2)|PLASMA ULTRAFILTRATE|1|FOLLOW-UP|2020-10-31|2|2020-12-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8e3ae12f-e4d8-4bcd-b444-979496e0cfe1|1|CLSTS|Last Nonzero Conc Norm by SA|[?]|NON-COMPARTMENTAL|[?]|(Bq/mL)/(kBq/kg)|[?]|1|L/(ug/m2)|KERATINOCYTE|2|TREATMENT|2020-10-01|49|2020-08-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3aea0861-8f67-4717-93ce-c1e322f151d9|1|RENALCLB|Renal CL Norm by BMI|[?]|COMPARTMENTAL|[?]|h*mmol/L/g|[?]|1|day*ng/mL/(kg/m2)|SERUM|4|FOLLOW-UP|2020-10-24|81|2020-10-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4fbe2ae7-4b86-4706-845c-d1f22f1a822f|1|AUCIFPS|AUC Infinity Pred Norm by SA|[?]|COMPARTMENTAL|[?]|(L/day)/(mg/m2/day)|[?]|1|g/mL/(ug/m2/day)|SOFT TISSUE|7|TREATMENT|2020-12-27|93|2020-09-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ec63ad33-0411-4d12-af68-e2cda3a3f1ac|1|SRAUC|Stationarity Ratio AUC|[?]|NON-COMPARTMENTAL|[?]|h*g/mL/m2|[?]|1|h*mg/mL/(kg/m2)|PLASMA|6|TREATMENT|2021-01-30|41|2021-02-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|39f51bd8-5edc-4434-92d4-7d8b683a6c32|1|RCPCIFOS|Pct Rec Infinity Obs Norm by SA|[?]|COMPARTMENTAL|[?]|min*pg/mL/(mg/g/day)|[?]|1|h2*mg/mL|VENOUS PLASMA|5|TREATMENT|2020-10-23|44|2020-10-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|80565a22-8cec-46a2-abd7-91daf0767035|1|VZFO|Vz Obs by F|[?]|NON-COMPARTMENTAL|[?]|GBq/ug|[?]|1|h*fg/mL/(mg/g/day)|ARTERIAL CORD BLOOD|3|WASHOUT|2021-02-16|29|2021-02-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|585a254e-c36b-44cf-b8a9-335fb98e0fd2|1|ERMAXD|Max Excretion Rate Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|h*pg/mL/(kg/m2)|[?]|1|/h|REFLEX TEAR|5|TREATMENT|2020-11-22|44|2020-11-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9ee3632d-4e99-4a46-b0b9-237467d97ca0|1|ARAUCD|Accum Ratio AUCTAU norm by dose|[?]|COMPARTMENTAL|[?]|ng/mL/(ug/m2/day)|[?]|1|nmol/L/(mg/day)|TUMOR TISSUE|6|TREATMENT|2020-09-14|15|2020-11-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|be576e43-f39f-4e7b-9df3-e3a3e1f52d7d|1|PTROUGHR|Peak Trough Ratio|[?]|NON-COMPARTMENTAL|[?]|h*nmol/L/m2|[?]|1|ug/mL/m2|SUPERNATANT, SERUM OR PLASMA|4|TREATMENT|2020-07-24|48|2020-08-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|34b2090b-13ac-4fb2-8d87-eca2839a62f2|1|VZFPS|Vz Pred by F Norm by SA|[?]|COMPARTMENTAL|[?]|h*fg/mL/(mg/g)|[?]|1|day*pmol/L/m2|HAIR|6|TREATMENT|2020-06-21|24|2020-07-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|bfc19b4b-51bb-4056-9195-8bd2db53a497|1|AUMCTAUW|AUMC Over Dosing Interval Norm by WT|[?]|COMPARTMENTAL|[?]|min*pmol/L|[?]|1|pmol/L|ENDOMETRIAL TISSUE|2|TREATMENT|2020-08-29|44|2020-08-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8620aadd-f97d-4bc1-9466-7e5a96ccc66f|1|RNCLINT|Renal CL from T1 to T2|[?]|COMPARTMENTAL|[?]|day*pg/mL/(kg/m2)|[?]|1|L/(mg/m2)|MECONIUM|7|SCREENING|2020-11-13|63|2020-11-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|64a70103-14bf-42f4-808b-fbdecec8bd4f|1|CHTMAX|Concentration at Half Tmax|[?]|NON-COMPARTMENTAL|[?]|ng/mL/(mg/cm2)|[?]|1|fg/mL/kg|PERITONEAL FLUID|5|TREATMENT|2020-10-31|62|2020-10-31|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|00f3949b-b14a-47c5-942c-2ab71e03e40f|1|R2ADJ|R Squared Adjusted|[?]|NON-COMPARTMENTAL|[?]|min*umol/L/m2|[?]|1|g/day|SERUM OR PLASMA|6|TREATMENT|2021-04-02|83|2021-01-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|bf3676e3-b1aa-48cc-b5ae-ac6427d2b7d6|1|AURCIFO|AURC Infinity Obs|[?]|COMPARTMENTAL|[?]|h*pg/mL/(kg/m2)|[?]|1|mol/L/m2|PLASMA ULTRAFILTRATE|5|TREATMENT|2021-02-02|47|2021-03-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c0d878ab-28d2-4c98-b1a9-26cd3fd3fd1e|1|HDER|Hemodialysis Extraction Ratio|[?]|COMPARTMENTAL|[?]|h*g/mL|[?]|1|h*ng/mL/(mg/g/day)|PLEURAL TISSUE|1|TREATMENT|2020-10-01|84|2020-10-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|44ca1fe6-76d2-4a94-9854-1ddbde638803|1|AUCLSTB|AUC to Last Nonzero Conc Norm by BMI|[?]|COMPARTMENTAL|[?]|h|[?]|1|h*nmol/L/(mg/g/day)|INTERSTITIAL FLUID|7|TREATMENT|2020-07-11|2|2020-07-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|edc935ed-3b94-43fa-9b7f-facf6eb6780e|1|VZFTAUB|Vz for Dose Int by F Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|nmol|[?]|1|umol/L/(kg/m2)|MUSCLE TISSUE|6|TREATMENT|2021-02-23|91|2021-01-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f997ad2a-e9b1-4341-96d5-caef4bcb7196|1|ARAUCINT|Accumulation Ratio AUC from T1 to T2|[?]|NON-COMPARTMENTAL|[?]|min*pg/mL/(mg/g)|[?]|1|ng/mL/(ug/m2/day)|DERMAL TISSUE|2|TREATMENT|2020-07-17|49|2020-07-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5a56874f-10e4-4cd0-842f-19552a04d1bd|1|AUMCIFPW|AUMC Infinity Pred Norm by WT|[?]|COMPARTMENTAL|[?]|h*ng/mL/mg|[?]|1|day*mmol/L/m2|CALCULUS|4|WASHOUT|2020-07-29|49|2020-08-31|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f1d4ebe5-fc72-447b-8872-67e971ff471b|1|FB|Fraction Bound|[?]|COMPARTMENTAL|[?]|h*ngEq/mL|[?]|1|min*mg/mL/m2|PLATELET RICH PLASMA|3|TREATMENT|2021-01-21|84|2020-11-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2a141b73-e336-4701-9067-8d51d532596b|1|VZTAUD|Vz for Dose Int Norm by Dose|[?]|COMPARTMENTAL|[?]|h*DNA copies/ug|[?]|1|day*nmol/L/(mg/g)|PERSPIRATION|1|TREATMENT|2020-06-14|12|2020-08-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4adf9a2c-3c43-4289-8156-1a109791580c|1|ARCTROUD|Accum Ratio Ctrough norm by dose|[?]|NON-COMPARTMENTAL|[?]|fg/mL/(mg/m2)|[?]|1|g/mL/(mg/kg/day)|VITREOUS HUMOR|3|FOLLOW-UP|2020-12-17|35|2020-12-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1781d0c2-60c1-49df-98ed-e7dbc63e5b40|1|AUMCIFOS|AUMC Infinity Obs Norm by SA|[?]|COMPARTMENTAL|[?]|h*pgEq/mL|[?]|1|day*mol/L/(mg/g/day)|PERIPHERAL BLOOD MONONUCLEAR CELL|3|TREATMENT|2020-06-17|35|2020-06-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1b2eda86-2d2c-4fdc-a88e-409ea5180603|1|ERINTD|Excret Rate from T1 to T2 Norm by Dose|[?]|COMPARTMENTAL|[?]|mIU/mL/(kg/m2)|[?]|1|h*ugEq/mL/mgEq|SEMEN|1|WASHOUT|2020-07-08|60|2020-08-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|fc02184a-dfba-4964-be3a-cfa5f5d7200e|1|LAMZNTAU|Number of Points for Lambda z TAU|[?]|NON-COMPARTMENTAL|[?]|min*ug/mL/kg|[?]|1|min*mol/L/m2|SEBUM|1|TREATMENT|2020-06-29|44|2020-08-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|37c59cfa-b952-4d16-a675-5e3b3a2e0288|1|ERLSTD|Last Meas Excretion Rate Norm by Dose|[?]|COMPARTMENTAL|[?]|L/(mg/m2)|[?]|1|day*mol/L/(kg/m2)|PLATELET|1|TREATMENT|2020-07-30|72|2020-06-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|11130b2c-e9fd-4a50-87ee-5dfa19199eba|1|VZFOB|Vz Obs by F Norm by BMI|[?]|COMPARTMENTAL|[?]|(L/min)/(kg/m2)|[?]|1|mL/(mg/m2)|LUNG SURFACTANT|4|TREATMENT|2021-03-01|98|2021-02-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|08e4310f-f868-4858-a321-f33a21a771e8|1|ERMAXW|Max Excretion Rate Norm by WT|[?]|COMPARTMENTAL|[?]|day*fg/mL|[?]|1|ng/mL|SUPERNATANT, SERUM|3|SCREENING|2020-07-03|59|2020-06-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|29edf133-8b5b-46d5-bf7a-f75af4658417|1|FLUCP|Fluctuation%|[?]|NON-COMPARTMENTAL|[?]|h*pg/mL/(kg/m2)|[?]|1|mmol/h|DIALYSIS FLUID, PERITONEAL|5|TREATMENT|2020-09-26|45|2020-10-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|49756233-e18f-4187-8d48-3b6b4fa7e5c2|1|AURCIFOS|AURC Infinity Obs Norm by SA|[?]|NON-COMPARTMENTAL|[?]|min*ug/mL/kg|[?]|1|pg/mg|ABSCESS FLUID|7|FOLLOW-UP|2020-08-31|32|2020-10-31|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7a046104-7215-4708-9d85-66683ceb8fe8|1|AUMCIFOS|AUMC Infinity Obs Norm by SA|[?]|COMPARTMENTAL|[?]|(L/day)/mg|[?]|1|IU/mL/(mg/day)|PLATELET RICH PLASMA|5|TREATMENT|2020-12-19|74|2020-10-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6a22373a-8b46-4b5a-94b2-fee3bcd59dda|1|CLSTS|Last Nonzero Conc Norm by SA|[?]|NON-COMPARTMENTAL|[?]|h*ug/mL|[?]|1|min|SKELETAL MUSCLE TISSUE|7|TREATMENT|2021-04-04|78|2021-04-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|bcbe7d50-2ebe-483a-9d71-dce4094f864e|1|RAAUCIFP|Ratio AUC Infinity Pred|[?]|NON-COMPARTMENTAL|[?]|IU/mL/(mg/m2)|[?]|1|(mL/min)/(mg/m2)|SERUM OR PLASMA OR BLOOD|3|TREATMENT|2020-06-29|45|2020-08-05|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2550ba24-7bcf-41e2-9eae-536e13d4b345|1|VZPD|Vz Pred Norm by Dose|[?]|COMPARTMENTAL|[?]|fg/mL/(mg/kg/day)|[?]|1|day*ng/mL/m2|ARTERIALIZED CAPILLARY BLOOD|5|TREATMENT|2021-02-18|39|2021-04-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|aeec3c61-c825-482e-b77e-a9b8e0bb1f68|1|VSSPB|Vol Dist Steady State Pred Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|(L/min)/(ug/m2/day)|[?]|1|h*fg/mL/(mg/g/day)|LEUKOCYTE|6|TREATMENT|2020-08-30|26|2020-11-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6ec23671-252e-4dc9-b919-88254fce68a5|1|CLFOB|Total CL Obs by F Norm by BMI|[?]|COMPARTMENTAL|[?]|min*ng/mL|[?]|1|GBq/uL|PLASMA ULTRAFILTRATE|1|TREATMENT|2020-08-28|41|2020-08-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|db59e5e1-ccda-480b-8955-da5157e16c4a|1|RARECIFO|Ratio Amt Rec Infinity Obs|[?]|NON-COMPARTMENTAL|[?]|h*fg/mL/(mg/g)|[?]|1|mol/L/(ug/kg)|COLOSTRUM|4|TREATMENT|2020-07-10|67|2020-08-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1dce856e-b7cb-4899-b27f-87ab8d918df4|1|AUCIFOUB|AUC Infinity Obs, Unbound Drug|[?]|NON-COMPARTMENTAL|[?]|h*nmol/L/(mg/g/day)|[?]|1|h*pmol/L/(mg/kg)|URINE|1|WASHOUT|2020-11-17|76|2020-11-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7449180b-e226-4e97-a059-8760f6523f77|1|ERINTS|Excret Rate from T1 to T2 Norm by SA|[?]|COMPARTMENTAL|[?]|day*nmol/L/(mg/g/day)|[?]|1|h*mg/mL/(mg/g/day)|PLATELET POOR PLASMA|4|TREATMENT|2020-07-15|21|2020-08-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f077c497-b0f0-4a20-b448-608b0cc6ab36|1|ERLSTD|Last Meas Excretion Rate Norm by Dose|[?]|COMPARTMENTAL|[?]|pmol/L/(mg/m2/day)|[?]|1|umol/L|STRIATED MUSCLE TISSUE|5|TREATMENT|2020-06-30|32|2020-08-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|172f12c6-0d7f-4e9b-be14-b64b94a26f9a|1|RENALCLB|Renal CL Norm by BMI|[?]|COMPARTMENTAL|[?]|min*umol/L/kg|[?]|1|h*mmol/L/g|KERATINOCYTE|1|FOLLOW-UP|2020-08-13|72|2020-07-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3f7c46ac-fe30-4ef3-a581-99c064a85efa|1|AURCALLW|AURC All Norm by WT|[?]|COMPARTMENTAL|[?]|day*pmol/L|[?]|1|min*mmol/L/(kg/m2)|MIXED VENOUS BLOOD|5|FOLLOW-UP|2021-03-15|73|2021-02-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8d944400-df75-4ec7-8fb4-239eb0f6de9d|1|CLFO|Total CL Obs by F|[?]|NON-COMPARTMENTAL|[?]|/day|[?]|1|fg/mL/(mg/m2)|MUSCLE TISSUE|6|TREATMENT|2020-11-10|59|2020-11-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7b201f93-bd8c-4507-a7b7-27a02e364647|1|CAVGW|Average Conc Norm by WT|[?]|COMPARTMENTAL|[?]|min*pmol/L/m2|[?]|1|mL/(mg/kg)|SKIN TISSUE|6|TREATMENT|2021-01-13|31|2021-03-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|fbc3f1fc-c3e7-4db5-8156-77ba9a459073|1|CAVGD|Average Conc Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|L/h|[?]|1|GBq/mg|INFRANATANT, SERUM|2|FOLLOW-UP|2020-08-13|18|2020-10-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3611b798-9b3d-4173-b23e-3017939847e0|1|CLFOD|Total CL Obs by F Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|(L/day)/mg|[?]|1|(L/h)/(ug/m2)|EPITHELIAL CELL|7|TREATMENT|2020-10-01|69|2020-09-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f651799b-9723-4c2c-88d1-de2f347e9a69|1|HDCL|Hemodialysis Clearance|[?]|COMPARTMENTAL|[?]|h*pmol/L/(mg/g)|[?]|1|h*ng/mL/(mg/kg/day)|PLEURAL FLUID|6|FOLLOW-UP|2020-08-05|52|2020-08-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|51c6f0e2-6a67-40cd-aac8-fd4cd0188b42|1|AUCIFOUB|AUC Infinity Obs, Unbound Drug|[?]|COMPARTMENTAL|[?]|min*mg/mL|[?]|1|/h|DIALYSIS FLUID|3|SCREENING|2020-12-09|61|2020-10-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|29b16c31-df0e-493c-a777-46113b904879|1|CLPS|Total CL Pred Norm by SA|[?]|NON-COMPARTMENTAL|[?]|day*fg/mL/(mg/g/day)|[?]|1|min*nmol/L/(mg/g/day)|BONE|6|TREATMENT|2020-08-23|87|2020-07-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|56b7d8fb-23b2-4f0a-9bc6-8e6621937251|1|CLTAUD|Total CL for Dose Int Norm by Dose|[?]|COMPARTMENTAL|[?]|L/(mg/m2/day)|[?]|1|day*g/mL/kg|MONOCYTE|3|TREATMENT|2020-10-26|97|2020-07-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|118914c8-9f6a-47c8-b427-296a99547756|1|AUMCTAU|AUMC Over Dosing Interval|[?]|COMPARTMENTAL|[?]|mol/min|[?]|1|(L/day)/(mg/m2)|BONE|5|TREATMENT|2020-10-29|14|2020-11-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9b936ec9-01d9-4626-8d6d-83f3a1aefd96|1|AUMCIFOW|AUMC Infinity Obs Norm by WT|[?]|NON-COMPARTMENTAL|[?]|min*g/mL|[?]|1|day*fg/mL/g|EPIDERMAL TISSUE|5|TREATMENT|2021-03-01|92|2021-01-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|571cbffe-c3e1-4f18-a9f7-cf11a4058f2c|1|VSSOUB|Vol Dist Steady State Obs by UB|[?]|NON-COMPARTMENTAL|[?]|(h*Bq/g)/(kBq/kg)|[?]|1|L/(ug/day)|CALCULUS|2|TREATMENT|2021-02-10|43|2021-03-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7a5ae465-03b9-4006-a29e-94822ed857aa|1|CLSTW|Last Nonzero Conc Norm by WT|[?]|COMPARTMENTAL|[?]|day*umol/L/(mg/g/day)|[?]|1|IU/mL/(mg/day)|INFRANATANT, PLASMA|5|SCREENING|2020-08-16|55|2020-09-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|179801c9-6c40-4d58-b8a6-6f2cee9c9d58|1|ARCTROUG|Accumulation Ratio Ctrough|[?]|NON-COMPARTMENTAL|[?]|nmol/L/kg|[?]|1|nmol/L/kg|SPERMATOZOON|7|WASHOUT|2020-10-26|44|2020-12-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2e4cd860-734a-40b0-bde5-ca08297415a9|1|VSSPUB|Vol Dist Steady State Pred by UB|[?]|NON-COMPARTMENTAL|[?]|mL/(mg/kg)|[?]|1|h*pg/mL/(mg/kg/day)|PERSPIRATION|3|WASHOUT|2021-02-16|93|2020-12-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3f1854fb-d14e-4699-888b-d5042fa9327c|1|RENALCLB|Renal CL Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|h*nmol/L|[?]|1|(mL/day)/(mg/day)|SERUM|4|WASHOUT|2020-08-28|34|2020-10-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f6e37eba-e224-47f3-baa0-59dfdfb47b70|1|VZFP|Vz Pred by F|[?]|NON-COMPARTMENTAL|[?]|uIU/mL|[?]|1|day*fg/mL/kg|AMNIOTIC FLUID|7|TREATMENT|2021-02-26|88|2020-12-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8298b45d-16ff-42ef-8404-0f3ce628f9e5|1|HDER|Hemodialysis Extraction Ratio|[?]|COMPARTMENTAL|[?]|day*umol/L/(mg/g)|[?]|1|mol/L/(ug/kg/day)|BONE MARROW|3|FOLLOW-UP|2020-08-25|35|2020-10-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ee5c6623-5cb4-4f18-99b0-6373328abc1d|1|RARECINT|Ratio Amt Rec from T1 to T2|[?]|NON-COMPARTMENTAL|[?]|h*umol/L/(kg/m2)|[?]|1|mol/L/(ug/m2)|PLEURAL TISSUE|3|SCREENING|2020-06-03|2|2020-08-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f8d6576b-b300-4c5f-8f5a-6bb35250d576|1|RCPCIFOB|Pct Rec Infinity Obs Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|day*nmol/L/m2|[?]|1|ug/mL/m2|PUS|2|TREATMENT|2020-09-21|98|2020-07-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8635a6b3-d16e-432c-90bf-53f1494dbe5e|1|AURCLSTB|AURC Dosing to Last Conc Norm by BMI|[?]|COMPARTMENTAL|[?]|min*ug/mL/kg|[?]|1|mol/L/(ug/day)|BONE|3|TREATMENT|2021-01-21|97|2020-12-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2cda4297-410a-49e4-949c-deb3dc4c6656|1|R2|R Squared|[?]|NON-COMPARTMENTAL|[?]|IU/mL/mg|[?]|1|h*pmol/L/(kg/m2)|ALVEOLAR AIR|7|FOLLOW-UP|2020-09-08|90|2020-07-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a74b51fe-34f5-4c8f-971f-d42e15f9cf41|1|VZFPW|Vz Pred by F Norm by WT|[?]|NON-COMPARTMENTAL|[?]|min*ug/mL/(mg/g/day)|[?]|1|day*pmol/L/kg|ENDOTRACHEAL FLUID|2|TREATMENT|2021-02-06|18|2021-02-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9e82141b-e2b9-42c7-b813-b79bda2bd216|1|CAVGD|Average Conc Norm by Dose|[?]|COMPARTMENTAL|[?]|pg/mL/m2|[?]|1|min*fg/mL/m2|ISOLATE|5|FOLLOW-UP|2020-07-11|51|2020-07-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4b432c61-c620-4c5e-8aad-411facc0f4db|1|MRTEVLST|MRT Extravasc to Last Nonzero Conc|[?]|COMPARTMENTAL|[?]|(L/min)/mg|[?]|1|mL/day|TISSUE|6|TREATMENT|2020-11-27|84|2020-09-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1a1e6863-26da-4b5d-b82a-5703e3e9056e|1|RAAUCLSD|RatioAUC to Last Nonzero Conc NormByDose|[?]|NON-COMPARTMENTAL|[?]|day*nmol/L/kg|[?]|1|nmol/L/kg|ADIPOSE TISSUE|6|SCREENING|2021-03-20|94|2021-01-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8c8053d1-adae-4d45-870e-cf4ad2475c74|1|C0D|Initial Conc Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|(L/day)/(mg/m2)|[?]|1|mg/min|INTERSTITIAL FLUID|4|TREATMENT|2020-07-29|89|2020-07-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c3b911a8-116e-4940-80a2-7128db004f4a|1|CMAXW|Max Conc Norm by WT|[?]|COMPARTMENTAL|[?]|uIU/mL/(mg/day)|[?]|1|L/mg|INFRANATANT, PLEURAL FLUID|5|FOLLOW-UP|2021-01-31|83|2020-12-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|401d66ba-bc00-4495-ba5d-796068dd1fd6|1|VSSOD|Vol Dist Steady State Obs Norm by Dose|[?]|COMPARTMENTAL|[?]|min*g/mL/kg|[?]|1|RATIO|TRANSUDATE|3|WASHOUT|2020-08-30|90|2020-07-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f8113725-4deb-48a1-876a-ba168a6d2cee|1|RNCLTAUB|Renal CL for Dose Int Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|day*nmol/L/(mg/g/day)|[?]|1|min*ug/mL/g|LAVAGE FLUID|7|WASHOUT|2021-03-15|62|2021-01-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f056c174-b6da-4df6-bf95-2e31911939fb|1|C0S|Initial Conc Norm by SA|[?]|COMPARTMENTAL|[?]|/min|[?]|1|day*fg/mL/kg|SWABBED MATERIAL|3|TREATMENT|2020-12-27|21|2021-03-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b265eb9f-88e1-42d8-83a5-4bc40e46ab54|1|AUCTAUB|AUC Over Dosing Interval Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|(Bq/mL)/(kBq/kg)|[?]|1|mg/dL|RETICULOCYTES|3|SCREENING|2020-10-06|30|2020-11-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|57b7f30f-5f2a-425d-8bf2-fd5915cac481|1|AUCIFPDW|AUCIFPDW Norm by Dose/WT|[?]|NON-COMPARTMENTAL|[?]|h*mmol/L/(mg/g/day)|[?]|1|(L/day)/(kg/m2)|SEMEN|7|SCREENING|2021-02-16|39|2021-02-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|02d9a74a-abc8-4b47-a4d4-a196d339f621|1|NRENLCLW|Nonrenal CL Norm by WT|[?]|COMPARTMENTAL|[?]|day*nmol/L|[?]|1|mL/(ug/kg)|SPERMATOZOON|7|TREATMENT|2020-09-08|4|2020-10-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|81480f83-206f-40c0-a5a4-f75b31cda363|1|CLOS|Total CL Obs Norm by SA|[?]|NON-COMPARTMENTAL|[?]|h*pmol/L/(mg/g)|[?]|1|(L/h)/(ug/kg)|CAPILLARY PLASMA|1|TREATMENT|2020-12-25|43|2021-02-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2b183b69-3ed8-4356-b9e2-0988128de3f2|1|RENALCLB|Renal CL Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|h*ng/mL/(mg/kg/day)|[?]|1|nmol/L/(mg/day)|GASTRIC FLUID|6|TREATMENT|2021-01-04|90|2020-11-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6ed8a749-81c0-4998-817d-efc86cfaa091|1|CTROUGHB|Conc Trough by BMI|[?]|COMPARTMENTAL|[?]|min*pmol/L/(kg/m2)|[?]|1|L/kg|CERUMEN|3|TREATMENT|2020-06-08|13|2020-08-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b0f061e5-5dc0-422d-8d96-e7b1af8bda6b|1|V0B|Vol Dist Initial Norm by BMI|[?]|COMPARTMENTAL|[?]|mL/(mg/day)|[?]|1|mmol/min|HAIR|4|TREATMENT|2021-03-10|61|2021-04-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e6162980-e240-4924-a13a-dde28b2345cd|1|AUCINTD|AUC from T1 to T2 Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|mg/h|[?]|1|(L/day)/(mg/kg)|MUCUS|7|SCREENING|2020-08-04|3|2020-09-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3dc9c666-8be3-4cfa-88d4-b18647e08d00|1|ARAUCIND|Accum Ratio AUC T1 to T2 norm by dose|[?]|COMPARTMENTAL|[?]|IU/mL/(mg/kg/day)|[?]|1|day*mg/mL/m2|BREAST MILK|4|SCREENING|2020-07-29|56|2020-08-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6aed5c2d-d5b1-4969-9a8a-14a79a839dbc|1|CLTAUS|Total CL for Dose Int Norm by SA|[?]|COMPARTMENTAL|[?]|h2*mmol/L|[?]|1|mg/dL|EXPIRED AIR|5|TREATMENT|2021-03-05|51|2021-02-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b3da6961-98dc-4f83-9cf4-dbc7f4a91c61|1|TLST|Time of Last Nonzero Conc|[?]|NON-COMPARTMENTAL|[?]|day*fg/mL/(mg/g/day)|[?]|1|ug/mL/(mg/kg)|PLATELET|2|TREATMENT|2021-01-31|83|2020-12-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2738b933-c71d-4239-a093-6b4aa7cc41df|1|FREXINT|Fract Excr from T1 to T2|[?]|NON-COMPARTMENTAL|[?]|h2*mol/L|[?]|1|(L/min)/(ug/m2)|SPUTUM|2|TREATMENT|2020-05-23|5|2020-08-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|68b9ff4e-9694-4545-a752-4d3ac0e89fda|1|RCPCIFP|Pct Rec Infinity Pred|[?]|COMPARTMENTAL|[?]|(L/min)/kg|[?]|1|mIU/mL/kg|CEREBROSPINAL FLUID|6|SCREENING|2021-04-06|98|2021-01-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0f0ec179-5100-4a3d-9f93-54140aca7d30|1|AUMCTAUB|AUMC Over Dosing Interval Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|(L/min)/(mg/m2/day)|[?]|1|(L/day)/mg|ALVEOLAR AIR|7|SCREENING|2020-09-09|25|2020-09-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6affe43d-e455-40af-8478-dc38019e89e1|1|AUCIFPD|AUC Infinity Pred Norm by Dose|[?]|COMPARTMENTAL|[?]|IU/mL/ug|[?]|1|(mL/h)/(mg/m2/day)|RETICULOCYTES|2|TREATMENT|2020-07-11|34|2020-08-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1c090c96-0a6c-45dd-b862-0aa3d9d579cb|1|CLTAU|Total CL for Dose Int|[?]|COMPARTMENTAL|[?]|h*pg/mL/(mg/kg)|[?]|1|mg/kg|LYMPH|2|WASHOUT|2020-07-16|49|2020-06-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e0258c95-7bcc-4b54-895c-f290a1364b5c|1|AUCALLW|AUC All Norm by WT|[?]|COMPARTMENTAL|[?]|h*umol/L/(mg/g/day)|[?]|1|min*nmol/L/kg|SUPERNATANT, PLASMA|2|WASHOUT|2021-02-16|61|2021-03-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7218f9ae-0119-4633-a8d3-7d98b2ae1671|1|CLOW|Total CL Obs Norm by WT|[?]|COMPARTMENTAL|[?]|(L/min)/(kg/m2)|[?]|1|min*fg/mL/(mg/g/day)|DIALYSIS FLUID|6|WASHOUT|2021-01-16|13|2021-02-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f8c938ff-21c8-4d0b-9335-08d2865543ab|1|V0D|Vol Dist Initial Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|(L/h)/(ug/day)|[?]|1|(L/h)/(ug/day)|SERUM|4|TREATMENT|2020-05-15|14|2020-06-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7176f852-7392-4636-800f-3aad48e93065|1|MRAUCTAU|Metabolite Ratio for AUC Dosing Interval|[?]|COMPARTMENTAL|[?]|IU/mL/m2|[?]|1|fg/mL/ug|SOFT TISSUE|5|TREATMENT|2021-02-22|47|2021-03-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|753d5d9d-ec84-46f5-a933-b18b8e3a6b0e|1|AUMCIFPD|AUMC Infinity Pred Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|IU|[?]|1|pg/mg|HAIR|6|SCREENING|2020-10-05|7|2021-01-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|69e41d6b-57f7-48b0-be7a-29fca953f8d9|1|RCAMIFOB|Amt Rec Infinity Obs Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|day*mmol/L/(mg/g/day)|[?]|1|min*ng/mL|EXHALED BREATH CONDENSATE|7|WASHOUT|2021-01-13|87|2020-11-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a38eb4fc-2422-4d4a-a435-58ae9bf42589|1|CLOW|Total CL Obs Norm by WT|[?]|NON-COMPARTMENTAL|[?]|pmol/L/(mg/kg/day)|[?]|1|mL/h|RETICULOCYTES|4|FOLLOW-UP|2021-01-11|59|2021-01-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|12ae2530-f9f6-4e7d-9daa-fdfaacb1c747|1|CONCW|Conc by WT|[?]|NON-COMPARTMENTAL|[?]|(L/h)/g|[?]|1|fg/mL/g|SKIN TISSUE|3|TREATMENT|2020-11-30|75|2020-10-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|29e42c28-c2f8-4c27-9a6d-12f0d5fa4ab3|1|RCPCIFOB|Pct Rec Infinity Obs Norm by BMI|[?]|COMPARTMENTAL|[?]|(h*Bq/mL)/(kBq/kg)|[?]|1|ng/mL/(mg/day)|LUNG SURFACTANT|6|WASHOUT|2021-03-23|91|2021-03-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|dd518f55-0280-445d-a29f-10f09b21fd53|1|RCAMIFOS|Amt Rec Infinity Obs Norm by SA|[?]|COMPARTMENTAL|[?]|IU/mL/(mg/kg/day)|[?]|1|min*g/mL/m2|PUS|4|WASHOUT|2020-06-03|26|2020-05-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|49a972da-dfad-438e-b5bc-26ee6b955a59|1|AURCINTD|AURC from T1 to T2 Norm by Dose|[?]|COMPARTMENTAL|[?]|(mL/day)/(mg/day)|[?]|1|mIU/mL/m2|MUSCLE TISSUE|3|TREATMENT|2020-08-16|63|2020-07-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|502a42a7-2ed6-46b9-9b10-728f849334b6|1|VZOS|Vz Obs Norm by SA|[?]|COMPARTMENTAL|[?]|(L/day)/(mg/day)|[?]|1|(L/h)/(ug/m2/day)|HAIR FOLLICLE|4|FOLLOW-UP|2020-12-06|25|2020-12-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|61cce2a8-16d6-4cb3-91fc-71f1f2f02551|1|CLRPCLEV|Renal CL as Pct CL EV|[?]|NON-COMPARTMENTAL|[?]|ug/mL/(kg/m2)|[?]|1|kBq|LYMPH|4|FOLLOW-UP|2020-12-16|61|2021-01-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|40c048ea-d637-426b-8afe-2da3a6961528|1|VZPB|Vz Pred Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|GBq/uL|[?]|1|h*umol/L|DIALYSIS FLUID, PERITONEAL|2|WASHOUT|2020-10-05|94|2020-09-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4d03b209-bd53-47f5-8251-f9fb2074bc38|1|AUCIFPD|AUC Infinity Pred Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|mmol/L/ug|[?]|1|nmol/L/(ug/m2)|INTERSTITIAL FLUID|2|WASHOUT|2021-01-19|27|2021-02-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|35f01eda-1acb-4700-8285-c8cd4b69b524|1|AUMCIFPB|AUMC Infinity Pred Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|day*pmol/L/m2|[?]|1|(Bq/g)/(kBq/kg)|DERMAL TISSUE|3|TREATMENT|2020-10-24|34|2020-10-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9df97277-7d07-4020-bae0-dfa982f21c8d|1|RACAVG|Ratio Average Concentration|[?]|COMPARTMENTAL|[?]|day*pmol/L/kg|[?]|1|%|STOOL|4|TREATMENT|2021-01-24|93|2020-11-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d1b522d5-557a-4361-a9da-292aa601fbc3|1|TLAG|Time Until First Nonzero Conc|[?]|COMPARTMENTAL|[?]|ug/mL/(kg/m2)|[?]|1|ug/mL/m2|DIALYSIS FLUID, PERITONEAL|5|TREATMENT|2021-01-05|98|2020-10-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c6343fe8-6005-4fe8-b3e6-cfcb56c2d360|1|RCPCIFOS|Pct Rec Infinity Obs Norm by SA|[?]|COMPARTMENTAL|[?]|(L/day)/(mg/kg/day)|[?]|1|ng/mL/(ug/day)|LAVAGE FLUID|5|TREATMENT|2020-08-30|44|2020-08-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|da2d0844-3608-4927-9103-cb7c52dd2c96|1|CLFTAU|Total CL by F for Dose Int|[?]|NON-COMPARTMENTAL|[?]|h*pg/mL/(mg/g)|[?]|1|ng/mL/(mg/kg/day)|BONE|4|FOLLOW-UP|2021-01-22|6|2021-03-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|30b6f8a7-4512-462d-a162-45c3dad853e5|1|RCAMINTS|Amt Rec from T1 to T2 Norm by SA|[?]|COMPARTMENTAL|[?]|h*pg/mL/(kg/m2)|[?]|1|mg/kg|SPUTUM|2|FOLLOW-UP|2021-01-21|60|2021-01-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1a3808b9-6004-4133-8f59-49905d04655e|1|ERMAX|Max Excretion Rate|[?]|NON-COMPARTMENTAL|[?]|mmol/L/ug|[?]|1|nmol/min|CERVICOVAGINAL SECRETION|4|SCREENING|2020-12-21|54|2020-11-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5c91894d-c756-4ade-9fc4-2a64d4acc53f|1|AUCINTD|AUC from T1 to T2 Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|min*mol/L/(kg/m2)|[?]|1|min*mg/mL/(mg/g/day)|MUSCLE TISSUE|7|WASHOUT|2021-02-13|35|2021-03-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|cc9d17ea-ec8b-46bb-af7d-ad19da3cfb20|1|VZOB|Vz Obs Norm by BMI|[?]|COMPARTMENTAL|[?]|min*mmol/L/g|[?]|1|nmol/L/(kg/m2)|CORD SERUM|6|SCREENING|2020-08-15|41|2020-08-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4a6cff44-d7c3-410f-afe0-a11ae0e8872b|1|CTROUGH|Conc Trough|[?]|COMPARTMENTAL|[?]|g/mL/(ug/m2)|[?]|1|pmol/L/(mg/m2/day)|WHITE MATTER TISSUE|1|TREATMENT|2020-11-16|72|2020-10-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|35fd3f79-60b3-4101-ab79-952ca0e8f1ce|1|CAVGS|Average Conc Norm by SA|[?]|COMPARTMENTAL|[?]|/h|[?]|1|day*ug/mL/(mg/g/day)|VITREOUS HUMOR|2|FOLLOW-UP|2020-07-09|39|2020-08-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|37610314-f803-4ffa-a584-ebfe09267a0d|1|CLPD|Total CL Pred Norm by Dose|[?]|COMPARTMENTAL|[?]|nmol/h|[?]|1|IU/mL/mg|DISCHARGE|3|TREATMENT|2020-08-19|60|2020-08-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|760ec5ce-3ae7-4268-9f76-b83085ad3754|1|AUMCIFPB|AUMC Infinity Pred Norm by BMI|[?]|COMPARTMENTAL|[?]|min*mg/mL/m2|[?]|1|(mL/min)/m2|VENOUS CORD BLOOD|5|SCREENING|2020-10-09|25|2020-11-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|13773a62-50b1-4b2a-a5c7-ec0e0245a97e|1|CLP|Total CL Pred|[?]|NON-COMPARTMENTAL|[?]|day*mmol/L/(mg/g/day)|[?]|1|h*g/mL/(mg/g)|RETICULOCYTES|7|FOLLOW-UP|2020-07-17|42|2020-07-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d0a9940e-a75f-4fcc-8d0c-5a8dae7d9344|1|RNCLINTS|Renal CL from T1 to T2 Norm by SA|[?]|COMPARTMENTAL|[?]|min*mg/mL/m2|[?]|1|(L/h)/(ug/m2/day)|PERSPIRATION|7|FOLLOW-UP|2021-03-28|73|2021-03-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8f0ff98a-fd19-4c9f-87ec-96200ced0f82|1|AUMCIFP|AUMC Infinity Pred|[?]|NON-COMPARTMENTAL|[?]|(mL/h)/(mg/kg/day)|[?]|1|day*g/mL/m2|KERATINOCYTE|4|TREATMENT|2021-01-05|63|2021-01-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d7b41e15-6725-4433-8a35-72629e342b47|1|CLFTAUS|Total CL by F for Dose Int Norm by SA|[?]|COMPARTMENTAL|[?]|nmol/L/(mg/kg/day)|[?]|1|h*ug/mL/(mg/g/day)|LUNG SURFACTANT|4|WASHOUT|2020-11-30|87|2020-11-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|aeddc1ed-545c-405e-b1f7-08131961f5ff|1|ERTLST|Midpoint of Interval of Last Nonzero ER|[?]|NON-COMPARTMENTAL|[?]|(L/day)/(mg/day)|[?]|1|mg/mL/(mg/day)|SYNOVIAL FLUID|3|TREATMENT|2020-11-08|34|2020-12-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3effe272-6a68-4163-a4f3-bd269af6061c|1|AURCLSTS|AURC Dosing to Last Conc Norm by SA|[?]|COMPARTMENTAL|[?]|(L/h)/(ug/m2)|[?]|1|min*umol/L/(mg/g/day)|ISOLATE|4|WASHOUT|2021-04-10|95|2021-01-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8153c765-a92a-4b0f-9ef3-6ca925337f54|1|AUCINTB|AUC from T1 to T2 Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|nmol/L/(kg/m2)|[?]|1|L/(ug/m2/day)|VENOUS PLASMA|1|TREATMENT|2020-10-18|29|2020-10-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8d27cdcf-768e-4630-95b5-da554f6f3b56|1|ERLSTD|Last Meas Excretion Rate Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|min*mol/L/(kg/m2)|[?]|1|day*mmol/L/(mg/g/day)|URINE SEDIMENT|1|TREATMENT|2021-01-02|74|2021-01-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5c2791ff-aaf6-413f-9827-6e97e2273388|1|CLFOD|Total CL Obs by F Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|uIU/mL/(kg/m2)|[?]|1|ug/mL/(kg/m2)|EPIDERMAL TISSUE|1|FOLLOW-UP|2020-11-29|94|2020-09-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b336d8c2-7bca-404e-aea3-5148d559ea99|1|C0B|Initial Conc Norm by BMI|[?]|COMPARTMENTAL|[?]|ug/mL/m2|[?]|1|h2*mg/mL|EMESIS|6|FOLLOW-UP|2020-11-02|54|2020-10-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|702b2f8f-63b9-44c1-a46d-1a41bc837c32|1|VZOD|Vz Obs Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|min*mg/mL/(mg/g/day)|[?]|1|mol/L/(kg/m2)|MIXED VENOUS BLOOD|7|TREATMENT|2020-07-02|25|2020-06-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1261eee1-f073-4419-b0b7-28abd0ec1513|1|ARCMAX|Accumulation Ratio Cmax|[?]|NON-COMPARTMENTAL|[?]|nmol/min|[?]|1|h*ug/mL/(mg/kg)|PLEURAL TISSUE|4|TREATMENT|2020-10-27|36|2020-09-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|46eefdf3-c314-4e61-963c-ce7f48c636e5|1|AUCALLB|AUC All Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|uIU/mL/(mg/m2/day)|[?]|1|day*ng/mL/(kg/m2)|SKELETAL MUSCLE TISSUE|7|TREATMENT|2021-02-11|54|2021-03-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f632159b-8c91-4f0d-81cb-e5b9195588c9|1|VSSPW|Vol Dist Steady State Pred Norm by WT|[?]|NON-COMPARTMENTAL|[?]|h*pmol/L/(mg/g)|[?]|1|mIU/mL/m2|SMOOTH MUSCLE TISSUE|3|FOLLOW-UP|2021-02-06|35|2021-02-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|898a9d2f-338b-41bf-8ac0-c4a025481349|1|VSSOF|Vol Dist Steady State Obs by F|[?]|COMPARTMENTAL|[?]|day*umol/L/(kg/m2)|[?]|1|mmol|PLASMA ULTRAFILTRATE|6|TREATMENT|2020-07-04|51|2020-07-31|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|db3824aa-375d-4e40-a14b-af0e4460914e|1|MAT|Mean Absorption Time|[?]|COMPARTMENTAL|[?]|mL/(mg/m2/day)|[?]|1|(L/day)/(ug/kg)|BLOOD|5|FOLLOW-UP|2020-08-02|84|2020-06-05|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0ea6be64-32f8-4e10-b993-687ea200e4e9|1|VZFPW|Vz Pred by F Norm by WT|[?]|COMPARTMENTAL|[?]|(L/day)/(kg/m2)|[?]|1|IU/day|BUFFY COAT|4|SCREENING|2021-04-01|73|2021-03-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|18504c4e-41c8-4c1a-a479-d179ccd318e3|1|ERLST|Last Meas Excretion Rate|[?]|COMPARTMENTAL|[?]|fg/mL/(mg/day)|[?]|1|uIU/mL/(mg/m2/day)|BONE|6|TREATMENT|2020-07-25|43|2020-07-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7f211d8a-7478-4082-8d95-4ace9ceee919|1|CLFTAU|Total CL by F for Dose Int|[?]|COMPARTMENTAL|[?]|fg/mL/(mg/kg)|[?]|1|ng/day|CAPILLARY PLASMA|5|TREATMENT|2020-08-20|11|2020-10-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0739e140-bcac-4df9-9629-bd0748d1fdd6|1|V0|Vol Dist Initial|[?]|COMPARTMENTAL|[?]|L/ug|[?]|1|(mL/min)/(mg/day)|SMOOTH MUSCLE TISSUE|3|TREATMENT|2020-10-27|28|2020-11-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4d44daf5-8ebc-4d4f-aa33-e8ab9f5442e0|1|C0D|Initial Conc Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|L/(mg/kg)|[?]|1|IU/h|DIALYSIS FLUID, PERITONEAL|2|TREATMENT|2021-03-17|96|2020-12-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f24b931a-2cdd-4432-a1dd-69c7286f4690|1|AURCINTD|AURC from T1 to T2 Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|g/mL/(ug/kg)|[?]|1|uIU/mL/(mg/kg)|ARTERIAL CORD BLOOD|6|SCREENING|2020-07-03|59|2020-06-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d394120d-7630-4fcf-a336-482599d88296|1|VZOUB|Vz Obs for UB|[?]|NON-COMPARTMENTAL|[?]|mIU/mL|[?]|1|h*ug/g|INTERSTITIAL FLUID|3|TREATMENT|2021-03-31|78|2021-04-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|bcda1d95-58ed-4991-9395-0b98efc1d9a1|1|MRTIVLST|MRT Intravasc to Last Nonzero Conc|[?]|COMPARTMENTAL|[?]|min*pmol/L/m2|[?]|1|IU/mL/(ug/m2)|LUNG SURFACTANT|4|SCREENING|2021-01-14|95|2020-12-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6999bd5c-0790-42b8-a4ff-e538776b0fb0|1|RAAUCINT|Ratio AUC from T1 to T2|[?]|COMPARTMENTAL|[?]|min*fg/mL|[?]|1|(mL/min)/(kg/m2)|WHITE MATTER TISSUE|2|TREATMENT|2020-11-06|93|2020-09-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5934d59a-b0f4-4377-a3c3-00d434d3ddfd|1|RAAUCALL|Ratio AUC All|[?]|COMPARTMENTAL|[?]|h*mol/L|[?]|1|L/(mg/day)|SEMINAL FLUID|5|SCREENING|2020-12-19|8|2020-12-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|59b0fee3-2294-448e-9837-38bd6b5c794b|1|RAMAXMIN|Ratio of CMAX to CMIN|[?]|NON-COMPARTMENTAL|[?]|min*pmol/L/(mg/g/day)|[?]|1|day*pmol/L|EMESIS|7|WASHOUT|2021-03-26|94|2021-01-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d9bdb1e3-4630-423f-be01-4873bce30422|1|VSSOB|Vol Dist Steady State Obs Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|uIU/mL/(mg/kg)|[?]|1|fg/mL/kg|ABSCESS FLUID|7|TREATMENT|2021-01-09|28|2021-01-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7a2e5851-3c3e-46b4-876f-7dd6c8005f9a|1|AUMCIFOB|AUMC Infinity Obs Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|h*DNA copies/ug|[?]|1|nmol/L|LOCHIA|2|SCREENING|2020-08-13|59|2020-08-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5546d86b-6a12-4b5f-b66f-8d85ba4691e6|1|ARAUCINT|Accumulation Ratio AUC from T1 to T2|[?]|COMPARTMENTAL|[?]|mL/(mg/kg)|[?]|1|fg/mL/m2|SOFT TISSUE|6|TREATMENT|2020-10-14|81|2020-10-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|933c3a61-59a0-4cfb-ae17-45bc48229323|1|RACMIN|Ratio Min Conc|[?]|COMPARTMENTAL|[?]|pg/h|[?]|1|pmol/L/(mg/m2)|SUPERNATANT, SERUM|3|TREATMENT|2020-09-18|19|2020-09-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|58d871e3-ef99-48da-ab12-fdfdc2e01da6|1|ERLSTS|Last Meas Excretion Rate Norm by SA|[?]|NON-COMPARTMENTAL|[?]|day*ng/mL/(kg/m2)|[?]|1|h*ng/mL/g|BUFFY COAT|3|TREATMENT|2021-01-22|98|2020-11-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ac66129e-3244-4cd8-a235-43b4bfb7dace|1|VSSOS|Vol Dist Steady State Obs Norm by SA|[?]|NON-COMPARTMENTAL|[?]|min*fg/mL/(mg/g/day)|[?]|1|umol/min|CALCULUS|5|TREATMENT|2020-12-11|53|2021-01-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2f2297c4-ed0a-45c2-bbd9-13c945abb67b|1|ARCMIND|Accum Ratio Cmin norm by dose|[?]|NON-COMPARTMENTAL|[?]|h2*nmol/L|[?]|1|(L/day)/(mg/kg)|COLOSTRUM|5|WASHOUT|2020-09-12|20|2020-10-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3d59a754-10bb-4847-93ea-433b43265a2f|1|NRENLCLD|Nonrenal CL Norm by Dose|[?]|COMPARTMENTAL|[?]|mol/day|[?]|1|g/mL/(ug/m2)|TUMOR TISSUE|6|TREATMENT|2021-01-21|99|2020-11-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0d3d37a5-2215-4b28-b6f7-7256abcdd97e|1|RCAMINTB|Amt Rec from T1 to T2 Norm by BMI|[?]|COMPARTMENTAL|[?]|min*fg/mL/m2|[?]|1|fg/mL/(ug/day)|EXHALED BREATH CONDENSATE|3|SCREENING|2021-02-24|45|2021-03-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|89209495-c485-4eb7-b858-8dc5490d2b64|1|VZTAUD|Vz for Dose Int Norm by Dose|[?]|COMPARTMENTAL|[?]|(mL/day)/(kg/m2)|[?]|1|min*g/mL/(mg/g/day)|CERUMEN|4|TREATMENT|2020-09-18|21|2020-11-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d80522bb-f146-4270-a6e1-326fde50d9ca|1|RCPCIFP|Pct Rec Infinity Pred|[?]|COMPARTMENTAL|[?]|pg/mL/(mg/kg/day)|[?]|1|IU/mL/(ug/kg/day)|SPERMATOZOON|3|TREATMENT|2020-12-29|8|2021-02-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3982a462-95f6-4e71-93e5-9df777770067|1|CAVG|Average Concentration|[?]|NON-COMPARTMENTAL|[?]|day*mg/mL|[?]|1|umol/day|HAIR|6|TREATMENT|2021-01-30|46|2021-01-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f3a3a6ca-2344-4cee-a6a5-59beee9304df|1|AUCIFPUB|AUC Infinity Pred, Unbound Drug|[?]|COMPARTMENTAL|[?]|mg/dL|[?]|1|mIU/mL/kg|COLOSTRUM|4|TREATMENT|2021-01-18|80|2021-01-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|175cfd82-a6fe-463b-81e5-07ae9e1253db|1|AUCIFODW|AUC Infinity Obs Norm by Dose/WT|[?]|NON-COMPARTMENTAL|[?]|pg/day|[?]|1|mmol/L/(ug/day)|LYSATE|2|FOLLOW-UP|2020-06-29|44|2020-08-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e19b469c-40d5-4506-8233-a86bebde880d|1|V0S|Vol Dist Initial Norm by SA|[?]|COMPARTMENTAL|[?]|pmol/L/(mg/day)|[?]|1|mmol/L/(ug/kg)|SALIVA|4|SCREENING|2021-01-25|13|2021-03-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f280a4a5-9826-4d77-adf1-992284cb3314|1|CLO|Total CL Obs|[?]|NON-COMPARTMENTAL|[?]|h*pg/mL/(mg/kg/day)|[?]|1|min*pmol/L/kg|INFRANATANT, PLASMA|3|WASHOUT|2021-02-19|72|2021-02-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|82840929-7800-4254-b60a-8af4786664f6|1|AUMCTAUW|AUMC Over Dosing Interval Norm by WT|[?]|NON-COMPARTMENTAL|[?]|mol/L/ug|[?]|1|mmol/h|EMESIS|1|FOLLOW-UP|2020-06-24|30|2020-08-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|dae25bdb-38fd-4852-9a9a-7627368e9497|1|MRAUCLST|Metabolite Ratio AUC Last Nonzero Conc|[?]|NON-COMPARTMENTAL|[?]|nmol/L/(ug/kg/day)|[?]|1|mg/mL/m2|PLATELET|1|TREATMENT|2020-10-23|61|2020-09-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9e009737-cd77-4b96-a4af-e9731ef7e9d0|1|C0B|Initial Conc Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|ng/mL/(mg/m2/day)|[?]|1|h*mmol/L|PLATELET RICH PLASMA|5|TREATMENT|2020-12-21|87|2020-11-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e7468d01-71b3-47c4-9715-62fe143364cb|1|AURCIFPD|AURC Infinity Pred Norm by Dose|[?]|COMPARTMENTAL|[?]|GBq/ug|[?]|1|mmol/L/(mg/kg)|SUPERNATANT, SERUM|5|TREATMENT|2020-11-03|29|2020-11-05|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6a021859-1b18-4eb5-9548-0e32c0c1edf7|1|CAVINTDW|CAVGINT Norm by Dose/WT|[?]|NON-COMPARTMENTAL|[?]|%|[?]|1|ngEq/mL|RETICULOCYTES|3|SCREENING|2020-06-04|27|2020-07-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|eb409ec5-4c02-41c8-a11f-03d990818c2a|1|RACMAX|Ratio CMAX|[?]|NON-COMPARTMENTAL|[?]|h*ng/mL/(mg/kg)|[?]|1|ug/mL/m2|INTERSTITIAL FLUID|2|TREATMENT|2020-12-30|31|2021-03-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2178f542-809d-4306-84e4-26d3b3b370b0|1|AUCLSTLN|AUC to Last Nonzero Conc LN Transformed|[?]|NON-COMPARTMENTAL|[?]|(L/day)/(ug/m2)|[?]|1|ng/mL/(mg/kg)|BREAST MILK|5|TREATMENT|2021-01-09|74|2020-11-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|da7423fb-461e-43a6-bcb9-aa87051bda0a|1|CHTMAX|Concentration at Half Tmax|[?]|NON-COMPARTMENTAL|[?]|pgEq/mL/mgEq|[?]|1|uIU/mL/(mg/day)|CIRCULATING TUMOR CELL|7|WASHOUT|2020-10-29|35|2020-10-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|40e4c69f-6115-4f0e-8555-45b12b222801|1|AUCLSTLN|AUC to Last Nonzero Conc LN Transformed|[?]|COMPARTMENTAL|[?]|ug/mL|[?]|1|(L/day)/(ug/day)|MONOCYTE|3|SCREENING|2021-02-24|35|2021-03-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1307d7f6-acb6-4096-a907-08345548a82b|1|ERTMAX|Midpoint of Interval of Maximum ER|[?]|NON-COMPARTMENTAL|[?]|ng/mL/kg|[?]|1|(mL/h)/(mg/kg)|BUFFY COAT|5|TREATMENT|2020-08-07|81|2020-08-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|bac23835-1120-43b2-9d99-694bef97f44b|1|CLFTAUD|Total CL by F for Dose Int Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|(L/min)/(ug/m2/day)|[?]|1|min*g/mL/(mg/g)|EMOTIONAL TEAR|7|FOLLOW-UP|2020-07-06|56|2020-07-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8cf8f8a1-5c55-4f82-b6bc-109acdf5b514|1|TMAX|Time of CMAX|[?]|NON-COMPARTMENTAL|[?]|GBq|[?]|1|min*ug/mL/(mg/g/day)|BONE MARROW MONONUCLEAR CELL|2|FOLLOW-UP|2020-09-28|14|2020-11-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|14cd64f5-f3c8-47a4-b40e-9c5090890870|1|ERINT|Excret Rate from T1 to T2|[?]|NON-COMPARTMENTAL|[?]|mIU/mL/(mg/m2/day)|[?]|1|ugEq/g|CORD BLOOD|5|FOLLOW-UP|2020-10-23|39|2020-12-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ca4a06be-5e6a-4220-9854-e5fe02b384af|1|AUCIFOLN|AUC Infinity Obs LN Transformed|[?]|COMPARTMENTAL|[?]|L/(mg/day)|[?]|1|day*nmol/L|BUFFY COAT|2|SCREENING|2020-11-29|67|2020-11-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|55504c69-a659-402b-a0cb-95ab4e08c086|1|CLFPB|Total CL Pred by F Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|h*ug/mL/m2|[?]|1|g/mL/(ug/kg)|LUNG SURFACTANT|7|TREATMENT|2021-02-01|28|2021-02-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|bffa468a-a27b-4e87-a60d-b5787a03c6f6|1|MRTIVLST|MRT Intravasc to Last Nonzero Conc|[?]|NON-COMPARTMENTAL|[?]|day*nmol/L|[?]|1|mmol/L/(ug/kg)|EXUDATE|1|TREATMENT|2021-02-24|96|2020-12-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2e25aa76-914f-41e3-82ce-7c56ba2f6271|1|AURCLSTB|AURC Dosing to Last Conc Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|h*mol/L/(mg/g/day)|[?]|1|ug/dL|COLOSTRUM|1|FOLLOW-UP|2021-02-09|70|2021-01-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|12c24fff-080b-4889-a455-ff55d5c0536c|1|R2|R Squared|[?]|NON-COMPARTMENTAL|[?]|(L/min)/(mg/m2)|[?]|1|h*pmol/L/m2|VENOUS BLOOD|3|SCREENING|2021-02-18|32|2021-03-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|aecfe062-4e0d-4c91-8b67-1f304c5765ae|1|AUMCLSTS|AUMC to Last Nonzero Conc Norm by SA|[?]|NON-COMPARTMENTAL|[?]|pmol/L/ug|[?]|1|(Bq/mL)/(kBq/kg)|ARTERIAL BLOOD|6|SCREENING|2021-02-15|35|2021-03-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|05a142dc-a779-44cb-ab2e-f961676a3940|1|CLOW|Total CL Obs Norm by WT|[?]|NON-COMPARTMENTAL|[?]|day*fg/mL/(kg/m2)|[?]|1|min*g/mL/(mg/g/day)|INFRANATANT, PLEURAL FLUID|6|SCREENING|2020-11-19|11|2021-01-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|498524c5-08c4-41a4-af81-876ab2452f64|1|CAVGINTS|Average Conc from T1 to T2 Norm by SA|[?]|NON-COMPARTMENTAL|[?]|L/(ug/m2/day)|[?]|1|mmol/min|CORD BLOOD|2|TREATMENT|2021-01-21|53|2021-01-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|93490930-01cd-470e-81a3-bcd7a140ccc1|1|CAVGS|Average Conc Norm by SA|[?]|NON-COMPARTMENTAL|[?]|fg/mL/(kg/m2)|[?]|1|(L/min)/(ug/m2)|ABSCESS FLUID|2|SCREENING|2021-01-24|78|2020-12-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|fd588c97-c57f-432f-81a0-a116a017c5dd|1|AUCALLW|AUC All Norm by WT|[?]|COMPARTMENTAL|[?]|min*ug/mL/(mg/g)|[?]|1|(mL/h)/(mg/day)|EXPIRED AIR|5|FOLLOW-UP|2020-07-01|38|2020-08-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|18028efc-33b9-4741-a47a-8fdac0a90e6e|1|AURCALLW|AURC All Norm by WT|[?]|COMPARTMENTAL|[?]|mol/L/(ug/day)|[?]|1|nmol/L/(ug/kg)|ISOLATE|2|FOLLOW-UP|2021-02-16|66|2021-01-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ec47a40e-dd7f-47ee-b571-d91ce72c1cf1|1|ERTMAX|Midpoint of Interval of Maximum ER|[?]|NON-COMPARTMENTAL|[?]|h*umol/L/kg|[?]|1|h*pmol/L/m2|ARTERIAL BLOOD|2|SCREENING|2020-07-18|54|2020-06-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|08fccce4-64bf-431e-81b0-a96566e77df6|1|AUMCTAUW|AUMC Over Dosing Interval Norm by WT|[?]|NON-COMPARTMENTAL|[?]|(mL/min)/(mg/m2/day)|[?]|1|min*fg/mL/kg|PUS|6|TREATMENT|2021-02-04|25|2021-01-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0354fab5-5636-4504-8345-af060ad4c90c|1|LAMZHL|Half-Life Lambda z|[?]|NON-COMPARTMENTAL|[?]|h*umol/L/(kg/m2)|[?]|1|(L/day)/mg|ERYTHROCYTES|3|TREATMENT|2021-02-09|27|2021-02-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f4f1a53a-d621-4f75-b44e-96b959aed03d|1|VZTAUB|Vz for Dose Int Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|day|[?]|1|h*pg/mL|URINE|4|SCREENING|2021-03-19|79|2021-03-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ed392c1a-0167-4ee9-b208-8b0c8d314bb4|1|RCPCIFOW|Pct Rec Infinity Obs Norm by WT|[?]|COMPARTMENTAL|[?]|min*ng/mL|[?]|1|nmol/L/kg|WHITE MATTER TISSUE|5|FOLLOW-UP|2020-10-24|33|2020-12-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|679423a4-92cf-4a93-8277-282f9b43f2ed|1|ERMAX|Max Excretion Rate|[?]|COMPARTMENTAL|[?]|day*pmol/L|[?]|1|day*ug/mL/kg|VENOUS BLOOD|7|SCREENING|2020-09-15|53|2020-08-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|fb686cda-337b-46aa-b67b-790414201d9a|1|CLSTD|Last Nonzero Conc Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|(mL/h)/m2|[?]|1|day*pg/mL/(mg/g/day)|SKELETAL MUSCLE TISSUE|6|TREATMENT|2020-08-16|92|2020-06-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|98d3c31c-8b79-4d8a-a39e-21b0a3fa653b|1|RAAUCTAU|Ratio AUC Over Dosing Interval|[?]|NON-COMPARTMENTAL|[?]|day*mol/L/(mg/g/day)|[?]|1|L/(kg/m2)|ADIPOSE TISSUE|1|FOLLOW-UP|2020-10-14|19|2020-11-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|92d7a180-9353-41f8-93e2-ebcee32a1c63|1|NRENALCL|Nonrenal CL|[?]|NON-COMPARTMENTAL|[?]|day*pmol/L|[?]|1|umol|KERATINOCYTE|2|TREATMENT|2021-01-04|39|2020-12-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5da18fbc-1274-4cb3-bb6b-b57872b9815b|1|AUCLSTD|AUC to Last Nonzero Conc Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|day*mg/mL/(mg/g/day)|[?]|1|(L/min)/(mg/m2)|WHITE MATTER TISSUE|6|TREATMENT|2020-11-12|36|2021-01-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|aca1ac29-8b75-4362-a3fd-f42d77f9ffc0|1|MRCMAX|Metabolite Ratio for Max Conc|[?]|COMPARTMENTAL|[?]|h*fg/mL|[?]|1|IU/day|SPERMATOZOON|2|TREATMENT|2020-12-05|24|2020-12-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4a195822-d646-4b22-a3b9-f6642442474d|1|NRENLCLS|Nonrenal CL Norm by SA|[?]|NON-COMPARTMENTAL|[?]|pmol|[?]|1|nmol/L/(ug/day)|MONOCYTE|4|FOLLOW-UP|2020-10-16|93|2020-10-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|515808c1-fda7-43bb-91dc-28e2d4e308cd|1|CAVGS|Average Conc Norm by SA|[?]|COMPARTMENTAL|[?]|(h*Bq/mL)/(kBq/kg)|[?]|1|g/mL/(ug/kg/day)|LEUKOCYTE|2|TREATMENT|2020-11-13|77|2020-11-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|18461665-388d-403b-90e4-2b42fcb4a01a|1|AUCIFPDW|AUCIFPDW Norm by Dose/WT|[?]|COMPARTMENTAL|[?]|ug|[?]|1|ng/mL/kg|VENOUS PLASMA|3|TREATMENT|2020-12-09|77|2020-12-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c3d2c2f3-6f3e-4671-b17b-47e6809bcca0|1|VZFPUB|Vz Pred by F for UB|[?]|NON-COMPARTMENTAL|[?]|pg/mL/(mg/kg/day)|[?]|1|mL/(kg/m2)|PLASMA ULTRAFILTRATE|6|WASHOUT|2020-10-19|76|2020-10-31|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e3ce1661-1b72-4835-88d1-5a6d3655b674|1|AILAMZ|Accumulation Index using Lambda z|[?]|COMPARTMENTAL|[?]|day*fg/mL/(kg/m2)|[?]|1|mL/(mg/kg)|EXHALED BREATH CONDENSATE|4|TREATMENT|2020-10-26|85|2020-08-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|240844e9-3dda-438e-81b2-8f6aa4e0427e|1|AUMCTAUW|AUMC Over Dosing Interval Norm by WT|[?]|NON-COMPARTMENTAL|[?]|h*mg/mL|[?]|1|h*ug/mL/(kg/m2)|PLEURAL TISSUE|3|SCREENING|2020-12-18|19|2020-12-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|fccf5c5d-deb6-4f13-a485-afcda3556578|1|ERLSTB|Last Meas Excretion Rate Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|pg/h|[?]|1|min*umol/L|NAIL|3|FOLLOW-UP|2020-10-15|82|2020-08-31|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|94620ed0-1ae8-4fa5-a629-9210860b0be9|1|SWING|Swing|[?]|COMPARTMENTAL|[?]|h*nmol/L/m2|[?]|1|IU/mL/(mg/kg/day)|SYNOVIAL FLUID|3|WASHOUT|2020-08-25|31|2020-09-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9c3b6912-19be-435c-87fc-781a08efb847|1|AUCIFPD|AUC Infinity Pred Norm by Dose|[?]|COMPARTMENTAL|[?]|(L/min)/(mg/m2/day)|[?]|1|ug/mL/(mg/kg/day)|ERYTHROCYTES|5|TREATMENT|2021-01-17|5|2021-02-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|171a6d85-ba2e-45da-b31b-01651b26e890|1|ARCMIN|Accumulation Ratio Cmin|[?]|COMPARTMENTAL|[?]|(mL/min)/(mg/day)|[?]|1|IU/mL/(mg/kg/day)|RETICULOCYTES|5|TREATMENT|2020-09-13|52|2020-08-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a8338164-1bb5-4474-9432-4d5a81ab30d8|1|AURCIFPW|AURC Infinity Pred Norm by WT|[?]|NON-COMPARTMENTAL|[?]|day*mmol/L/(kg/m2)|[?]|1|h*mol/L|PLASMA|7|WASHOUT|2021-03-03|93|2020-12-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6d64077e-1f18-4bd6-ba86-53d90121f7a9|1|RACMIN|Ratio Min Conc|[?]|COMPARTMENTAL|[?]|DNA copies/ug|[?]|1|h*pmol/L/kg|ATHEROSCLEROTIC PLAQUE|7|SCREENING|2020-07-09|32|2020-08-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|91d08486-3db7-4c71-a63f-fd060f4ae1a4|1|RAAUC|Ratio AUC|[?]|COMPARTMENTAL|[?]|day*g/mL/kg|[?]|1|h*ng/mL/(mg/g)|STRIATED MUSCLE TISSUE|4|TREATMENT|2021-02-22|69|2021-03-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f44ad5ae-71d0-462e-8d57-b5f8fffaf2da|1|VZOUB|Vz Obs for UB|[?]|NON-COMPARTMENTAL|[?]|mgEq|[?]|1|(L/min)/kg|ARTERIAL BLOOD|4|WASHOUT|2020-08-23|19|2020-10-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7b8a488a-ffd8-45bd-9b6d-8c16b1f24997|1|NRENLCLW|Nonrenal CL Norm by WT|[?]|NON-COMPARTMENTAL|[?]|Bq/mg|[?]|1|Bq/g|CORD SERUM|3|TREATMENT|2021-02-24|56|2021-01-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|87998e13-813a-464d-935c-d5513cd0db5e|1|VZFOW|Vz Obs by F Norm by WT|[?]|COMPARTMENTAL|[?]|pmol/L/kg|[?]|1|(L/day)/(ug/m2/day)|PLEURAL FLUID|4|TREATMENT|2020-09-06|16|2020-10-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7812e96e-ea53-4eb0-8160-d4118c567c9d|1|CLPUB|Total CL Pred for Unbound Drug|[?]|COMPARTMENTAL|[?]|h*ug/g|[?]|1|ng/mL/(ug/day)|CERVICOVAGINAL SECRETION|3|SCREENING|2021-03-31|73|2021-04-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f9c6c448-0e3d-421f-a63f-be4aeb965256|1|CMAXW|Max Conc Norm by WT|[?]|COMPARTMENTAL|[?]|h*pg/mL/(mg/g/day)|[?]|1|uIU/mL/kg|PLATELET RICH PLASMA|4|TREATMENT|2021-02-04|98|2020-11-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e8da815a-b53c-46f4-a546-e8553152719f|1|C0D|Initial Conc Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|pmol/L/m2|[?]|1|h*mmol/L/(kg/m2)|LEUKOCYTE|3|TREATMENT|2020-12-28|11|2020-12-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|701d794b-07b4-4394-a2a4-d31a9f5b743a|1|RACAVG|Ratio Average Concentration|[?]|NON-COMPARTMENTAL|[?]|umol/day|[?]|1|mmol|PERIPHERAL BLOOD MONONUCLEAR CELL|6|SCREENING|2021-04-25|96|2021-01-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|45a9c2a7-3f0e-4bed-ac5b-e9ef5ba4fffd|1|ERLSTD|Last Meas Excretion Rate Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|ngEq/mL|[?]|1|L/(ug/day)|PLEURAL FLUID|6|SCREENING|2021-02-14|61|2020-12-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|060a73b7-19d8-4a73-9976-6bbc8a83a6d5|1|AUCLSTB|AUC to Last Nonzero Conc Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|ng/day|[?]|1|(L/h)/(mg/kg)|PLASMA|5|TREATMENT|2020-10-14|75|2020-08-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|fe8b11f0-70b9-4c5e-8075-6cdb4dd95c5a|1|RCPCIFPB|Pct Rec Infinity Pred Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|uIU/mL/(mg/kg/day)|[?]|1|(L/day)/(kg/m2)|FLUID|3|SCREENING|2021-02-25|64|2021-02-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|bb2487c3-cc05-48f8-9031-0e433c07e3d6|1|RCAMINT|Amt Rec from T1 to T2|[?]|NON-COMPARTMENTAL|[?]|(mL/min)/(mg/day)|[?]|1|mL/kg|VENOUS PLASMA|3|WASHOUT|2020-12-01|12|2021-01-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2661da18-b539-49d8-ac80-9da03c127d21|1|VZOUB|Vz Obs for UB|[?]|NON-COMPARTMENTAL|[?]|h*mg/mL|[?]|1|ug/mL/m2|AQUEOUS HUMOR|6|SCREENING|2020-10-17|93|2020-07-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f1835786-c567-4235-9bd1-f7ffcec12741|1|AUMCIFOS|AUMC Infinity Obs Norm by SA|[?]|NON-COMPARTMENTAL|[?]|g|[?]|1|h*ng/mL/m2|TUMOR TISSUE|6|TREATMENT|2020-09-01|36|2020-08-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|019eb415-1da3-40fa-b4ba-b1f381ec3cac|1|ERINTS|Excret Rate from T1 to T2 Norm by SA|[?]|COMPARTMENTAL|[?]|h*pg/mL/(kg/m2)|[?]|1|mmol/L/(mg/m2/day)|BUFFY COAT|4|TREATMENT|2020-08-14|45|2020-07-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2506c6e2-018f-4300-b3b5-44ff8d6e13df|1|MRTIVIFO|MRT Intravasc Infinity Obs|[?]|COMPARTMENTAL|[?]|h*ngEq/mL|[?]|1|h*ng/mL/(mg/g/day)|GASTRIC CONTENTS|7|WASHOUT|2020-07-23|10|2020-09-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|65c439f8-9658-4ac5-9eae-0837182a90fd|1|AUCPEO|AUC %Extrapolation Obs|[?]|COMPARTMENTAL|[?]|min*ug/mL/g|[?]|1|nmol/L/(mg/kg)|GASTRIC FLUID|3|TREATMENT|2020-05-27|2|2020-08-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5b73ad4c-bb28-47d1-a2f6-8508444059a5|1|CMINDW|Min Conc Norm by Dose/WT|[?]|NON-COMPARTMENTAL|[?]|mol/L|[?]|1|h*g/mL/(mg/kg/day)|SEMEN|1|TREATMENT|2020-06-14|12|2020-08-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|16dcaefa-701c-4863-b010-8ac640aeb55a|1|AURCALLB|AURC All Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|IU/mL/(ug/m2)|[?]|1|h*ug/mL/mg|ISOLATE|2|SCREENING|2020-06-12|5|2020-09-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4c19e870-9195-41d8-9c8a-8a54bb428732|1|AILAMZ|Accumulation Index using Lambda z|[?]|NON-COMPARTMENTAL|[?]|mol/L/(ug/kg)|[?]|1|ng/mL|EXPIRED AIR|6|WASHOUT|2020-08-01|8|2020-08-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7682184f-0801-4315-9c5f-116f7321a2b0|1|RCPCINTB|Pct Rec from T1 to T2 Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|uIU/mL/(mg/kg)|[?]|1|mmol/L/(ug/m2)|RETICULOCYTES|3|SCREENING|2020-12-15|3|2021-03-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c40f9cb3-b597-4614-8ba5-d40849030ff9|1|AURCLSTS|AURC Dosing to Last Conc Norm by SA|[?]|NON-COMPARTMENTAL|[?]|ng/kg/min|[?]|1|h*mmol/L/(mg/g)|CELL PELLET|2|TREATMENT|2020-12-17|15|2021-01-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5e850a5f-cfce-4bdd-a8f2-22996b8a6a64|1|CLSTW|Last Nonzero Conc Norm by WT|[?]|NON-COMPARTMENTAL|[?]|(L/h)/(mg/kg/day)|[?]|1|L/h|BASAL TEAR|3|SCREENING|2020-11-17|79|2020-12-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c9308aa7-f38f-4b54-a919-d3f893b18cd1|1|MRAUCIFO|Metabolite Ratio for AUC Infinity Obs|[?]|COMPARTMENTAL|[?]|g/mL/g|[?]|1|ug/mL/(kg/m2)|BLOOD|3|TREATMENT|2020-12-24|57|2021-01-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e7cfb803-a0be-4020-9982-e0c3cdd90cd1|1|VZFO|Vz Obs by F|[?]|COMPARTMENTAL|[?]|min*umol/L|[?]|1|(L/h)/(kg/m2)|SOFT TISSUE|7|FOLLOW-UP|2020-11-01|81|2020-08-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3da865e8-9680-4112-b6d3-1f5763cfdaae|1|LAMZLTAU|Lambda z Lower Limit TAU|[?]|COMPARTMENTAL|[?]|RATIO|[?]|1|pg/mL/m2|EPIDERMAL TISSUE|5|SCREENING|2021-01-21|11|2021-04-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|60afc3a3-56b7-4988-9006-e12f3bc1097c|1|CLSTS|Last Nonzero Conc Norm by SA|[?]|NON-COMPARTMENTAL|[?]|(L/day)/(ug/kg)|[?]|1|min*fg/mL|GASTRIC FLUID|4|SCREENING|2020-10-15|70|2020-09-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|440119fb-ad46-4348-b236-8e2979c7bf2e|1|AUMCTAUS|AUMC Over Dosing Interval Norm by SA|[?]|NON-COMPARTMENTAL|[?]|(L/day)/m2|[?]|1|(L/min)/(ug/kg/day)|INFRANATANT, SERUM|7|SCREENING|2021-03-05|89|2021-03-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|af45a9de-c8aa-4602-8e3b-d16998740ebd|1|VSSPD|Vol Dist Steady State Pred Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|ng/mL/(ug/m2)|[?]|1|h*pg/mL/(kg/m2)|ARTERIALIZED CAPILLARY BLOOD|4|WASHOUT|2020-08-20|76|2020-06-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|23306866-3fcb-418d-861b-de3bd779260d|1|AUCALLW|AUC All Norm by WT|[?]|NON-COMPARTMENTAL|[?]|h*pg/mL/(mg/kg/day)|[?]|1|day*mol/L/g|SKELETAL MUSCLE TISSUE|1|WASHOUT|2020-08-01|17|2020-07-31|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|144d2eb9-d79a-4a61-91f5-6a807832d8ca|1|AUCPEO|AUC %Extrapolation Obs|[?]|NON-COMPARTMENTAL|[?]|g/mL/(ug/m2)|[?]|1|h*umol/L/m2|LEUKOCYTE|4|FOLLOW-UP|2020-08-31|37|2020-08-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|92855d33-eee6-449f-a9e6-c06a1532571f|1|RCAMIFOW|Amt Rec Infinity Obs Norm by WT|[?]|NON-COMPARTMENTAL|[?]|min*ng/mL/kg|[?]|1|min*nmol/L/(mg/g)|URINE SEDIMENT|7|WASHOUT|2021-02-04|77|2020-12-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0204e2fc-bc80-44cd-a749-90c1bf21a2bb|1|ERMAXS|Max Excretion Rate Norm by SA|[?]|COMPARTMENTAL|[?]|/day|[?]|1|h*g/mL/m2|SUPERNATANT, CEREBROSPINAL FLUID|4|SCREENING|2021-02-28|40|2021-01-31|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|40cb9bc3-abec-4158-bdee-becdeceba727|1|ARCTROUD|Accum Ratio Ctrough norm by dose|[?]|COMPARTMENTAL|[?]|g/mL/(mg/m2/day)|[?]|1|uIU/mL/(kg/m2)|PLASMA ULTRAFILTRATE|1|TREATMENT|2020-11-10|32|2020-11-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f4dbdcd5-52ca-498c-b72a-1c0209c9a286|1|CTROUGHW|Conc Trough by WT|[?]|COMPARTMENTAL|[?]|min*nmol/L/(mg/g/day)|[?]|1|h*mg/mL/(kg/m2)|BUFFY COAT|7|TREATMENT|2020-12-01|55|2021-01-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|616b284a-3fed-4009-bafe-7da10acd537e|1|ARAUCIPD|Accum Ratio AUCIFP Norm by Dose|[?]|COMPARTMENTAL|[?]|day*fg/mL/kg|[?]|1|mol/L/(ug/kg/day)|EPIDERMAL TISSUE|6|FOLLOW-UP|2020-09-16|23|2020-10-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d39b53da-187f-4da6-9614-2bd301e9ad05|1|LAMZUTAU|Lambda z Upper Limit TAU|[?]|COMPARTMENTAL|[?]|min*nmol/L/(mg/g)|[?]|1|GBq/nL|HAIR|3|SCREENING|2020-10-24|32|2020-11-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c2a43fc4-83c4-4522-b3b2-d4cb1a92a4b7|1|RCPCTAU|Pct Rec Over Dosing Interval|[?]|NON-COMPARTMENTAL|[?]|/day|[?]|1|fg/mL/(ug/m2/day)|URINE SEDIMENT|6|SCREENING|2021-01-17|54|2021-02-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e51cf168-af89-44d9-9e56-14785071f6b0|1|AURCINTS|AURC from T1 to T2 Norm by SA|[?]|NON-COMPARTMENTAL|[?]|day*mol/L/(kg/m2)|[?]|1|mg/mL/(mg/kg)|EMESIS|6|WASHOUT|2021-02-07|82|2021-01-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8416f8c6-d0e4-43fc-9a66-6a916e853e87|1|VSSOUB|Vol Dist Steady State Obs by UB|[?]|COMPARTMENTAL|[?]|(mL/day)/(mg/m2/day)|[?]|1|nmol/h|ADIPOSE TISSUE|3|SCREENING|2020-08-27|85|2020-09-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a110e924-90a1-4e84-b47a-410f800fa201|1|AUMCIFPD|AUMC Infinity Pred Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|day*pmol/L/m2|[?]|1|g/mL/(mg/kg/day)|MIXED VENOUS BLOOD|1|TREATMENT|2021-01-04|77|2020-11-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|40681cb8-5d49-4e1d-b893-f5fad62a0885|1|RAAUCALL|Ratio AUC All|[?]|NON-COMPARTMENTAL|[?]|h*pmol/L/(mg/g/day)|[?]|1|ng/mL/(ug/day)|INFRANATANT, PLASMA|3|FOLLOW-UP|2020-08-29|31|2020-11-05|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7a7dd1e0-46b7-4a46-bbde-601c5ee3ceeb|1|RCAMIFPB|Amt Rec Infinity Pred Norm by BMI|[?]|COMPARTMENTAL|[?]|pg/h|[?]|1|mg|COLOSTRUM|3|SCREENING|2021-02-03|58|2021-01-31|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|96e65c5c-723c-42d9-8e88-0bcb600e9f88|1|CONCB|Conc by BMI|[?]|COMPARTMENTAL|[?]|day*g/mL/m2|[?]|1|(mL/day)/kg|TUMOR TISSUE|3|SCREENING|2020-10-19|49|2020-11-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|eaf1edbe-1848-4614-b7b1-dcbcba5f0a15|1|AURCIFOS|AURC Infinity Obs Norm by SA|[?]|NON-COMPARTMENTAL|[?]|day*pmol/L/(kg/m2)|[?]|1|nmol/L|BONE MARROW|5|TREATMENT|2020-08-23|52|2020-08-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f81742a2-5250-43d7-a6e2-8fcb1625a114|1|ERINTB|Excret Rate from T1 to T2 Norm by BMI|[?]|COMPARTMENTAL|[?]|min*mol/L/(mg/g/day)|[?]|1|ug/min|ISOLATE|6|TREATMENT|2020-07-13|54|2020-08-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c6bad1d0-3514-4f98-b229-d093a94dfbc4|1|VSSOW|Vol Dist Steady State Obs Norm by WT|[?]|COMPARTMENTAL|[?]|min*pg/mL/(mg/g)|[?]|1|h*mmol/L/(mg/g/day)|SERUM OR PLASMA|4|TREATMENT|2020-08-10|57|2020-07-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|84d68bcc-dc7a-4366-9630-40ce8885351d|1|RCAMTAUW|Amt Rec Over Dosing Interval Norm by WT|[?]|COMPARTMENTAL|[?]|h*umol/L|[?]|1|h|EMOTIONAL TEAR|5|TREATMENT|2020-08-17|72|2020-06-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|517f3930-5202-4e0a-b3e1-85ed4bd7e117|1|CMAXLN|Max Conc LN Transformed|[?]|NON-COMPARTMENTAL|[?]|min*ug/mL/m2|[?]|1|day*mg/mL/(mg/g/day)|CAPILLARY BLOOD|2|FOLLOW-UP|2021-01-09|11|2021-03-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|edd73650-27bb-474f-bab7-d2c3d57b2dc4|1|RCAMIFOS|Amt Rec Infinity Obs Norm by SA|[?]|NON-COMPARTMENTAL|[?]|min*fg/mL/g|[?]|1|h*g/mL/m2|PLATELET|2|SCREENING|2021-02-25|76|2020-12-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|98737dfa-0058-4420-a515-38526f01f90d|1|AUCINTB|AUC from T1 to T2 Norm by BMI|[?]|COMPARTMENTAL|[?]|mmol/L/(mg/kg)|[?]|1|(L/day)/ug|STOOL|5|TREATMENT|2020-10-08|39|2020-09-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e713c631-cdd8-428f-a3a6-0195f6fb80b4|1|LAMZUL|Lambda z Upper Limit|[?]|COMPARTMENTAL|[?]|pmol/L/kg|[?]|1|mol/L/(kg/m2)|PERSPIRATION|7|SCREENING|2020-10-12|19|2020-11-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a3964bed-1273-4bce-bbb4-b8d768b30aa3|1|CMAXLN|Max Conc LN Transformed|[?]|NON-COMPARTMENTAL|[?]|day*g/mL/kg|[?]|1|(mL/h)/m2|ERYTHROCYTES|7|TREATMENT|2020-10-02|22|2020-09-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b77116ca-2b32-411f-a0ff-fa70d74eb4bd|1|VSSPBD|Vol Dist Steady State Pred by B|[?]|NON-COMPARTMENTAL|[?]|mIU/mL/(mg/kg/day)|[?]|1|h*g/mL/(mg/kg)|PLEURAL TISSUE|2|SCREENING|2021-03-20|99|2021-03-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|cedc258a-b0e3-4590-afe1-9ed2b6ba28bc|1|RNCLTAUW|Renal CL for Dose Int Norm by WT|[?]|COMPARTMENTAL|[?]|nmol/min|[?]|1|mIU/mL/(mg/kg/day)|ALVEOLAR AIR|3|SCREENING|2020-08-11|73|2020-06-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|597ff319-c16e-4aae-a7d9-ed2bc25684dc|1|AUMCLSTW|AUMC to Last Nonzero Conc Norm by WT|[?]|NON-COMPARTMENTAL|[?]|(L/h)/(kg/m2)|[?]|1|L/day|AMNIOTIC FLUID|6|TREATMENT|2020-06-25|38|2020-07-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7d845e3e-8bd1-4647-a3e8-352a52b585cb|1|VZPD|Vz Pred Norm by Dose|[?]|COMPARTMENTAL|[?]|(L/min)/(mg/m2)|[?]|1|h*ng/mL/(mg/kg)|WHITE MATTER TISSUE|6|WASHOUT|2020-11-25|27|2021-02-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7e9f4283-f90b-4f74-939c-b42648e8373c|1|RCAMLST|Amt Rec to Last Nonzero Conc|[?]|COMPARTMENTAL|[?]|nmol/L/m2|[?]|1|IU/mL/(ug/kg/day)|SUPERNATANT, PLEURAL FLUID|1|WASHOUT|2021-01-19|45|2020-12-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|20a637e6-83d2-4a86-9ecc-8ddb0523997f|1|CAVGW|Average Conc Norm by WT|[?]|COMPARTMENTAL|[?]|h*mmol/L/m2|[?]|1|nmol/L/g|MENSTRUAL BLOOD|5|TREATMENT|2021-01-24|95|2021-01-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|29b5d32c-0c0e-42b2-8dfd-ff92a7a6229e|1|CTROUGHB|Conc Trough by BMI|[?]|NON-COMPARTMENTAL|[?]|min*mol/L/(mg/g)|[?]|1|min*fg/mL/m2|STRIATED MUSCLE TISSUE|1|TREATMENT|2020-08-10|96|2020-06-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|595aa95c-4378-47c1-96e9-5512d08fb653|1|CMAXLN|Max Conc LN Transformed|[?]|COMPARTMENTAL|[?]|g/mL/(mg/m2/day)|[?]|1|mg/mL/(mg/kg/day)|SPUTUM|3|TREATMENT|2020-11-06|85|2020-09-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b528dc24-e791-41b1-95b3-fc0be18da47f|1|CAVGINTB|Average Conc from T1 to T2 Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|min*nmol/L/(mg/g/day)|[?]|1|(L/day)/(ug/kg/day)|VITREOUS HUMOR|4|SCREENING|2021-02-07|52|2021-01-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7a43c892-0e7f-4f33-9130-e175e475531f|1|ARCMAX|Accumulation Ratio Cmax|[?]|NON-COMPARTMENTAL|[?]|ug/mL/m2|[?]|1|day*g/mL/(mg/g)|VENOUS BLOOD|7|SCREENING|2020-06-12|36|2020-05-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8cce3de1-e56d-4c2c-9b45-cdf1f226dc5e|1|ERLSTS|Last Meas Excretion Rate Norm by SA|[?]|COMPARTMENTAL|[?]|/h|[?]|1|(L/day)/kg|SUPERNATANT, PLASMA|1|TREATMENT|2021-02-11|73|2021-03-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|bde9096e-9ab9-45fe-8e96-1ec9762824a0|1|MRAUCIFP|Metabolite Ratio for AUC Infinity Pred|[?]|COMPARTMENTAL|[?]|min*ng/mL/(mg/g)|[?]|1|(mL/min)/kg|SEMINAL FLUID|1|TREATMENT|2020-10-21|65|2020-11-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ea7907aa-811e-48ec-9fc6-ab8affde8913|1|RNCLINTD|Renal CL from T1 to T2 Norm by Dose|[?]|COMPARTMENTAL|[?]|IU/mL/(kg/m2)|[?]|1|day*fg/mL/(mg/g/day)|SKELETAL MUSCLE TISSUE|3|WASHOUT|2020-09-15|89|2020-09-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3aa9935c-943d-406a-bb6e-fc067fa8a487|1|CMAXB|Max Conc Norm by BMI|[?]|COMPARTMENTAL|[?]|(mL/day)/(mg/day)|[?]|1|L/(kg/m2)|PLASMA|2|TREATMENT|2020-09-15|29|2020-11-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0cac2007-ca12-45ba-9b1c-70f753232f05|1|CLFOW|Total CL Obs by F Norm by WT|[?]|NON-COMPARTMENTAL|[?]|pmol/L|[?]|1|(L/min)/(ug/m2/day)|EPITHELIAL CELL|6|SCREENING|2020-12-19|28|2021-02-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2339e91a-b93e-426f-9b60-3d3b6969268d|1|VZFOUB|Vz Obs by F for UB|[?]|NON-COMPARTMENTAL|[?]|(Bq/mL)/(kBq/kg)|[?]|1|min*mg/mL/(mg/g)|FLUID|5|WASHOUT|2020-09-15|80|2020-08-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0d09e35b-e864-4492-a341-21c71d92b551|1|VSSOS|Vol Dist Steady State Obs Norm by SA|[?]|NON-COMPARTMENTAL|[?]|day*mol/L/(mg/g/day)|[?]|1|min*mmol/L|SEMEN|2|FOLLOW-UP|2020-11-22|33|2020-11-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0f8b5d32-6c34-4ea3-bab7-816c1d755ffd|1|ARAUCD|Accum Ratio AUCTAU norm by dose|[?]|NON-COMPARTMENTAL|[?]|IU/mL/m2|[?]|1|L/min|EMOTIONAL TEAR|3|TREATMENT|2020-08-29|95|2020-06-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0a5b1036-cd00-4221-b218-ee2664e5a43e|1|AUMCLSTW|AUMC to Last Nonzero Conc Norm by WT|[?]|COMPARTMENTAL|[?]|pg/mL/m2|[?]|1|pmol/L/kg|LOCHIA|5|TREATMENT|2021-03-27|94|2021-02-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a4f74465-7abc-4cc2-a0be-25d1c802af8c|1|AUCLSTW|AUC to Last Nonzero Conc Norm by WT|[?]|COMPARTMENTAL|[?]|day*ng/mL/(mg/g)|[?]|1|umol/L/m2|WHITE MATTER TISSUE|4|TREATMENT|2020-12-09|80|2020-12-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2d38f416-c40c-41a1-a4be-bcbfa4a97ad9|1|AURCIFPW|AURC Infinity Pred Norm by WT|[?]|COMPARTMENTAL|[?]|IU/mL/(mg/m2)|[?]|1|min*pg/mL/m2|AQUEOUS HUMOR|4|SCREENING|2020-12-24|52|2021-02-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e7262592-01e8-4cb3-b967-ec1037505e81|1|RENALCL|Renal CL|[?]|NON-COMPARTMENTAL|[?]|mIU/mL|[?]|1|day*pmol/L/(mg/g)|ISOLATE|7|TREATMENT|2020-10-17|45|2020-11-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|bf150829-1b25-418a-9bc6-61716984387c|1|RARECIFO|Ratio Amt Rec Infinity Obs|[?]|COMPARTMENTAL|[?]|min*mol/L/(mg/g)|[?]|1|fg/mL/(ug/day)|COLOSTRUM|6|TREATMENT|2020-08-28|84|2020-09-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5c1cc260-97a0-493c-bc11-57f31ffd7455|1|ARCMIN|Accumulation Ratio Cmin|[?]|COMPARTMENTAL|[?]|(mL/min)/(mg/kg)|[?]|1|h*nmol/L|PLATELET|6|WASHOUT|2020-11-28|93|2020-09-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|cca2835b-ca8d-4db6-89b4-9f2855968a8a|1|AUCINTDW|AUCINT Norm by Dose/WT|[?]|COMPARTMENTAL|[?]|(L/min)/(mg/day)|[?]|1|mol/L/(ug/kg)|STRIATED MUSCLE TISSUE|4|SCREENING|2020-10-13|96|2020-08-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|420e3ac1-ba3f-4baf-bcfb-121c0fdc947e|1|V0W|Vol Dist Initial Norm by WT|[?]|NON-COMPARTMENTAL|[?]|fg/mL/(kg/m2)|[?]|1|min*ng/mL/(mg/g/day)|LAVAGE FLUID|4|TREATMENT|2020-11-10|44|2020-12-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|74cd0a4f-f9fe-4df9-93b8-7832512d0828|1|LAMZUL|Lambda z Upper Limit|[?]|COMPARTMENTAL|[?]|h2*mol/L|[?]|1|h*pgEq/mL/mgEq|SEBUM|1|TREATMENT|2020-05-24|19|2020-07-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|09238251-feaf-45a9-b295-dfed9a75fbb2|1|VZFPW|Vz Pred by F Norm by WT|[?]|COMPARTMENTAL|[?]|GBq/nL|[?]|1|g/mL/(ug/day)|SPERMATOZOON|1|TREATMENT|2020-07-27|41|2020-09-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3e896568-85dc-4a14-ba41-eb3575940a9d|1|TROUGHPR|Trough Peak Ratio|[?]|COMPARTMENTAL|[?]|h*g/mL/(mg/kg/day)|[?]|1|mmol/L/(ug/kg)|CORD BLOOD|1|TREATMENT|2021-04-04|78|2021-01-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7e759204-4cf5-49fb-9d9e-82e0199c7ccc|1|NRENALCL|Nonrenal CL|[?]|NON-COMPARTMENTAL|[?]|min*mol/L/g|[?]|1|ug/day|SKIN TISSUE|1|SCREENING|2020-11-14|33|2020-12-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|725c5a91-72b0-4b2c-a51a-d1006303373e|1|RCAMIFOB|Amt Rec Infinity Obs Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|h*pmol/L/(kg/m2)|[?]|1|h*g/mL/g|AMNIOTIC FLUID|2|TREATMENT|2020-11-17|4|2020-12-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5bf5b31d-a59d-46b7-8f8f-97919d449565|1|AUCIFP|AUC Infinity Pred|[?]|COMPARTMENTAL|[?]|uIU/mL/(mg/m2)|[?]|1|day*ug/mL/m2|KERATINOCYTE|5|TREATMENT|2021-02-21|61|2021-03-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7fc35880-1672-4e64-ba3b-aa3f1e42764b|1|CLFTAUB|Total CL by F for Dose Int Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|mg/kg/day|[?]|1|pgEq/g|FLUID|3|TREATMENT|2020-07-20|65|2020-07-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f093c85b-c6bc-414d-a6e3-a8dcb33226ff|1|LAMZSPN|Lambda z Span|[?]|NON-COMPARTMENTAL|[?]|min*pg/mL/(mg/g/day)|[?]|1|nmol/L/(mg/m2)|GASTRIC CONTENTS|1|WASHOUT|2020-11-23|50|2020-11-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f8878ffd-67af-414c-b346-596dbec640cf|1|RNCLTAUW|Renal CL for Dose Int Norm by WT|[?]|COMPARTMENTAL|[?]|mg/dL|[?]|1|(mL/h)/(mg/kg)|SEMEN|1|TREATMENT|2021-03-15|80|2021-03-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d8212248-cd8c-4404-8ad8-2c89c05bee9e|1|VSSOD|Vol Dist Steady State Obs Norm by Dose|[?]|COMPARTMENTAL|[?]|(L/day)/(ug/m2)|[?]|1|ugEq|TISSUE|4|WASHOUT|2020-06-25|55|2020-07-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ea9c56ad-d69c-47c2-b486-65ce91e1f60d|1|ERLST|Last Meas Excretion Rate|[?]|NON-COMPARTMENTAL|[?]|umol/h|[?]|1|pmol/L/(mg/m2/day)|SERUM OR PLASMA OR BLOOD|7|TREATMENT|2020-07-20|28|2020-07-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b832144e-88c4-4ad6-b173-abac7802a36c|1|CMIN|Min Conc|[?]|COMPARTMENTAL|[?]|ngEq/mL/mgEq|[?]|1|h*fg/mL/(kg/m2)|SPERMATOZOON|2|TREATMENT|2021-03-19|74|2021-03-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6acacd87-c487-401c-8888-76ccf97b640d|1|ARCTROUD|Accum Ratio Ctrough norm by dose|[?]|COMPARTMENTAL|[?]|day*mg/mL/(kg/m2)|[?]|1|(L/day)/g|PLATELET POOR PLASMA|1|TREATMENT|2020-06-29|45|2020-07-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3e9b342f-56c3-45cb-9b9f-5b6e5f555bdf|1|RCPCLST|Pct Rec to Last Nonzero Conc|[?]|NON-COMPARTMENTAL|[?]|ngEq/mL/mgEq|[?]|1|mL/h|PERSPIRATION|5|TREATMENT|2020-09-07|63|2020-10-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|73988e01-56c0-4b31-84e2-c23ce0bac5ac|1|ARAUCLST|Accum Ratio AUC to Last Nonzero Conc|[?]|COMPARTMENTAL|[?]|day*fg/mL/g|[?]|1|h*nmol/L/(kg/m2)|URINE|2|TREATMENT|2021-02-09|47|2021-02-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0670f6a3-18c9-4027-91c1-56f5555589a8|1|RNCLTAUB|Renal CL for Dose Int Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|min*ug/mL|[?]|1|IU/mL/(ug/kg)|INFRANATANT, SERUM|5|TREATMENT|2020-06-30|58|2020-07-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|59179734-8784-4a88-aa6b-51b6082ffc1b|1|AUCLSTW|AUC to Last Nonzero Conc Norm by WT|[?]|COMPARTMENTAL|[?]|L/m2|[?]|1|/h|CIRCULATING TUMOR CELL|2|TREATMENT|2020-10-05|65|2020-08-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ef21c401-3b32-478b-9a7d-e25ccc3e3c60|1|R2ADJ|R Squared Adjusted|[?]|NON-COMPARTMENTAL|[?]|(mL/day)/(mg/m2)|[?]|1|mL/(mg/m2/day)|PLATELET|3|SCREENING|2020-08-16|4|2020-09-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|01c642f8-48ef-4375-aa2b-d0940b74e580|1|RCPCIFOS|Pct Rec Infinity Obs Norm by SA|[?]|COMPARTMENTAL|[?]|min*mg/mL/m2|[?]|1|ng/mL/(mg/cm2)|EXHALED BREATH CONDENSATE|7|SCREENING|2020-09-20|11|2020-11-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c0e7028c-6f5c-410a-afde-e56af2177983|1|VZFOB|Vz Obs by F Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|day*nmol/L/(mg/g)|[?]|1|mg/mL/m2|REFLEX TEAR|6|FOLLOW-UP|2020-08-07|42|2020-09-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|eba928ed-9434-4e75-b49d-169298f966e1|1|TMAX|Time of CMAX|[?]|COMPARTMENTAL|[?]|(L/day)/mg|[?]|1|h*fg/mL/(mg/g)|LEUKOCYTE|3|TREATMENT|2020-08-27|25|2020-10-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4772aa80-2097-4867-a549-b6f9b140f141|1|AILAMZ|Accumulation Index using Lambda z|[?]|NON-COMPARTMENTAL|[?]|min*ug/mL|[?]|1|nmol/L/(mg/m2)|ALVEOLAR AIR|4|WASHOUT|2020-09-03|63|2020-09-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|74acb1a5-6dab-4b9e-ac7b-d242bdd44d26|1|VZTAUD|Vz for Dose Int Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|pmol/L/(mg/m2)|[?]|1|mmol/L/(mg/m2)|PUS|7|TREATMENT|2020-06-30|33|2020-07-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4d8dd0d0-407d-4374-8345-c11f30603273|1|MRCMAX|Metabolite Ratio for Max Conc|[?]|COMPARTMENTAL|[?]|ugEq/g|[?]|1|umol/L/(kg/m2)|INTERSTITIAL FLUID|2|TREATMENT|2021-03-14|82|2021-03-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6996077b-556a-47b9-bbff-20c1b4df35ea|1|VZFTAUD|Vz for Dose Int by F Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|pmol/L/m2|[?]|1|mmol/L/(mg/day)|ALVEOLAR AIR|5|TREATMENT|2020-08-06|69|2020-06-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d79d31c5-d51a-46a7-b22c-20d6d483f46e|1|AUCINTD|AUC from T1 to T2 Norm by Dose|[?]|COMPARTMENTAL|[?]|mIU/mL/m2|[?]|1|h*nmol/L/m2|PLASMA|1|SCREENING|2020-11-22|40|2020-12-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|738d539e-a810-4207-8904-fc6a5d055424|1|CMAXDW|Max Conc Norm by Dose/WT|[?]|COMPARTMENTAL|[?]|day*ng/mL/kg|[?]|1|Bq/ug|FLUID|7|SCREENING|2021-01-22|24|2021-02-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|95e3cff6-3c61-4e31-97ff-cfcbe1cab4f7|1|VSSPD|Vol Dist Steady State Pred Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|(L/h)/(mg/kg)|[?]|1|nmol/L|MIXED VENOUS BLOOD|5|TREATMENT|2020-10-31|91|2020-08-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|20841d37-0444-4d1d-b934-1e805cdacdaf|1|CMAXW|Max Conc Norm by WT|[?]|COMPARTMENTAL|[?]|day*ng/mL/kg|[?]|1|mL|SALIVA|5|TREATMENT|2021-01-24|73|2021-01-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a96323a5-4d4f-4ea4-b3da-89b8cca46ee0|1|RCPCINTW|Pct Rec from T1 to T2 Norm by WT|[?]|COMPARTMENTAL|[?]|day*ng/mL/kg|[?]|1|day*mg/mL|URINE SEDIMENT|5|WASHOUT|2020-12-25|64|2020-11-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d74682f1-824e-449d-bdf1-db517d8fdf2e|1|ERLSTS|Last Meas Excretion Rate Norm by SA|[?]|COMPARTMENTAL|[?]|kBq/uL|[?]|1|(mL/day)/(mg/kg/day)|ERYTHROCYTES|2|TREATMENT|2020-08-28|30|2020-10-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a3c226dc-d8f4-4fbc-b840-f1dc1b2680dd|1|VZP|Vz Pred|[?]|NON-COMPARTMENTAL|[?]|h*DNA copies/ug|[?]|1|ug/mL/(kg/m2)|ARTERIAL BLOOD|3|WASHOUT|2021-02-13|78|2021-03-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|33cc0c60-b4f3-4b6c-9c7f-a4b0f536b0ac|1|AURCPEO|AURC % Extrapolation Obs|[?]|COMPARTMENTAL|[?]|mol/h|[?]|1|(mL/day)/(mg/m2/day)|ALVEOLAR AIR|4|TREATMENT|2020-07-03|11|2020-09-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|94c7f1e8-9703-4376-9cb2-6a1344dbf8cd|1|RCAMINTW|Amt Rec from T1 to T2 Norm by WT|[?]|COMPARTMENTAL|[?]|h*mg/mL/m2|[?]|1|nmol/L/(mg/m2)|CIRCULATING TUMOR CELL|7|TREATMENT|2021-02-14|99|2020-12-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|20abe0d2-bbe5-422b-b9a7-ae645928b0bf|1|CAVGINTW|Average Conc from T1 to T2 Norm by WT|[?]|COMPARTMENTAL|[?]|h*mol/L|[?]|1|h*mmol/L/kg|EPIDERMAL TISSUE|6|TREATMENT|2021-01-03|78|2020-11-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b5644705-65e9-4d9b-9f5c-f8f62d26e257|1|CLFTAUD|Total CL by F for Dose Int Norm by Dose|[?]|COMPARTMENTAL|[?]|h*mmol/L/m2|[?]|1|nmol/L/(ug/kg)|DERMAL TISSUE|3|TREATMENT|2020-12-29|15|2021-03-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ec82f59b-197a-4ccc-b5e5-d91627a86a27|1|ERTLST|Midpoint of Interval of Last Nonzero ER|[?]|NON-COMPARTMENTAL|[?]|nmol/L/(mg/day)|[?]|1|min*mol/L/m2|BUFFY COAT|1|TREATMENT|2020-08-07|93|2020-05-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|527fd604-110f-47b1-bd8b-b1de2f5b0d29|1|VZFPD|Vz Pred by F Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|fg/mL/(mg/m2)|[?]|1|(L/h)/(mg/kg/day)|MENSTRUAL BLOOD|3|TREATMENT|2020-12-04|15|2020-11-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1e1de453-920a-4132-b2f7-6335ee81ec83|1|AUCPEO|AUC %Extrapolation Obs|[?]|NON-COMPARTMENTAL|[?]|h*pg/mL/m2|[?]|1|mg/mL/(kg/m2)|BONE MARROW|7|TREATMENT|2020-10-28|16|2020-10-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e553ad8e-96f4-4cb0-a005-51e9b64513b7|1|VZTAUW|Vz for Dose Int Norm by WT|[?]|COMPARTMENTAL|[?]|h*ng/mL/(mg/g/day)|[?]|1|(mL/min)/(mg/day)|SYNOVIAL FLUID|6|WASHOUT|2020-07-17|28|2020-08-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9bd9a8ad-dafd-46e0-a51c-c086ca4e9c0c|1|RNCLINTB|Renal CL from T1 to T2 Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|umol/min|[?]|1|h2*umol/L|ARTERIAL BLOOD|6|SCREENING|2021-03-03|87|2021-02-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c041c7ce-8c14-49cd-a2b2-e7e18b5bc579|1|ARCTROUD|Accum Ratio Ctrough norm by dose|[?]|COMPARTMENTAL|[?]|IU/mL/g|[?]|1|pg/mg|MIXED VENOUS BLOOD|2|TREATMENT|2020-07-04|35|2020-06-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2c9752be-9479-4c18-bb2c-19ffa8dfec3a|1|VSSOS|Vol Dist Steady State Obs Norm by SA|[?]|NON-COMPARTMENTAL|[?]|IU/mL/g|[?]|1|uIU/mL/(mg/m2/day)|SWABBED MATERIAL|2|TREATMENT|2020-10-22|3|2021-01-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|083f3f2b-c66c-4a98-95c6-fc2bbceecf7e|1|CMAXD|Max Conc Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|h*mol/L|[?]|1|(mL/min)/m2|BLOOD|5|WASHOUT|2021-01-21|38|2021-03-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ad04ec90-9fd5-49f2-ae23-264273eb0a24|1|VSSOBD|Vol Dist Steady State Obs by B|[?]|COMPARTMENTAL|[?]|(L/day)/(mg/day)|[?]|1|day*nmol/L|PERIPHERAL BLOOD MONONUCLEAR CELL|5|WASHOUT|2020-10-11|4|2020-11-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a1d203ef-7ee1-4373-988a-370532bae2b1|1|VSSOUB|Vol Dist Steady State Obs by UB|[?]|NON-COMPARTMENTAL|[?]|mol/L/(ug/kg/day)|[?]|1|ng/mL/(mg/cm2)|PLASMA|5|TREATMENT|2021-04-25|97|2021-03-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4389d158-cb51-4779-b19a-f38dbef0806a|1|AUCTAUD|AUC Over Dosing Interval Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|(mL/h)/(kg/m2)|[?]|1|h*ng/mL/g|BONE MARROW|7|TREATMENT|2020-06-29|17|2020-07-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3a973b7a-3583-4383-b59e-3dab51b511bd|1|RCAMIFO|Amt Rec Infinity Obs|[?]|NON-COMPARTMENTAL|[?]|h*pg/mL/(mg/g/day)|[?]|1|min*mmol/L/(mg/g)|SUPERNATANT, SERUM|3|WASHOUT|2021-01-26|17|2021-02-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d283591c-2085-459e-94f2-d3eb6b81aea7|1|CLTAUW|Total CL for Dose Int Norm by WT|[?]|NON-COMPARTMENTAL|[?]|mg/min|[?]|1|h*Bq/mL|SMOOTH MUSCLE TISSUE|6|TREATMENT|2020-10-23|35|2020-10-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|da31f695-9f6a-46b2-8002-5c1c21b55cf3|1|NRENALCL|Nonrenal CL|[?]|NON-COMPARTMENTAL|[?]|Bq/uL|[?]|1|%|BASAL TEAR|6|TREATMENT|2020-10-27|36|2020-10-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4cd63e56-3d93-403a-8011-3b4fcf26e445|1|AURCINTB|AURC from T1 to T2 Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|mg/mL/(mg/day)|[?]|1|nmol/L/m2|EMOTIONAL TEAR|6|TREATMENT|2021-01-01|15|2020-12-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|379e3838-eef8-45a4-bd0b-5b8b3ec3e204|1|EFFHL|Effective Half-Life|[?]|COMPARTMENTAL|[?]|h*nmol/L|[?]|1|min*ng/mL/(mg/g/day)|AQUEOUS HUMOR|6|FOLLOW-UP|2020-08-01|80|2020-08-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f31bab3b-3624-44a5-a62f-f8cf9055eec4|1|VSSOS|Vol Dist Steady State Obs Norm by SA|[?]|NON-COMPARTMENTAL|[?]|IU/mL/(ug/m2/day)|[?]|1|h*ng/mL/(mg/cm2)|CORD SERUM|2|TREATMENT|2020-10-24|86|2020-10-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0b5675aa-4ec0-4548-9a0b-a13f8de89883|1|VZOUB|Vz Obs for UB|[?]|COMPARTMENTAL|[?]|mL/(mg/m2)|[?]|1|min*mmol/L/(mg/g/day)|ISOLATE|6|SCREENING|2020-09-17|91|2020-09-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9bdf9856-3b2a-43db-b369-3e13868ef413|1|FREXINT|Fract Excr from T1 to T2|[?]|NON-COMPARTMENTAL|[?]|L/(ug/m2/day)|[?]|1|ng/mL/(mg/cm2)|LYSATE|7|TREATMENT|2021-03-06|52|2021-04-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5cc53922-60c0-4bce-8d4a-bc59e9203d63|1|VZFP|Vz Pred by F|[?]|COMPARTMENTAL|[?]|kBq|[?]|1|h*mol/L/(mg/g/day)|SERUM OR PLASMA|1|TREATMENT|2021-01-17|30|2021-03-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ae4761e8-2ede-43b6-8ec4-40c97add3cfa|1|HDCL|Hemodialysis Clearance|[?]|COMPARTMENTAL|[?]|h*ug/g|[?]|1|uIU/mL/(kg/m2)|DIALYSIS FLUID, PERITONEAL|2|WASHOUT|2021-01-29|41|2021-01-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|066281d3-27b8-439f-8340-f59115f646ef|1|AURCPEP|AURC % Extrapolation Pred|[?]|COMPARTMENTAL|[?]|h*umol/L/(mg/g)|[?]|1|pgEq/mL/mgEq|ISOLATE|2|SCREENING|2020-11-27|47|2020-10-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d23cc47e-da96-4042-a69f-60097beaef0e|1|AURCIFO|AURC Infinity Obs|[?]|COMPARTMENTAL|[?]|min*mg/mL|[?]|1|(mL/min)/(kg/m2)|BUFFY COAT|5|TREATMENT|2021-03-07|55|2021-02-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b896c679-87d0-4e29-ad27-3944cf09b3ec|1|ERINT|Excret Rate from T1 to T2|[?]|COMPARTMENTAL|[?]|ugEq/mL|[?]|1|min*mol/L/(mg/g)|CERUMEN|6|SCREENING|2021-02-15|54|2021-03-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6d0ec221-6eb6-4fed-806e-2bc700968333|1|AILAMZ|Accumulation Index using Lambda z|[?]|NON-COMPARTMENTAL|[?]|day*g/mL/m2|[?]|1|h*mg/mL/(mg/g/day)|CARDIAC MUSCLE TISSUE|7|TREATMENT|2020-09-18|63|2020-09-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1ba07712-d5a0-41a5-b5ee-636fa0bce22a|1|AUMCLSTS|AUMC to Last Nonzero Conc Norm by SA|[?]|COMPARTMENTAL|[?]|pg/mL|[?]|1|mmol/L/ug|CELL PELLET|1|TREATMENT|2020-10-11|18|2020-10-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|15e5e7ca-b832-450c-a20c-b21585086328|1|VSSOB|Vol Dist Steady State Obs Norm by BMI|[?]|COMPARTMENTAL|[?]|h*mg/mL/(mg/kg/day)|[?]|1|(L/h)/(ug/m2)|VENOUS PLASMA|5|SCREENING|2021-04-02|97|2021-02-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b46ff3a2-f257-4803-8064-e29bd1114bfc|1|ERLSTS|Last Meas Excretion Rate Norm by SA|[?]|COMPARTMENTAL|[?]|nmol/L/m2|[?]|1|fg/mL/(ug/m2/day)|EXHALED BREATH CONDENSATE|3|SCREENING|2020-11-08|36|2021-01-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b269c0ea-d3db-4052-9dc7-a55ac59d82a6|1|AUCALLW|AUC All Norm by WT|[?]|COMPARTMENTAL|[?]|h*ng/mL/kg|[?]|1|MBq/uL|CELL PELLET|2|SCREENING|2021-01-08|43|2021-02-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a5c667d1-d2ac-49f7-ad44-bf9a44762025|1|RENALCLD|Renal CL Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|day*pg/mL/(mg/g)|[?]|1|mol/L/(ug/m2/day)|CAPILLARY PLASMA|4|TREATMENT|2020-12-04|69|2020-10-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|944a2627-13f1-4ecf-9545-8819a1327138|1|RACMIN|Ratio Min Conc|[?]|COMPARTMENTAL|[?]|mIU/mL/(kg/m2)|[?]|1|nmol/L/g|STRIATED MUSCLE TISSUE|6|TREATMENT|2021-01-10|3|2021-01-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7902955a-6336-45e5-a15d-7c368a28ac4f|1|CAVINTDW|CAVGINT Norm by Dose/WT|[?]|NON-COMPARTMENTAL|[?]|(Bq/g)/(kBq/kg)|[?]|1|day*mg/mL/(mg/g)|PUS|2|TREATMENT|2020-06-13|22|2020-06-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|aeef8a2d-167c-41e7-baa6-a3dc756bbb49|1|VZFOS|Vz Obs by F Norm by SA|[?]|COMPARTMENTAL|[?]|mgEq|[?]|1|h|TUMOR TISSUE|7|SCREENING|2020-12-29|19|2020-12-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6071d81f-2f38-414f-90ca-4ad80c971054|1|VSSOB|Vol Dist Steady State Obs Norm by BMI|[?]|COMPARTMENTAL|[?]|nmol/L/(ug/m2/day)|[?]|1|pg/min|WHITE MATTER TISSUE|7|SCREENING|2020-10-29|62|2020-09-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|22ffaa50-941f-4d52-b73b-84e13d2bb4bd|1|AURCPEO|AURC % Extrapolation Obs|[?]|NON-COMPARTMENTAL|[?]|mmol/L/(mg/kg/day)|[?]|1|(Bq/mL)/(kBq/kg)|LUNG SURFACTANT|7|WASHOUT|2020-12-11|84|2020-10-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a046d48d-b1fa-4d46-902e-3984aed00ec7|1|RCAMLST|Amt Rec to Last Nonzero Conc|[?]|COMPARTMENTAL|[?]|min*g/mL|[?]|1|min*g/mL/kg|SUPERNATANT, SERUM OR PLASMA|4|SCREENING|2020-10-27|97|2020-10-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8b60e1b0-2cd9-419d-b345-9006af042932|1|RCPCIFPB|Pct Rec Infinity Pred Norm by BMI|[?]|COMPARTMENTAL|[?]|nmol/L/(ug/kg)|[?]|1|h*ng/mL/(mg/g/day)|ABSCESS FLUID|2|SCREENING|2020-12-17|11|2021-02-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|712029bc-471a-4e3d-9123-e38b3c38bc6c|1|V0|Vol Dist Initial|[?]|COMPARTMENTAL|[?]|mol/L/(ug/day)|[?]|1|nmol/L/g|ATHEROSCLEROTIC PLAQUE|2|TREATMENT|2021-01-26|12|2021-01-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|92c0183d-5704-45ad-9aec-e24bc5777b80|1|CORRXY|Correlation Between TimeX and Log ConcY|[?]|COMPARTMENTAL|[?]|umol/h|[?]|1|h*mol/L/(mg/g)|SUPERNATANT, CEREBROSPINAL FLUID|2|FOLLOW-UP|2021-04-16|96|2021-01-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|52ce3b1f-9500-4323-861d-73c8b96f59de|1|CAVGW|Average Conc Norm by WT|[?]|COMPARTMENTAL|[?]|h|[?]|1|g|SERUM OR PLASMA OR BLOOD|4|TREATMENT|2020-11-12|27|2020-11-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3655d198-2e7e-419e-8337-d7eea7d795ca|1|RENALCLD|Renal CL Norm by Dose|[?]|COMPARTMENTAL|[?]|day*fg/mL/(kg/m2)|[?]|1|mL/m2|BILE|3|TREATMENT|2020-12-05|22|2020-11-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d47da6bf-8abf-4b62-8bb8-797155981158|1|AUCINT|AUC from T1 to T2|[?]|COMPARTMENTAL|[?]|h*g/mL|[?]|1|pg/day|CEREBROSPINAL FLUID|6|TREATMENT|2020-11-04|65|2020-11-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|25e81c81-8c23-4c9e-be79-35247384dd1f|1|ERLSTW|Last Meas Excretion Rate Norm by WT|[?]|NON-COMPARTMENTAL|[?]|min*mol/L/m2|[?]|1|(L/day)/mg|ABSCESS FLUID|7|TREATMENT|2020-09-03|36|2020-08-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4fd91c6c-3bc6-498a-a977-ee834c3bcb97|1|RCAMLST|Amt Rec to Last Nonzero Conc|[?]|COMPARTMENTAL|[?]|h*umol/L/(kg/m2)|[?]|1|h*mol/L/m2|STRIATED MUSCLE TISSUE|7|FOLLOW-UP|2020-08-31|45|2020-09-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|21d29ae6-bb12-4c5c-b32a-32ab4ddcf547|1|RCAMINTW|Amt Rec from T1 to T2 Norm by WT|[?]|COMPARTMENTAL|[?]|ng/h|[?]|1|day*mg/mL/(mg/g/day)|ENDOTRACHEAL FLUID|6|FOLLOW-UP|2020-12-15|43|2021-01-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5ba70148-c29b-47af-9280-10d1a942380a|1|ERMAXS|Max Excretion Rate Norm by SA|[?]|COMPARTMENTAL|[?]|(mL/min)/(mg/day)|[?]|1|pg/day|CAPILLARY PLASMA|1|SCREENING|2020-12-29|41|2020-12-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|93b3c298-d81f-4d71-9c5d-ba5b4d4bdf42|1|CAVGS|Average Conc Norm by SA|[?]|NON-COMPARTMENTAL|[?]|day*g/mL/kg|[?]|1|(L/h)/ug|SPUTUM|1|TREATMENT|2020-05-28|11|2020-07-05|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2d8f8b1e-7914-400b-afc5-8dc23a626d76|1|VZFTAUB|Vz for Dose Int by F Norm by BMI|[?]|COMPARTMENTAL|[?]|day*ug/mL/(mg/g/day)|[?]|1|min*mol/L/m2|URINE SEDIMENT|7|TREATMENT|2020-09-13|96|2020-07-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9d3f5b5e-ebd4-4540-8b4d-14733497ed8e|1|LAMZSPN|Lambda z Span|[?]|COMPARTMENTAL|[?]|ng/mL/(ug/day)|[?]|1|h2*mg/mL|SERUM OR PLASMA OR BLOOD|6|WASHOUT|2020-09-27|48|2020-11-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a73142e4-e34b-4144-b95f-7a5562574c1b|1|KDIST|K Slope of Distribution|[?]|COMPARTMENTAL|[?]|(mL/h)/kg|[?]|1|fg/mL|CORD BLOOD|3|TREATMENT|2020-08-07|9|2020-11-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a9bdb550-aa73-4194-a4b1-c69fa5dd2d4b|1|RAAUCIFP|Ratio AUC Infinity Pred|[?]|NON-COMPARTMENTAL|[?]|day*ug/mL/(mg/g/day)|[?]|1|ng/mL/mg|BONE|6|TREATMENT|2020-07-10|47|2020-08-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0f682806-b63c-4c3f-9fda-1e59befbd3a3|1|C0S|Initial Conc Norm by SA|[?]|COMPARTMENTAL|[?]|umol/L/(kg/m2)|[?]|1|pg/mL/m2|ARTERIALIZED CAPILLARY BLOOD|3|FOLLOW-UP|2020-06-30|42|2020-05-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1d8aba56-f62e-4116-b447-899dedd3d4df|1|MRAUCIFO|Metabolite Ratio for AUC Infinity Obs|[?]|NON-COMPARTMENTAL|[?]|(L/min)/(ug/day)|[?]|1|g/mL/m2|DIALYSIS FLUID|1|TREATMENT|2020-10-30|41|2020-11-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|77bbd5c9-a7c4-43d1-a392-5dd44cfbfe4f|1|CTROUGHS|Conc Trough by SA|[?]|NON-COMPARTMENTAL|[?]|h*mol/L/(mg/g/day)|[?]|1|min*ng/mL/(kg/m2)|PROSTATIC FLUID|1|TREATMENT|2020-11-05|93|2020-09-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|383d3f30-14b7-48c3-b1a8-0f481ef37a50|1|AUCIFODW|AUC Infinity Obs Norm by Dose/WT|[?]|COMPARTMENTAL|[?]|uIU/mL/(kg/m2)|[?]|1|pmol|EPITHELIAL CELL|7|SCREENING|2020-07-29|62|2020-08-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b4f81b74-fee9-4544-9404-206d931ed8e5|1|AURCIFOS|AURC Infinity Obs Norm by SA|[?]|COMPARTMENTAL|[?]|L/(mg/day)|[?]|1|mIU/mL/(mg/m2)|URINE SEDIMENT|1|TREATMENT|2020-10-29|21|2020-12-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9e69b457-20db-45e5-a535-0cd8ac102fea|1|RENALCL|Renal CL|[?]|NON-COMPARTMENTAL|[?]|day*mg/mL/(kg/m2)|[?]|1|min*fg/mL/(mg/g/day)|AQUEOUS HUMOR|5|TREATMENT|2020-07-09|42|2020-08-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|14211798-ddf6-47c8-bd9d-056d95bad8ff|1|AURCIFO|AURC Infinity Obs|[?]|COMPARTMENTAL|[?]|uIU/mL/(kg/m2)|[?]|1|day*g/mL/g|PLATELET POOR PLASMA|3|TREATMENT|2020-09-30|14|2020-11-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|63f3194e-9b88-491a-9a68-19109ed86e2b|1|CMAXLN|Max Conc LN Transformed|[?]|COMPARTMENTAL|[?]|(L/day)/(mg/m2/day)|[?]|1|g/mL/ug|MENSTRUAL BLOOD|4|FOLLOW-UP|2020-08-29|90|2020-06-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b6208258-d7c2-4dde-addf-4677946ab165|1|CLRPCLIV|Renal CL as Pct CL IV|[?]|NON-COMPARTMENTAL|[?]|L/min|[?]|1|fg/mL/(mg/kg)|PLATELET RICH PLASMA|5|WASHOUT|2020-10-01|21|2020-10-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a669a7b9-2034-4bca-aa80-0371c5fb46d3|1|AUCLSTB|AUC to Last Nonzero Conc Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|L/(mg/kg/day)|[?]|1|h*ng/mL/g|PLATELET POOR PLASMA|4|TREATMENT|2021-03-30|73|2021-02-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e148c13d-ee41-4503-a7e5-397dd6155f04|1|MRAUCINT|Metabolite Ratio AUC from T1 to T2|[?]|COMPARTMENTAL|[?]|(mL/h)/(mg/day)|[?]|1|day*ng/mL|ALVEOLAR AIR|1|TREATMENT|2020-10-09|93|2020-08-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|815de94a-f259-41ee-8951-8df150184a25|1|RNCLTAUW|Renal CL for Dose Int Norm by WT|[?]|NON-COMPARTMENTAL|[?]|(mL/h)/(kg/m2)|[?]|1|uIU/mL/m2|INFRANATANT, PLASMA|1|TREATMENT|2020-09-01|66|2020-09-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c897cd09-0cbc-4a2f-a902-1c736a6c3a02|1|CMAXW|Max Conc Norm by WT|[?]|NON-COMPARTMENTAL|[?]|nmol/L/(ug/day)|[?]|1|day*nmol/L/m2|CIRCULATING TUMOR CELL|6|TREATMENT|2020-06-06|31|2020-06-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d68e5fe0-ab34-4565-9e5d-6ff1f72217f1|1|MRCMAX|Metabolite Ratio for Max Conc|[?]|COMPARTMENTAL|[?]|day*ug/mL|[?]|1|(mL/day)/(mg/m2/day)|LEUKOCYTE|3|TREATMENT|2021-01-29|14|2021-02-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a616ef00-05d6-459a-8474-06ab3eb493b1|1|RENALCLS|Renal CL Norm by SA|[?]|NON-COMPARTMENTAL|[?]|day*ug/mL/(kg/m2)|[?]|1|(L/min)/(ug/day)|ALVEOLAR AIR|7|SCREENING|2020-09-27|12|2020-09-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a6cbce6b-ec22-4f4e-9990-b2c106a4554e|1|ERINT|Excret Rate from T1 to T2|[?]|NON-COMPARTMENTAL|[?]|(L/min)/(mg/kg/day)|[?]|1|Bq/L|BILE|6|TREATMENT|2020-09-08|29|2020-09-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|870f5f68-aa8a-4484-8d9d-febc7d5b83a2|1|RNCLTAUW|Renal CL for Dose Int Norm by WT|[?]|NON-COMPARTMENTAL|[?]|pg/mL/(mg/kg)|[?]|1|min*umol/L/(kg/m2)|MECONIUM|2|FOLLOW-UP|2020-12-15|65|2020-11-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ffbb87da-c0a3-4acf-94e2-b1473cbd60e3|1|CTROUGHW|Conc Trough by WT|[?]|NON-COMPARTMENTAL|[?]|(L/day)/(ug/day)|[?]|1|mg/mL/m2|KERATINOCYTE|7|SCREENING|2020-08-08|45|2020-08-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2014bcd0-1430-4096-87f5-650a01dae626|1|AURCIFOD|AURC Infinity Obs Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|h*fg/mL/m2|[?]|1|(h*Bq/mL)/(kBq/kg)|PUS|4|WASHOUT|2020-06-08|18|2020-08-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e043f1b3-6b65-45c0-bdae-eb783406c263|1|RCPCINTW|Pct Rec from T1 to T2 Norm by WT|[?]|COMPARTMENTAL|[?]|pg/day|[?]|1|(L/day)/(mg/day)|PLATELET RICH PLASMA|4|TREATMENT|2021-01-09|69|2021-01-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|45623c39-86de-4b2f-bf2d-998d0e941e92|1|AURCIFPW|AURC Infinity Pred Norm by WT|[?]|NON-COMPARTMENTAL|[?]|(L/h)/m2|[?]|1|nmol/L/(mg/kg)|EMESIS|3|FOLLOW-UP|2020-10-16|96|2020-07-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a753f9c8-2f9a-4f54-80e0-b080e82dcb94|1|CLSTD|Last Nonzero Conc Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|day*nmol/L|[?]|1|IU/mL/m2|ERYTHROCYTES|1|FOLLOW-UP|2020-12-13|66|2020-11-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e5a105f7-38ac-4f19-aace-4149ed9b1100|1|AURCINTD|AURC from T1 to T2 Norm by Dose|[?]|COMPARTMENTAL|[?]|g/mL/(mg/day)|[?]|1|h*pg/mL/(mg/kg)|SUPERNATANT, CEREBROSPINAL FLUID|3|WASHOUT|2020-10-16|53|2020-09-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c568ab93-8e7f-4e4e-9685-f0c13f293606|1|ERTLST|Midpoint of Interval of Last Nonzero ER|[?]|NON-COMPARTMENTAL|[?]|umol/L|[?]|1|h*ng/mL/kg|COLOSTRUM|5|TREATMENT|2021-02-07|34|2021-03-05|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|bccd8af0-2ecf-4091-92e4-681597b57ca4|1|AURCIFPW|AURC Infinity Pred Norm by WT|[?]|COMPARTMENTAL|[?]|h*pmol/L/(mg/g)|[?]|1|min*fg/mL/g|SKELETAL MUSCLE TISSUE|1|TREATMENT|2020-09-29|9|2020-11-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|bf069a02-03a6-4013-b16d-d7c954a6cc3d|1|CLTAUB|Total CL for Dose Int Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|mL/(mg/kg)|[?]|1|uIU/mL/(mg/m2)|VITREOUS HUMOR|3|WASHOUT|2020-10-03|68|2020-08-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c40fc52b-2668-4fab-b051-5b258da72f2c|1|AURCINTS|AURC from T1 to T2 Norm by SA|[?]|NON-COMPARTMENTAL|[?]|h*mmol/L/(mg/g)|[?]|1|ng/mL/(ug/day)|ISOLATE|3|SCREENING|2020-10-15|14|2020-11-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d7c792d8-fc98-41ab-8a9e-59de1e186a06|1|NRENLCLB|Nonrenal CL Norm by BMI|[?]|COMPARTMENTAL|[?]|g/h|[?]|1|mmol/L/ug|SPUTUM|7|TREATMENT|2020-08-21|34|2020-09-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f7773659-f207-4b29-8389-3aa766a6337a|1|CLSTW|Last Nonzero Conc Norm by WT|[?]|COMPARTMENTAL|[?]|day*umol/L|[?]|1|h*pg/mL/kg|TISSUE|1|TREATMENT|2020-11-14|36|2020-10-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9fa8c7af-c759-420d-a548-cc24c7ddbcdf|1|MRAUCINT|Metabolite Ratio AUC from T1 to T2|[?]|COMPARTMENTAL|[?]|fg/mL/g|[?]|1|ug/mL/(mg/kg/day)|KERATINOCYTE|3|TREATMENT|2021-01-17|20|2021-04-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c0b85664-0ef6-4f93-8f84-ee87e1ca9f0f|1|AURCIFOS|AURC Infinity Obs Norm by SA|[?]|NON-COMPARTMENTAL|[?]|day*mol/L/(mg/g/day)|[?]|1|mg/mL/(kg/m2)|ADIPOSE TISSUE|5|FOLLOW-UP|2021-03-30|73|2021-03-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|700049a2-ef66-466b-b1d8-f0800bcfde43|1|RCPCLST|Pct Rec to Last Nonzero Conc|[?]|NON-COMPARTMENTAL|[?]|h*ugEq/mL|[?]|1|nmol/g|STRIATED MUSCLE TISSUE|6|TREATMENT|2020-07-15|28|2020-08-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|00d906a6-2d14-4199-aff9-524388c5117f|1|RCPCIFO|Pct Rec Infinity Obs|[?]|COMPARTMENTAL|[?]|g/mL/(ug/kg/day)|[?]|1|h*pg/mL/(mg/kg)|LYMPH|2|TREATMENT|2020-11-19|5|2020-11-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2fcc5910-bce0-4510-b17e-3925850d6d32|1|CLOS|Total CL Obs Norm by SA|[?]|NON-COMPARTMENTAL|[?]|mmol/h|[?]|1|nmol|AMNIOTIC FLUID|1|TREATMENT|2021-02-13|69|2021-01-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a17fa9ed-b1fa-451c-8f51-ed1ab1b75366|1|RCAMIFPB|Amt Rec Infinity Pred Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|(mL/min)/(kg/m2)|[?]|1|mIU/mL/(mg/m2/day)|ENDOMETRIAL TISSUE|3|SCREENING|2020-08-30|9|2020-11-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6020ccb5-0bbe-4318-b99f-7a69b10b85a4|1|CMAXUB|Max Conc, Unbound Drug|[?]|NON-COMPARTMENTAL|[?]|(mL/day)/(mg/day)|[?]|1|L/(mg/m2)|ISOLATE|4|FOLLOW-UP|2020-08-17|32|2020-08-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b6e22f6b-25a9-4d18-8de1-2bb4c261e4c9|1|RACMAX|Ratio CMAX|[?]|COMPARTMENTAL|[?]|uIU/mL/kg|[?]|1|day*mmol/L/g|CAPILLARY PLASMA|6|SCREENING|2020-11-09|22|2020-12-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ff163542-abec-4260-b257-f15a11e580ee|1|VZOUB|Vz Obs for UB|[?]|NON-COMPARTMENTAL|[?]|nmol/kg|[?]|1|min*mol/L|BASAL TEAR|1|FOLLOW-UP|2020-09-07|32|2020-11-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|bb73f732-a52f-4013-9ae6-60ff23b9c224|1|AUCIFO|AUC Infinity Obs|[?]|NON-COMPARTMENTAL|[?]|h*pmol/L/(mg/kg)|[?]|1|mol/L/(ug/m2/day)|MUSCLE TISSUE|6|TREATMENT|2020-09-26|62|2020-08-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|56fd91d0-502c-4e19-b7df-1e7dd2ad3cd5|1|R2ADJ|R Squared Adjusted|[?]|NON-COMPARTMENTAL|[?]|day*pg/mL/m2|[?]|1|ug/min|STRIATED MUSCLE TISSUE|1|WASHOUT|2020-08-16|36|2020-10-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8e056558-ffd2-4c43-bbfa-40914b38af34|1|AUCIFPS|AUC Infinity Pred Norm by SA|[?]|COMPARTMENTAL|[?]|mL/kg|[?]|1|uIU/mL/(mg/m2/day)|CEREBROSPINAL FLUID|7|FOLLOW-UP|2021-04-06|77|2021-02-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b7ffe7f2-7eb9-42a1-a548-9f26ee72799b|1|AURCALL|AURC All|[?]|COMPARTMENTAL|[?]|umol/L|[?]|1|h*nmol/L/(mg/g/day)|BONE MARROW MONONUCLEAR CELL|2|WASHOUT|2020-08-14|87|2020-08-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|624c1353-347a-417d-9aab-7f1e7077ba7f|1|VSSOBD|Vol Dist Steady State Obs by B|[?]|COMPARTMENTAL|[?]|pgEq/mL|[?]|1|min*mol/L/(kg/m2)|CAPILLARY PLASMA|5|TREATMENT|2020-11-16|90|2020-10-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ef1cddb8-f4ce-45c4-8671-32fe95f00993|1|AUCIFOUB|AUC Infinity Obs, Unbound Drug|[?]|NON-COMPARTMENTAL|[?]|day*umol/L/g|[?]|1|pgEq/mL|ARTERIAL CORD BLOOD|3|SCREENING|2020-07-31|8|2020-10-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|da6294b5-de91-4bf7-b160-55d22fefcb07|1|AUCIFPDW|AUCIFPDW Norm by Dose/WT|[?]|COMPARTMENTAL|[?]|mmol/L/(ug/m2)|[?]|1|ug/mL/mg|GASTRIC CONTENTS|4|TREATMENT|2020-08-28|71|2020-08-05|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c01c16d4-7a37-421d-9191-1874eba6a1e3|1|CLP|Total CL Pred|[?]|COMPARTMENTAL|[?]|min*nmol/L|[?]|1|pmol/L/(mg/day)|WHITE MATTER TISSUE|3|WASHOUT|2020-12-25|87|2020-10-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6036407d-5ac8-400d-91f7-afd63f3cab88|1|LAMZSPN|Lambda z Span|[?]|COMPARTMENTAL|[?]|mg/h|[?]|1|pmol/L/ug|ARTERIAL BLOOD|6|FOLLOW-UP|2020-07-28|46|2020-07-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|69cf0c4b-13f6-4955-8046-72a333059d6e|1|AUMCIFOD|AUMC Infinity Obs Norm by Dose|[?]|COMPARTMENTAL|[?]|mmol/L/(mg/day)|[?]|1|GBq/nL|PERITONEAL FLUID|4|WASHOUT|2021-03-01|85|2020-12-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|19829028-595c-4811-90e3-0ca696a04ba3|1|CONCDW|Concentration Norm by Dose/WT|[?]|COMPARTMENTAL|[?]|h*pg/mL/kg|[?]|1|day*ug/mL/g|AMNIOTIC FLUID|3|FOLLOW-UP|2020-09-16|73|2020-07-31|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|562a8182-8e9b-4a68-9b95-bc52df58ed46|1|VZTAUD|Vz for Dose Int Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|min*mg/mL|[?]|1|pg/min|CARDIAC MUSCLE TISSUE|7|TREATMENT|2020-08-31|5|2020-11-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b29e6912-42f4-471b-ad90-1ec446f89ac0|1|RAAUC|Ratio AUC|[?]|NON-COMPARTMENTAL|[?]|day*g/mL/m2|[?]|1|(L/min)/(mg/day)|SMEGMA|3|SCREENING|2021-02-11|33|2021-02-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2cb58751-c0c4-432c-8f60-22dba6e1ec9a|1|NRENALCL|Nonrenal CL|[?]|COMPARTMENTAL|[?]|day*umol/L/(mg/g/day)|[?]|1|h*umol/L/(kg/m2)|ALVEOLAR AIR|4|TREATMENT|2020-07-24|55|2020-06-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|396295ba-9f4c-4689-88c2-f80cb28b567a|1|RCAMINTS|Amt Rec from T1 to T2 Norm by SA|[?]|COMPARTMENTAL|[?]|min*mol/L/m2|[?]|1|g/mL/(mg/m2/day)|KERATINOCYTE|3|FOLLOW-UP|2020-12-23|2|2021-03-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|56072c44-67c3-4c93-8db7-2d1570b2bbbc|1|RACAVG|Ratio Average Concentration|[?]|COMPARTMENTAL|[?]|mol/L/m2|[?]|1|IU/mL/(kg/m2)|SUPERNATANT, SERUM|7|TREATMENT|2020-11-15|91|2020-11-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|55b23180-01f2-498e-a0af-cb9cd7d81750|1|ARCTROUG|Accumulation Ratio Ctrough|[?]|NON-COMPARTMENTAL|[?]|mol/day|[?]|1|mmol/L|LYMPH|7|FOLLOW-UP|2020-08-25|65|2020-09-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|22e2b674-dc3f-476d-b3d7-2b1f4ddeea1a|1|CLOW|Total CL Obs Norm by WT|[?]|NON-COMPARTMENTAL|[?]|day*pg/mL|[?]|1|nmol/L/(mg/m2)|STRIATED MUSCLE TISSUE|1|TREATMENT|2020-11-14|15|2020-11-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|940e4aef-5648-46b3-9c3e-7c40f7930030|1|CLFOW|Total CL Obs by F Norm by WT|[?]|COMPARTMENTAL|[?]|h*g/mL/m2|[?]|1|(mL/h)/(mg/day)|URINE|3|TREATMENT|2021-01-17|73|2020-11-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e4bece1e-6672-4b55-824f-56aa923e60f9|1|VZTAUB|Vz for Dose Int Norm by BMI|[?]|COMPARTMENTAL|[?]|mmol|[?]|1|Bq/mg|EMOTIONAL TEAR|7|SCREENING|2020-07-26|44|2020-07-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|12e607da-f53c-4078-9742-23a111db6f54|1|RCPCTAU|Pct Rec Over Dosing Interval|[?]|NON-COMPARTMENTAL|[?]|h*DNA copies/ug|[?]|1|day*ng/mL/(mg/g/day)|LYMPH|3|SCREENING|2020-11-11|49|2020-11-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ca763b7f-2e60-4423-a7a8-b5fad4a74b25|1|VZFOD|Vz Obs by F Norm by Dose|[?]|COMPARTMENTAL|[?]|L/kg|[?]|1|GBq|AMNIOTIC FLUID|4|WASHOUT|2021-02-16|31|2021-04-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1f6b4ff8-fc33-46c7-8298-fe2e9ea62d60|1|VZP|Vz Pred|[?]|NON-COMPARTMENTAL|[?]|L/m2|[?]|1|g/mL/g|LUNG SURFACTANT|3|SCREENING|2020-08-04|29|2020-09-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3260122d-3bf4-45ff-a026-2379158721d0|1|RCAMTAUB|Amt Rec Over Dosing Interval Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|h*mg/mL/(kg/m2)|[?]|1|(L/h)/ug|GASTRIC FLUID|3|SCREENING|2020-08-29|96|2020-05-31|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|05eb4e29-887e-4cdb-8854-49939a8a13d1|1|CLSTS|Last Nonzero Conc Norm by SA|[?]|COMPARTMENTAL|[?]|day*mmol/L/g|[?]|1|(L/min)/mg|PERSPIRATION|2|FOLLOW-UP|2020-10-28|2|2021-01-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c8390c70-766d-4252-9356-39591651bcdf|1|RAMAXMIN|Ratio of CMAX to CMIN|[?]|NON-COMPARTMENTAL|[?]|min*pmol/L|[?]|1|nmol/L/(ug/day)|SUPERNATANT, PLASMA|1|TREATMENT|2020-10-16|76|2020-08-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a40bf877-c070-40b3-89df-d566b942246e|1|RCAMIFO|Amt Rec Infinity Obs|[?]|COMPARTMENTAL|[?]|h*mg/mL/(mg/g)|[?]|1|mol/L/(ug/day)|STOOL|3|TREATMENT|2020-07-18|42|2020-08-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e9633621-3d08-4b47-b394-5bd3fa47c07f|1|AUCTAUB|AUC Over Dosing Interval Norm by BMI|[?]|COMPARTMENTAL|[?]|min*pmol/L/kg|[?]|1|pg/mL/(mg/kg)|DIALYSIS FLUID, PERITONEAL|3|TREATMENT|2021-02-28|53|2021-03-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ff56cb6e-b6c4-49cc-ad21-9a4d20aad7ee|1|RNCLINTW|Renal CL from T1 to T2 Norm by WT|[?]|COMPARTMENTAL|[?]|mmol/L|[?]|1|pmol/L/kg|LYMPH|4|WASHOUT|2020-06-04|6|2020-08-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ee525e77-38dd-4b0b-88f4-69759d5dbfd9|1|AUCIFO|AUC Infinity Obs|[?]|NON-COMPARTMENTAL|[?]|(L/day)/(ug/kg/day)|[?]|1|min*mmol/L|PERIPHERAL BLOOD MONONUCLEAR CELL|2|TREATMENT|2020-08-19|44|2020-09-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|63f43990-e56e-440c-a445-76e7d114cf26|1|AUCPEP|AUC %Extrapolation Pred|[?]|COMPARTMENTAL|[?]|ng/mL/(mg/m2)|[?]|1|(L/day)/(mg/kg/day)|LOCHIA|5|WASHOUT|2020-10-21|29|2020-11-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|380c89f4-2650-4a54-92f5-5e1278b9a91e|1|CMAXLN|Max Conc LN Transformed|[?]|NON-COMPARTMENTAL|[?]|min*nmol/L|[?]|1|h*fg/mL/kg|BILE|7|WASHOUT|2020-10-22|10|2021-01-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|84c1f5f4-6415-49d8-b854-22e7529d65b6|1|ERLST|Last Meas Excretion Rate|[?]|COMPARTMENTAL|[?]|(L/min)/(mg/m2/day)|[?]|1|g/mL/g|PLEURAL TISSUE|1|TREATMENT|2021-01-14|50|2021-02-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|77c26a0c-0c84-44d7-8351-a50f3236e59a|1|CMINDW|Min Conc Norm by Dose/WT|[?]|COMPARTMENTAL|[?]|min*mol/L/(mg/g)|[?]|1|day*pmol/L/kg|PLEURAL FLUID|7|SCREENING|2020-06-20|47|2020-07-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a201c78a-e826-4f42-a997-7c6a019e2c91|1|CLFPW|Total CL Pred by F Norm by WT|[?]|NON-COMPARTMENTAL|[?]|ugEq/mL|[?]|1|day*nmol/L/m2|SERUM|5|TREATMENT|2020-10-11|79|2020-07-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c41880bd-1e29-4961-b74d-bb0d979ab00f|1|CLFOW|Total CL Obs by F Norm by WT|[?]|NON-COMPARTMENTAL|[?]|mmol/L/(mg/m2/day)|[?]|1|ug/dL|VENOUS CORD BLOOD|4|SCREENING|2020-11-14|74|2020-11-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7de60015-fa9d-4a39-bd19-51c718a624e6|1|AURCALLS|AURC All Norm by SA|[?]|COMPARTMENTAL|[?]|mol/L/(ug/m2/day)|[?]|1|mmol/L/(ug/m2/day)|SEBUM|5|SCREENING|2020-11-05|22|2020-11-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|34d03f58-155a-4908-bba3-aa979be84610|1|VZTAU|Vz for Dose Int|[?]|COMPARTMENTAL|[?]|(mL/day)/(mg/kg)|[?]|1|h*ug/mL/(kg/m2)|EXPIRED AIR|6|FOLLOW-UP|2020-08-18|60|2020-06-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3818424f-cbc9-4e79-94b8-7edbc706bdbc|1|CAVGD|Average Conc Norm by Dose|[?]|COMPARTMENTAL|[?]|min*nmol/L/(mg/g)|[?]|1|min*mmol/L/g|PLASMA|7|TREATMENT|2020-08-30|17|2020-11-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4191788e-b2dc-4885-87d8-da9feb6deea5|1|AURCINT|AURC from T1 to T2|[?]|NON-COMPARTMENTAL|[?]|pmol/L/(mg/day)|[?]|1|nmol/g|SKIN TISSUE|2|TREATMENT|2020-09-03|2|2020-12-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8572a9c4-eb87-4745-81b9-8316bc8de69e|1|AUMCLST|AUMC to Last Nonzero Conc|[?]|COMPARTMENTAL|[?]|L/m2|[?]|1|h*mg/mL|SWABBED MATERIAL|6|TREATMENT|2021-02-18|66|2021-02-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|74c9d1b3-6466-43c1-95b0-b720a0dd6e37|1|AUCINTW|AUC from T1 to T2 Norm by WT|[?]|COMPARTMENTAL|[?]|ugEq/g|[?]|1|min*fg/mL|CELL PELLET|6|SCREENING|2020-11-27|11|2021-01-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3eceae61-a4a0-49fd-964b-9f142e0da067|1|MAT|Mean Absorption Time|[?]|NON-COMPARTMENTAL|[?]|(mL/h)/kg|[?]|1|day*pg/mL/(mg/g/day)|SMOOTH MUSCLE TISSUE|7|FOLLOW-UP|2020-08-30|12|2020-09-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|fe7ad71c-601d-4909-b56a-401c9a10f00c|1|RNCLINTS|Renal CL from T1 to T2 Norm by SA|[?]|NON-COMPARTMENTAL|[?]|IU/mL/ug|[?]|1|h*ug/mL/(mg/kg)|PLATELET POOR PLASMA|7|TREATMENT|2020-05-15|4|2020-05-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|cc52d895-5819-46c0-b8e6-b948f1cd2408|1|AUCIFODW|AUC Infinity Obs Norm by Dose/WT|[?]|COMPARTMENTAL|[?]|ng/mL/(mg/kg)|[?]|1|(L/min)/(ug/kg)|LOCHIA|2|WASHOUT|2020-07-06|10|2020-08-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b56a5fe6-1191-4e36-ad30-2f9fc0a2fb72|1|RACMIN|Ratio Min Conc|[?]|NON-COMPARTMENTAL|[?]|h*pmol/L/m2|[?]|1|min*mol/L/(kg/m2)|SERUM|4|FOLLOW-UP|2021-02-17|29|2021-02-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1409edea-a372-4938-889b-df6ee93b8543|1|RCPCIFOW|Pct Rec Infinity Obs Norm by WT|[?]|NON-COMPARTMENTAL|[?]|(L/min)/ug|[?]|1|day*g/mL/(mg/g/day)|INFRANATANT, PLEURAL FLUID|2|TREATMENT|2020-10-24|68|2020-10-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3dc16ad2-d49d-4fad-9823-d0197fb57a42|1|RCAMINTB|Amt Rec from T1 to T2 Norm by BMI|[?]|COMPARTMENTAL|[?]|mg/mL/(mg/kg/day)|[?]|1|(L/day)/(mg/m2)|ISOLATE|5|FOLLOW-UP|2020-11-21|88|2020-11-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7c244128-0508-422f-88ba-ecce68cec054|1|VSSPD|Vol Dist Steady State Pred Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|(mL/min)/kg|[?]|1|h*ug/mL/mg|CORD SERUM|5|TREATMENT|2020-08-10|15|2020-08-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|247814c7-9fb3-43f2-9e0a-db70b27b3d95|1|VZFPB|Vz Pred by F Norm by BMI|[?]|COMPARTMENTAL|[?]|h*umol/L/(kg/m2)|[?]|1|min*ng/mL/(kg/m2)|LYSATE|3|TREATMENT|2021-02-03|59|2021-02-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e870fe2f-b08c-41d9-a672-07da09fe2b99|1|AURCALLS|AURC All Norm by SA|[?]|NON-COMPARTMENTAL|[?]|mmol/L/(ug/m2)|[?]|1|day*pg/mL/m2|ENDOTRACHEAL FLUID|6|WASHOUT|2020-08-16|14|2020-09-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|32979638-fb88-4cbb-a110-a4d2016e9bc5|1|VZTAUB|Vz for Dose Int Norm by BMI|[?]|COMPARTMENTAL|[?]|g/mL|[?]|1|day*ng/mL/m2|PLASMA|2|FOLLOW-UP|2020-07-16|11|2020-07-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|39b8db88-810b-4402-9ca3-c2bab1939c1c|1|RCAMTAUB|Amt Rec Over Dosing Interval Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|h*mmol/L|[?]|1|(L/min)/(ug/day)|SYNOVIAL FLUID|1|SCREENING|2021-01-30|86|2021-02-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b6cce9a5-9b5d-4dd2-80ad-0c6a5b1ed640|1|CAVINTDW|CAVGINT Norm by Dose/WT|[?]|COMPARTMENTAL|[?]|min*g/mL|[?]|1|(L/h)/mg|SWABBED MATERIAL|7|TREATMENT|2020-09-29|74|2020-10-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|bca1f50d-04e6-46f5-afb3-e48aaea1069d|1|TAU|Dosing Interval|[?]|COMPARTMENTAL|[?]|g/mL/(ug/day)|[?]|1|(L/day)/m2|EPITHELIAL CELL|7|TREATMENT|2021-01-28|96|2020-12-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6bddadef-13fb-4fab-b281-aa33aa97aa8f|1|AUCIFOW|AUC Infinity Obs Norm by WT|[?]|COMPARTMENTAL|[?]|mmol/L/(mg/day)|[?]|1|%|BONE MARROW|2|TREATMENT|2020-07-29|76|2020-07-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6edb7414-d8f4-44da-8483-504b93a7e705|1|CONCW|Conc by WT|[?]|COMPARTMENTAL|[?]|fg/mL/(ug/m2/day)|[?]|1|h*mmol/L/kg|EMOTIONAL TEAR|7|SCREENING|2020-06-24|27|2020-06-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3fd8445d-f3b1-46ac-b5ae-a0e5a7f32210|1|VZFOB|Vz Obs by F Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|ngEq/g|[?]|1|h*mg/mL/(mg/g)|EXUDATE|1|SCREENING|2020-05-12|6|2020-08-05|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b005dec4-0aed-484d-b20a-bb18cf8ddbe6|1|ERLSTW|Last Meas Excretion Rate Norm by WT|[?]|NON-COMPARTMENTAL|[?]|h*ng/mL/(kg/m2)|[?]|1|(L/day)/kg|VENOUS CORD BLOOD|3|TREATMENT|2020-08-07|91|2020-05-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|47d55e87-e559-424d-a6ad-d533a0d77f39|1|RACMAX|Ratio CMAX|[?]|COMPARTMENTAL|[?]|day*ng/mL/kg|[?]|1|min*mmol/L/m2|EMOTIONAL TEAR|7|WASHOUT|2021-01-25|23|2021-02-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f89c08df-2e24-4c97-a451-1980cecebf14|1|AUCALL|AUC All|[?]|NON-COMPARTMENTAL|[?]|L/ug|[?]|1|h*ng/mL/m2|SUPERNATANT, PLASMA|3|TREATMENT|2020-12-30|22|2021-01-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|dbb225ed-e322-4946-a60a-0fafd7e22953|1|RCAMIFPB|Amt Rec Infinity Pred Norm by BMI|[?]|COMPARTMENTAL|[?]|min*mmol/L/(mg/g)|[?]|1|fg/mL/(ug/m2/day)|CARDIAC MUSCLE TISSUE|2|TREATMENT|2021-02-28|45|2021-02-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|95e61698-43f7-4cc5-aafa-06dac7870743|1|ERINTW|Excret Rate from T1 to T2 Norm by WT|[?]|COMPARTMENTAL|[?]|min*mg/mL|[?]|1|min*g/mL/(mg/g)|LOCHIA|4|TREATMENT|2021-03-13|88|2021-02-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|151308c7-03aa-4a0b-b13f-9838edb218ef|1|AURCLSTS|AURC Dosing to Last Conc Norm by SA|[?]|COMPARTMENTAL|[?]|day*umol/L/(mg/g)|[?]|1|day*pmol/L/kg|SEMEN|3|WASHOUT|2020-12-11|99|2020-10-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f38e0fff-e3f9-4687-b35b-f11f58b2b5f5|1|CAVGS|Average Conc Norm by SA|[?]|COMPARTMENTAL|[?]|h*pgEq/mL/mgEq|[?]|1|day*pg/mL/(mg/g)|EPIDERMAL TISSUE|2|FOLLOW-UP|2020-06-09|4|2020-07-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|23605586-1b30-4f05-bb15-417dd3a79994|1|CONCS|Conc by SA|[?]|COMPARTMENTAL|[?]|IU/mL/(ug/kg/day)|[?]|1|min*pg/mL|BONE MARROW|4|WASHOUT|2021-01-16|87|2020-10-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|57d15ac0-06a6-40e0-9201-4d947651c9b0|1|MAT|Mean Absorption Time|[?]|NON-COMPARTMENTAL|[?]|day*mg/mL/(mg/g/day)|[?]|1|h*Bq/mL|SUPERNATANT, SERUM|5|WASHOUT|2020-10-15|58|2020-10-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7dbd7e4e-12c2-48c2-9ac2-4d9176922722|1|VZFPUB|Vz Pred by F for UB|[?]|NON-COMPARTMENTAL|[?]|mol/L/(ug/day)|[?]|1|ng/mL/(ug/day)|SUPERNATANT, PLEURAL FLUID|2|WASHOUT|2020-08-15|13|2020-11-05|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5dbb73e4-6e14-45c4-bcaa-2c571199c74f|1|RNCLTAUS|Renal CL for Dose Int Norm by SA|[?]|NON-COMPARTMENTAL|[?]|(L/day)/(ug/day)|[?]|1|mL/(mg/m2)|EXHALED BREATH CONDENSATE|1|TREATMENT|2020-09-29|39|2020-10-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ec2c7d40-5bcb-408d-bf6c-77667a92e2d1|1|RNCLTAUS|Renal CL for Dose Int Norm by SA|[?]|COMPARTMENTAL|[?]|nmol/L/(ug/kg)|[?]|1|GBq|BLOOD|4|TREATMENT|2021-02-18|66|2021-03-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|24c65d59-8d34-4d91-bf0b-6fc6aaaab8ae|1|RENALCLD|Renal CL Norm by Dose|[?]|COMPARTMENTAL|[?]|fg/mL/(mg/kg)|[?]|1|L/m2|SERUM OR PLASMA|4|WASHOUT|2020-08-30|69|2020-08-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|81f62132-123e-4888-abbe-8e289599e965|1|AUCINTD|AUC from T1 to T2 Norm by Dose|[?]|COMPARTMENTAL|[?]|pgEq/mL|[?]|1|h2*mmol/L|SEBUM|3|WASHOUT|2021-01-02|39|2021-01-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c16c0dd1-8d1a-4be6-9017-457db68bb8e4|1|AUCTAUDW|AUCTAU Norm by Dose/WT|[?]|COMPARTMENTAL|[?]|nmol/L/kg|[?]|1|(mL/h)/(mg/kg/day)|PLATELET|7|SCREENING|2020-08-05|91|2020-07-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|49282406-97ec-4108-adf9-e01c18ce59c6|1|ERMAXB|Max Excretion Rate Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|MBq/uL|[?]|1|mIU/mL/(mg/day)|SUPERNATANT, PLEURAL FLUID|3|FOLLOW-UP|2020-08-06|91|2020-06-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|310936c8-7d24-4eea-9892-1cd8bb675421|1|AUMCLSTS|AUMC to Last Nonzero Conc Norm by SA|[?]|NON-COMPARTMENTAL|[?]|h*ug/g|[?]|1|mol/h|SPERMATOZOON|4|TREATMENT|2020-07-18|22|2020-09-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|034e303b-5675-4188-bcea-fc2e53b155d6|1|RENALCLW|Renal CL Norm by WT|[?]|NON-COMPARTMENTAL|[?]|g/mL/(ug/day)|[?]|1|(mL/day)/(mg/m2/day)|CORD SERUM|6|TREATMENT|2020-08-22|92|2020-07-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b09e4a17-0a71-4cd9-bb8d-97e2cca0f649|1|CLFP|Total CL Pred by F|[?]|COMPARTMENTAL|[?]|pg/min|[?]|1|h2*mmol/L|EXPIRED AIR|5|TREATMENT|2020-09-30|95|2020-09-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c912affb-cbc2-4919-81b4-ecaa03908261|1|CLRPCLIV|Renal CL as Pct CL IV|[?]|NON-COMPARTMENTAL|[?]|/h|[?]|1|mmol/min|DIALYSIS FLUID|1|WASHOUT|2020-09-03|63|2020-08-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5af817f0-5dfb-4046-ac7c-4bae16a90036|1|RCAMIFOB|Amt Rec Infinity Obs Norm by BMI|[?]|COMPARTMENTAL|[?]|(mL/h)/(mg/kg/day)|[?]|1|min*fg/mL/(mg/g)|MUCUS|2|TREATMENT|2020-09-06|72|2020-08-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|dcefd656-a59a-4b71-9260-efcbcecd2132|1|AUMCIFOD|AUMC Infinity Obs Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|day*umol/L/kg|[?]|1|(L/h)/(ug/kg/day)|SEMEN|5|TREATMENT|2020-08-13|80|2020-07-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|641c8067-941a-4f1a-a7b1-4eea0242f1d7|1|EFFHL|Effective Half-Life|[?]|NON-COMPARTMENTAL|[?]|(L/h)/(ug/m2/day)|[?]|1|fg/mL/kg|CAPILLARY BLOOD|3|TREATMENT|2021-01-13|32|2021-03-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ab6fb8ca-d455-4141-82f7-cdb7eaf7dfda|1|HTMAX|Half Tmax|[?]|COMPARTMENTAL|[?]|h*ng/mL/(mg/g)|[?]|1|g/mL/(mg/day)|PERSPIRATION|3|FOLLOW-UP|2020-12-16|93|2020-10-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b7a9c5a6-98ed-4ca1-98ea-4cfc03749c0f|1|CLFTAUS|Total CL by F for Dose Int Norm by SA|[?]|NON-COMPARTMENTAL|[?]|mIU/mL/(kg/m2)|[?]|1|ng/mL/(mg/kg)|PLATELET RICH PLASMA|6|TREATMENT|2021-01-23|94|2020-12-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|46304edd-0b05-4819-8fcb-35cf9c02764d|1|NRENLCLS|Nonrenal CL Norm by SA|[?]|NON-COMPARTMENTAL|[?]|ugEq/mL/mgEq|[?]|1|pmol/L/(mg/m2/day)|CEREBROSPINAL FLUID|6|WASHOUT|2020-12-14|21|2021-01-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3fd6dab2-b35f-4cc5-88dd-b507583d9539|1|VZOW|Vz Obs Norm by WT|[?]|COMPARTMENTAL|[?]|h*mg/mL/(mg/kg/day)|[?]|1|ngEq/g|SEBUM|7|TREATMENT|2020-07-15|60|2020-06-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|daa3b89e-637a-43de-86c1-d0db93f00430|1|AUCIFOS|AUC Infinity Obs Norm by SA|[?]|NON-COMPARTMENTAL|[?]|(L/h)/(ug/day)|[?]|1|h*ug/mL/(mg/kg)|BONE|2|FOLLOW-UP|2020-12-15|75|2020-12-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|14e9cde0-92f5-48d4-82ec-cc72f07ba40b|1|VZFO|Vz Obs by F|[?]|NON-COMPARTMENTAL|[?]|mol/day|[?]|1|ng/mL/(ug/m2/day)|SUPERNATANT, SERUM|1|TREATMENT|2020-07-02|8|2020-08-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c22014f2-2d7b-4897-8ad5-e46785e51837|1|CTROUGHB|Conc Trough by BMI|[?]|NON-COMPARTMENTAL|[?]|day*ug/mL/(mg/g)|[?]|1|mol/L|BUFFY COAT|1|TREATMENT|2020-09-06|34|2020-11-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|987102b2-fe2f-4d72-b8dc-14a71bf034b5|1|VZOD|Vz Obs Norm by Dose|[?]|COMPARTMENTAL|[?]|ug/mL/(kg/m2)|[?]|1|mmol/L/(mg/kg)|PLATELET|1|TREATMENT|2020-12-10|70|2020-11-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|24ce0c77-1921-4b87-91da-3627e2afd399|1|AUCLSTW|AUC to Last Nonzero Conc Norm by WT|[?]|COMPARTMENTAL|[?]|ng/min|[?]|1|h*nmol/L/(mg/g/day)|PERITONEAL FLUID|7|TREATMENT|2021-02-04|16|2021-03-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|097351a3-9bb2-4af7-8e96-6d4d9d8ccf87|1|AURCIFP|AURC Infinity Pred|[?]|NON-COMPARTMENTAL|[?]|h*pg/mL/(kg/m2)|[?]|1|mol/L/(ug/m2)|BILE|3|WASHOUT|2020-08-13|3|2020-11-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f4b83a72-7cde-4e02-8883-05e789c617a8|1|AURCIFOD|AURC Infinity Obs Norm by Dose|[?]|COMPARTMENTAL|[?]|min*nmol/L/(mg/g)|[?]|1|mol/L/(ug/day)|HAIR FOLLICLE|7|TREATMENT|2021-02-12|59|2021-01-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c4087538-422a-4bcf-af25-ed4aab36ed4b|1|AUCPBEP|AUC %Back Extrapolation Pred|[?]|NON-COMPARTMENTAL|[?]|(L/h)/(mg/m2/day)|[?]|1|h*Bq/mL|INFRANATANT, SERUM|3|TREATMENT|2021-01-29|30|2021-02-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|947aefaf-20c7-47fc-ac56-140f9b6f38f3|1|CLOUB|Total CL Obs for Unbound Drug|[?]|NON-COMPARTMENTAL|[?]|IU/mL/(mg/m2)|[?]|1|min*mol/L/(mg/g)|SMEGMA|2|WASHOUT|2020-12-08|42|2020-11-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3a0c00eb-5614-4053-844d-6bdb71efb1cd|1|AUCLSTUB|AUC to Last Nonzero Conc, Unbound Drug|[?]|COMPARTMENTAL|[?]|pgEq/mL/mgEq|[?]|1|h*g/mL|SUPERNATANT, SERUM|2|FOLLOW-UP|2020-11-04|95|2020-10-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|dc3ce247-24dd-4255-85a8-ec7a58d30c86|1|VZOD|Vz Obs Norm by Dose|[?]|COMPARTMENTAL|[?]|day*mmol/L/(mg/g/day)|[?]|1|min*mol/L/(mg/g)|ARTERIALIZED CAPILLARY BLOOD|3|TREATMENT|2021-01-02|93|2021-01-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|61c19f94-bdfc-456d-ba7a-c9097ca1c645|1|CLTAU|Total CL for Dose Int|[?]|COMPARTMENTAL|[?]|pmol/L/(mg/m2/day)|[?]|1|h*fg/mL/(kg/m2)|TRANSUDATE|4|TREATMENT|2020-08-06|43|2020-07-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1e577f2d-2c45-477d-b74f-af24b81d6d20|1|RENALCLB|Renal CL Norm by BMI|[?]|COMPARTMENTAL|[?]|h*pg/mL/(mg/g/day)|[?]|1|min*ug/mL/g|BLOOD|7|WASHOUT|2020-11-15|63|2020-09-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f845101e-c057-4f84-94b3-6043afb42ac7|1|AUMCIFOD|AUMC Infinity Obs Norm by Dose|[?]|COMPARTMENTAL|[?]|h*umol/L/(mg/g/day)|[?]|1|pmol/L/(mg/kg)|COLOSTRUM|5|TREATMENT|2020-11-21|35|2020-11-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4ddb2076-6837-4028-81bc-3e8057475977|1|VSSPB|Vol Dist Steady State Pred Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|h*g/mL/(mg/kg/day)|[?]|1|nmol/L/(kg/m2)|PERIPHERAL BLOOD MONONUCLEAR CELL|1|SCREENING|2021-03-01|74|2021-01-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c165c69c-2ab2-495c-a190-e32d1204bc4e|1|CMAXB|Max Conc Norm by BMI|[?]|COMPARTMENTAL|[?]|min*mg/mL|[?]|1|(L/min)/(mg/m2/day)|SKELETAL MUSCLE TISSUE|3|TREATMENT|2021-03-14|82|2021-03-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|fa6801a8-544d-44d7-a3e4-e8e18b2f2f69|1|CLSTS|Last Nonzero Conc Norm by SA|[?]|NON-COMPARTMENTAL|[?]|ugEq|[?]|1|nmol/kg|REFLEX TEAR|7|WASHOUT|2021-01-20|32|2021-03-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|024a9f6d-4ff1-4673-8617-3790f831fce7|1|VZPUB|Vz Pred for UB|[?]|COMPARTMENTAL|[?]|ug/mL/(mg/kg/day)|[?]|1|(Bq/g)/(kBq/kg)|BREAST MILK|1|SCREENING|2020-09-02|91|2020-06-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|40936fc6-251d-4a17-ae9d-3bd1150f8d20|1|AUMCPEP|AUMC % Extrapolation Pred|[?]|COMPARTMENTAL|[?]|mmol/L/(ug/kg)|[?]|1|ug/mL/m2|BONE|5|TREATMENT|2021-01-23|76|2021-02-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|17b9fa7a-f15d-423a-9671-99cd0cbbd362|1|ARAUC|Accumulation Ratio AUCTAU|[?]|NON-COMPARTMENTAL|[?]|mg/kg|[?]|1|h*mg/mL/(mg/g/day)|RETICULOCYTES|6|WASHOUT|2020-12-09|38|2021-01-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|95c4465b-162a-433d-83c9-6d67dd729c9e|1|V0S|Vol Dist Initial Norm by SA|[?]|COMPARTMENTAL|[?]|mg/h|[?]|1|h*pmol/L/g|SUPERNATANT, SERUM OR PLASMA|1|WASHOUT|2021-01-18|98|2020-11-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9a205b50-21a9-4fbc-9ca9-a9378aadd5de|1|RCPCINTS|Pct Rec from T1 to T2 Norm by SA|[?]|NON-COMPARTMENTAL|[?]|ng/day|[?]|1|pg/mL/(kg/m2)|ALVEOLAR AIR|7|FOLLOW-UP|2020-09-05|80|2020-08-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|beb6b1ab-1264-456a-bf2b-81e28493301d|1|AUCALLS|AUC All Norm by SA|[?]|COMPARTMENTAL|[?]|mg|[?]|1|ngEq/mL|SUPERNATANT, PLASMA|1|WASHOUT|2020-06-12|12|2020-08-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4292c06d-044e-4dff-aea0-830178a6e220|1|AUMCPEO|AUMC % Extrapolation Obs|[?]|COMPARTMENTAL|[?]|mmol/L/(mg/kg)|[?]|1|fg/mL/kg|SUPERNATANT, CEREBROSPINAL FLUID|5|WASHOUT|2020-12-14|22|2020-12-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|050c12d2-cf9f-402b-9332-d6a9771ed115|1|AURCALLS|AURC All Norm by SA|[?]|COMPARTMENTAL|[?]|IU|[?]|1|h*mmol/L|CERUMEN|3|TREATMENT|2020-10-01|54|2020-09-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2f1073e4-607f-423f-a5de-f531b828e2d3|1|AURCLST|AURC to Last Nonzero Rate|[?]|COMPARTMENTAL|[?]|g/mL/(ug/kg/day)|[?]|1|h*mol/L/g|CARDIAC MUSCLE TISSUE|2|TREATMENT|2020-10-22|17|2020-10-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|df466903-3212-4e73-bff0-a183447c7408|1|CONC|Concentration|[?]|COMPARTMENTAL|[?]|day*fg/mL/(mg/g)|[?]|1|h*mol/L|LOCHIA|1|WASHOUT|2020-11-25|34|2020-11-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4eeb68ac-cd3a-4d3c-8381-2d715c8fa442|1|CLSTS|Last Nonzero Conc Norm by SA|[?]|NON-COMPARTMENTAL|[?]|h*mg/mL/(kg/m2)|[?]|1|(mL/day)/(kg/m2)|SEMINAL FLUID|6|TREATMENT|2020-10-09|98|2020-07-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c37df2f6-be8a-4709-b97d-061ab9754e0d|1|CLFPD|Total CL Pred by F Norm by Dose|[?]|COMPARTMENTAL|[?]|(L/h)/(mg/kg/day)|[?]|1|IU/mL/(kg/m2)|ATHEROSCLEROTIC PLAQUE|6|TREATMENT|2020-09-16|56|2020-08-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c0120c9e-c421-4a2e-a85b-170f2d1c0f3f|1|AUMCIFPD|AUMC Infinity Pred Norm by Dose|[?]|COMPARTMENTAL|[?]|h*umol/L/(mg/g)|[?]|1|mg/mL|ENDOTRACHEAL FLUID|3|TREATMENT|2020-07-02|60|2020-05-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|cec9e0ce-4d09-470c-9c26-df661d316a69|1|TAU|Dosing Interval|[?]|COMPARTMENTAL|[?]|h*g/mL/(kg/m2)|[?]|1|ug/mL|MUCUS|2|SCREENING|2021-03-11|75|2021-02-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b98b4e19-51ac-40cc-80d5-cb6d8000c112|1|RCPCIFOW|Pct Rec Infinity Obs Norm by WT|[?]|COMPARTMENTAL|[?]|h*ng/mL/(kg/m2)|[?]|1|h*pmol/L/m2|SEMINAL FLUID|3|TREATMENT|2021-02-27|51|2021-03-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|525e8b0c-b2cf-46b0-a1e1-9f5368ba97df|1|CTROUGHD|Conc Trough by Dose|[?]|NON-COMPARTMENTAL|[?]|ng/mL/kg|[?]|1|day*ng/mL/(mg/g)|TRANSUDATE|7|WASHOUT|2020-07-12|15|2020-09-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4bc30b18-c8d8-41a3-91d5-33b8b064087b|1|VZPUB|Vz Pred for UB|[?]|NON-COMPARTMENTAL|[?]|min*mg/mL/(kg/m2)|[?]|1|day*ug/mL/(mg/g/day)|VITREOUS HUMOR|7|TREATMENT|2020-08-10|39|2020-09-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7ff27a70-0472-4cc1-b057-6b161ab29568|1|VZFO|Vz Obs by F|[?]|COMPARTMENTAL|[?]|IU/mL/mg|[?]|1|h*g/mL/(mg/kg/day)|CERUMEN|1|TREATMENT|2020-11-22|13|2020-12-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|40529b01-9a80-4ada-a8df-96eec0e65043|1|AUCIFOLN|AUC Infinity Obs LN Transformed|[?]|NON-COMPARTMENTAL|[?]|day*ng/mL|[?]|1|(L/min)/(ug/m2)|SEBUM|4|TREATMENT|2020-09-01|86|2020-08-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f3e22efc-0948-4c6e-9173-8e284d342d33|1|RNCLINTS|Renal CL from T1 to T2 Norm by SA|[?]|NON-COMPARTMENTAL|[?]|Bq/uL|[?]|1|nmol/L/(mg/kg/day)|ALVEOLAR AIR|4|SCREENING|2021-01-22|57|2020-12-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|919eb5b4-a3df-41c6-86f7-c78501bb4335|1|CLRPCLEV|Renal CL as Pct CL EV|[?]|NON-COMPARTMENTAL|[?]|min*mmol/L|[?]|1|min*ug/mL/kg|CEREBROSPINAL FLUID|3|TREATMENT|2020-12-20|90|2020-11-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f918d6e0-6fc2-4303-b323-521c5d531773|1|CLFUB|Apparent CL for Unbound Drug|[?]|COMPARTMENTAL|[?]|pmol|[?]|1|h*mg/mL/(mg/g/day)|SUPERNATANT, SERUM|2|TREATMENT|2020-10-28|99|2020-09-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1d9bccfd-ab01-460f-b1b5-9d1859ee7f66|1|CLST|Last Nonzero Conc|[?]|COMPARTMENTAL|[?]|IU/day|[?]|1|h*ng/mL/(mg/g/day)|CIRCULATING TUMOR CELL|6|TREATMENT|2021-02-02|80|2020-12-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4b1e011f-a16d-4ff6-902d-451d5d13ee97|1|RCAMTAUW|Amt Rec Over Dosing Interval Norm by WT|[?]|NON-COMPARTMENTAL|[?]|Bq|[?]|1|pmol/L/(mg/m2)|PERSPIRATION|5|TREATMENT|2020-09-17|98|2020-09-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d6d26e31-eaa0-4d4b-9df3-3c3d6b38f571|1|VZFPUB|Vz Pred by F for UB|[?]|COMPARTMENTAL|[?]|h*pgEq/mL|[?]|1|mmol/L/(mg/day)|SUPERNATANT, SERUM|1|SCREENING|2020-08-09|31|2020-09-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b49e6f4b-862e-4ad5-8964-51c94d2a03ec|1|CLFUB|Apparent CL for Unbound Drug|[?]|NON-COMPARTMENTAL|[?]|h*mg/mL/(mg/kg)|[?]|1|nmol/L/(mg/m2)|CORD BLOOD|5|TREATMENT|2020-11-28|11|2021-01-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5c7645b5-5b4c-4280-878b-f5bd0e4349a7|1|AUCPEP|AUC %Extrapolation Pred|[?]|COMPARTMENTAL|[?]|min*nmol/L/(kg/m2)|[?]|1|h*ug/mL/(mg/kg)|SUPERNATANT, SERUM|3|FOLLOW-UP|2020-12-09|10|2020-12-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|87cd5d40-3ece-4e63-8f8f-13761cc94a2b|1|ARAUCIFP|Accum Ratio AUC Infinity Pred|[?]|COMPARTMENTAL|[?]|ugEq/mL/mgEq|[?]|1|GBq/mg|PLASMA|6|FOLLOW-UP|2020-09-02|68|2020-07-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7f1e0661-ebbd-4abd-9031-cb6b424977e2|1|AUCIFPD|AUC Infinity Pred Norm by Dose|[?]|COMPARTMENTAL|[?]|h*pgEq/mL|[?]|1|g|SEMINAL FLUID|1|TREATMENT|2021-01-07|35|2021-02-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|324a2c67-4802-4806-aff2-04fb9c7394d4|1|CMAXS|Max Conc Norm by SA|[?]|NON-COMPARTMENTAL|[?]|mg/mL/(mg/m2/day)|[?]|1|nmol/L/(ug/kg/day)|EPITHELIAL CELL|2|SCREENING|2020-07-18|62|2020-08-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9e6a2b90-c6ec-4d7d-96a3-8445f34ad4e7|1|CLOUB|Total CL Obs for Unbound Drug|[?]|COMPARTMENTAL|[?]|h*ng/mL/(kg/m2)|[?]|1|pg/min|INFRANATANT, PLASMA|6|SCREENING|2020-12-11|2|2021-02-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f00837ad-bf06-4fbc-a50b-289ac5c5dc03|1|CMAXD|Max Conc Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|fg/mL/(mg/day)|[?]|1|fg/mL/(ug/m2/day)|EMOTIONAL TEAR|3|FOLLOW-UP|2020-11-03|81|2020-09-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|911dc297-91cb-42b1-8a26-18f6c83c32a6|1|AUCIFPS|AUC Infinity Pred Norm by SA|[?]|NON-COMPARTMENTAL|[?]|h*umol/L/(kg/m2)|[?]|1|mmol/L/mg|ENDOTRACHEAL FLUID|5|FOLLOW-UP|2021-01-24|64|2020-12-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d87b795c-d158-4429-bdc6-1a2db7dc1a7d|1|CLFTAUW|Total CL by F for Dose Int Norm by WT|[?]|NON-COMPARTMENTAL|[?]|mmol/L/(mg/kg)|[?]|1|g/min|ADIPOSE TISSUE|7|SCREENING|2021-01-16|62|2020-12-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9bfcd733-2233-4e54-a6cd-641a59fc8a01|1|RACTRGH|Ratio Conc Trough|[?]|NON-COMPARTMENTAL|[?]|day*nmol/L/kg|[?]|1|min*ng/mL/(mg/g)|SMEGMA|2|FOLLOW-UP|2020-09-30|56|2020-11-05|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7eb97152-173c-4923-8604-5dad3140cc25|1|VSSOW|Vol Dist Steady State Obs Norm by WT|[?]|NON-COMPARTMENTAL|[?]|min*g/mL|[?]|1|nmol/min|BREAST MILK|5|SCREENING|2020-11-02|68|2020-09-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0b2104d0-e1e3-4516-8c4b-de5d42f82784|1|CLST|Last Nonzero Conc|[?]|NON-COMPARTMENTAL|[?]|fg/mL/(ug/m2/day)|[?]|1|g/mL/(mg/m2/day)|ERYTHROCYTES|4|TREATMENT|2020-09-11|44|2020-08-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|96f68979-6869-403b-a8bd-78c8f965f98a|1|C0W|Initial Conc Norm by WT|[?]|COMPARTMENTAL|[?]|ngEq/g|[?]|1|pmol/L/(mg/m2/day)|INTERSTITIAL FLUID|4|FOLLOW-UP|2020-07-02|47|2020-06-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e0f67610-b86a-4f5a-88eb-905b1e0aa609|1|RCPCIFPB|Pct Rec Infinity Pred Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|min*fg/mL/(mg/g/day)|[?]|1|(L/min)/(mg/kg/day)|EPIDERMAL TISSUE|7|WASHOUT|2021-01-13|99|2020-10-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d62dc655-8865-4592-af0b-744524d9a24c|1|RAAUCIND|Ratio AUC from T1 to T2 Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|(L/min)/(ug/kg)|[?]|1|h*fg/mL/(mg/g)|MONOCYTE|6|FOLLOW-UP|2020-10-12|23|2020-10-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6f2a59ba-1a8e-475f-b8c7-d8c6a9bf8b63|1|CLP|Total CL Pred|[?]|COMPARTMENTAL|[?]|mg/kg|[?]|1|(L/h)/(mg/m2)|ENDOMETRIAL TISSUE|2|WASHOUT|2021-01-25|27|2021-03-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8005bd56-3bd6-477a-a466-b9a3bd189770|1|ERMAXB|Max Excretion Rate Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|min*pmol/L/(mg/g/day)|[?]|1|uIU/mL/(mg/m2)|PLEURAL FLUID|2|FOLLOW-UP|2021-01-10|28|2021-02-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|078ea33d-4114-4320-9116-740b8385a94e|1|CLSTD|Last Nonzero Conc Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|(L/min)/(mg/day)|[?]|1|h*mol/L/(mg/g/day)|INFRANATANT, PLASMA|2|TREATMENT|2020-10-02|78|2020-07-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1ca91975-9a42-4f4d-9c55-53f7561d82fa|1|CLFPD|Total CL Pred by F Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|fg/mL/m2|[?]|1|L/ug|LYMPH|3|FOLLOW-UP|2020-06-05|12|2020-08-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c5f292ad-1729-402b-820f-83ecd29ba00d|1|LAMZNTAU|Number of Points for Lambda z TAU|[?]|NON-COMPARTMENTAL|[?]|ng/day|[?]|1|min*umol/L|WHITE MATTER TISSUE|2|TREATMENT|2020-09-01|95|2020-09-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a746aefb-16c8-43db-a0c4-8e9a4efdb244|1|AUCPBEP|AUC %Back Extrapolation Pred|[?]|COMPARTMENTAL|[?]|(L/day)/ug|[?]|1|fg/mL/(mg/kg/day)|WHITE MATTER TISSUE|4|SCREENING|2020-08-02|46|2020-08-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7f95b9c0-3b77-4c60-8890-ecc955f97122|1|RARECIFO|Ratio Amt Rec Infinity Obs|[?]|COMPARTMENTAL|[?]|IU/min|[?]|1|mIU/mL/(mg/kg)|SUPERNATANT, SERUM|4|TREATMENT|2020-10-16|31|2020-10-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2be43c56-83f3-4148-9cb1-97c6d191d20e|1|AURCLSTW|AURC Dosing to Last Conc Norm by WT|[?]|COMPARTMENTAL|[?]|h*mmol/L/kg|[?]|1|Bq/mg|DIALYSIS FLUID|6|SCREENING|2020-12-14|82|2020-10-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e27e0325-5fbe-46c0-8264-982d83124203|1|RCAMLST|Amt Rec to Last Nonzero Conc|[?]|NON-COMPARTMENTAL|[?]|g/mL/ug|[?]|1|(L/h)/kg|LAVAGE FLUID|4|TREATMENT|2020-07-13|16|2020-07-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9ff51377-d75c-4c9a-aa45-f2f8d6f4ffbf|1|VZO|Vz Obs|[?]|COMPARTMENTAL|[?]|(L/day)/ug|[?]|1|(L/min)/(mg/m2)|SUPERNATANT, CEREBROSPINAL FLUID|7|WASHOUT|2020-12-16|7|2021-02-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|29e08650-9eae-461f-981e-f2a20d8d4492|1|AUCIFO|AUC Infinity Obs|[?]|COMPARTMENTAL|[?]|h*g/mL/g|[?]|1|day*g/mL/(kg/m2)|INFRANATANT, PLEURAL FLUID|2|FOLLOW-UP|2021-01-21|75|2020-11-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2b944a62-10bc-475e-a90d-da3f07a2c4df|1|EFFHL|Effective Half-Life|[?]|NON-COMPARTMENTAL|[?]|day*mol/L/(mg/g/day)|[?]|1|ng/min|NAIL|3|WASHOUT|2020-09-02|11|2020-11-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d6e51edb-0983-4ffb-b5a6-59afc2696ce8|1|AURCPEP|AURC % Extrapolation Pred|[?]|NON-COMPARTMENTAL|[?]|ngEq/g|[?]|1|IU/mL/(mg/kg/day)|REFLEX TEAR|3|FOLLOW-UP|2020-10-07|38|2020-11-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8aa77db3-b078-4073-a7f3-9b9a7fb14570|1|MAT|Mean Absorption Time|[?]|NON-COMPARTMENTAL|[?]|day*mg/mL/(mg/g/day)|[?]|1|(L/day)/(kg/m2)|PROSTATIC FLUID|4|FOLLOW-UP|2021-01-08|67|2020-12-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1fce031b-680b-414f-9b74-d6383e10091d|1|CLTAUB|Total CL for Dose Int Norm by BMI|[?]|COMPARTMENTAL|[?]|h*pmol/L/(mg/g/day)|[?]|1|fg/mL/(ug/m2)|SMOOTH MUSCLE TISSUE|5|TREATMENT|2020-07-29|69|2020-06-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|dcc67696-e91a-4cef-81dd-f2d2711363ae|1|FLUCP|Fluctuation%|[?]|COMPARTMENTAL|[?]|min*mol/L|[?]|1|h*pgEq/mL|NAIL|6|TREATMENT|2021-01-10|23|2021-03-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|91e83d7a-186a-4fed-8750-af796d77d356|1|ARCTROUG|Accumulation Ratio Ctrough|[?]|NON-COMPARTMENTAL|[?]|mol|[?]|1|h*mg/mL|VENOUS PLASMA|3|TREATMENT|2020-06-10|18|2020-08-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|fdd8b4e9-8499-45ad-bd93-9de5992faf1e|1|TAUHL|Half-Life TAU|[?]|NON-COMPARTMENTAL|[?]|pmol|[?]|1|day*umol/L/(mg/g/day)|PUS|1|SCREENING|2020-06-21|49|2020-06-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0145dfac-a107-4368-b358-bcd136e1ecb3|1|VZTAUW|Vz for Dose Int Norm by WT|[?]|COMPARTMENTAL|[?]|min*mmol/L/(mg/g/day)|[?]|1|h*mg/mL/(kg/m2)|SUPERNATANT, CEREBROSPINAL FLUID|2|FOLLOW-UP|2021-03-10|71|2021-03-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|cfbbaa65-9742-4682-9ec0-4d503bca0bb1|1|RNCLTAUW|Renal CL for Dose Int Norm by WT|[?]|COMPARTMENTAL|[?]|(L/min)/(mg/kg/day)|[?]|1|h*ng/mL/kg|DERMAL TISSUE|7|TREATMENT|2021-03-06|77|2021-03-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d4d79f6a-ba90-4503-934b-8a86286d83d3|1|AURCIFOB|AURC Infinity Obs Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|mmol/L/(mg/m2/day)|[?]|1|h*mol/L/m2|BUFFY COAT|2|TREATMENT|2020-11-16|9|2021-01-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a329c350-49e2-415d-ba3c-e1ee929aec86|1|RACMIN|Ratio Min Conc|[?]|NON-COMPARTMENTAL|[?]|L/h|[?]|1|mol/day|CELL PELLET|5|SCREENING|2020-11-02|89|2020-09-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ff0e3543-c1f3-47f8-987f-7b00a4a33704|1|EFFHL|Effective Half-Life|[?]|NON-COMPARTMENTAL|[?]|ugEq/mL|[?]|1|mg/kg/day|BILE|4|TREATMENT|2020-09-24|3|2020-12-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|128153ce-7bee-4f8d-bb60-fb1776370b6d|1|AUCIFPB|AUC Infinity Pred Norm by BMI|[?]|COMPARTMENTAL|[?]|(L/day)/(ug/m2/day)|[?]|1|mmol/L/m2|PLATELET|2|WASHOUT|2021-01-06|5|2021-02-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|22ee2f20-4a66-458f-a153-9d7e871e1db2|1|RARECINT|Ratio Amt Rec from T1 to T2|[?]|COMPARTMENTAL|[?]|mg/h|[?]|1|ug/min|PROSTATIC FLUID|4|TREATMENT|2020-06-12|5|2020-07-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b7caaa04-bcc7-4350-ad98-85670a19778f|1|CAVGINTW|Average Conc from T1 to T2 Norm by WT|[?]|NON-COMPARTMENTAL|[?]|h*ng/mL/kg|[?]|1|h*pmol/L/kg|SMOOTH MUSCLE TISSUE|1|TREATMENT|2020-09-24|90|2020-07-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2b58d5fd-3ec8-415b-bb53-a252049f228a|1|NRENLCLS|Nonrenal CL Norm by SA|[?]|NON-COMPARTMENTAL|[?]|h*mg/mL/(mg/g/day)|[?]|1|mmol/h|EXUDATE|7|FOLLOW-UP|2021-02-19|74|2021-02-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|60b23345-43f6-42eb-9225-5a674456c9b9|1|AURCIFOD|AURC Infinity Obs Norm by Dose|[?]|COMPARTMENTAL|[?]|min*mg/mL/(kg/m2)|[?]|1|ng/mL/(ug/m2/day)|PLASMA|3|TREATMENT|2021-02-22|48|2021-01-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7979239e-2a6b-48e3-9d11-41c97b33d229|1|ARAUCIFO|Accum Ratio AUC Infinity Obs|[?]|COMPARTMENTAL|[?]|pmol/L|[?]|1|min*pmol/L/(kg/m2)|SUPERNATANT, SERUM|6|SCREENING|2021-02-07|33|2021-03-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|027cd2f5-6bb8-41b2-8fb7-16ebff6155f1|1|CLPB|Total CL Pred Norm by BMI|[?]|COMPARTMENTAL|[?]|(mL/day)/kg|[?]|1|h*mg/mL/(mg/g)|ERYTHROCYTES|1|TREATMENT|2020-09-16|51|2020-10-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3107cfa6-4eb9-433c-9cc6-79ec64f916f9|1|C0|Initial Conc|[?]|COMPARTMENTAL|[?]|(L/h)/(ug/kg)|[?]|1|(L/h)/(ug/kg/day)|GASTRIC CONTENTS|1|FOLLOW-UP|2021-01-27|32|2021-01-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|da35fc01-4258-4e4d-99d9-4172e84c46e8|1|CTROUGHB|Conc Trough by BMI|[?]|COMPARTMENTAL|[?]|ng/mL/(mg/cm2)|[?]|1|mg/mL/m2|ALVEOLAR AIR|5|FOLLOW-UP|2020-07-23|11|2020-10-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|bd163bba-f977-4f1a-8baf-5b6e7ecd94d9|1|AUMCIFOD|AUMC Infinity Obs Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|nmol/L/(ug/m2/day)|[?]|1|(mL/h)/(mg/kg/day)|PROSTATIC FLUID|4|TREATMENT|2020-09-15|52|2020-09-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ddcd6b0e-ca09-4693-bdfc-33e7d7979a6f|1|R2ADJ|R Squared Adjusted|[?]|NON-COMPARTMENTAL|[?]|IU/mL/(mg/day)|[?]|1|min*ug/mL/(mg/g/day)|PLASMA ULTRAFILTRATE|5|WASHOUT|2021-01-18|45|2021-01-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|31b865ec-cf8f-499f-85e9-931dbfa2cf1c|1|CONCS|Conc by SA|[?]|COMPARTMENTAL|[?]|Bq/g|[?]|1|g/mL/(ug/day)|GASTRIC CONTENTS|5|WASHOUT|2020-08-24|86|2020-08-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3f5d82c3-eb6c-4b9a-8fb7-10cf59e6d4bd|1|ERLSTB|Last Meas Excretion Rate Norm by BMI|[?]|COMPARTMENTAL|[?]|min*g/mL/(mg/g/day)|[?]|1|uIU/mL/(mg/day)|PERIPHERAL BLOOD MONONUCLEAR CELL|7|TREATMENT|2020-07-20|67|2020-08-05|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|136d59c6-9645-447a-a047-68d33dbb708e|1|NRENALCL|Nonrenal CL|[?]|NON-COMPARTMENTAL|[?]|day*mol/L/g|[?]|1|day*mol/L/(kg/m2)|PERSPIRATION|3|TREATMENT|2020-10-04|20|2020-11-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2e393b90-213c-4661-ad55-cabb2008bf14|1|VZOUB|Vz Obs for UB|[?]|COMPARTMENTAL|[?]|min*g/mL/(kg/m2)|[?]|1|nmol/L/(ug/day)|EPITHELIAL CELL|6|SCREENING|2020-09-06|82|2020-08-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f72002d8-262b-49da-84a4-42e6011286f0|1|RCPCTAUS|Pct Rec Over Dosing Interval Norm by SA|[?]|COMPARTMENTAL|[?]|fg/mL/ug|[?]|1|h*fg/mL/(mg/g)|PERSPIRATION|7|WASHOUT|2021-01-03|91|2020-11-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|68869dda-531d-4218-b2b0-4f5f46825569|1|VSSPF|Vol Dist Steady State Pred by F|[?]|COMPARTMENTAL|[?]|mg/mL/(mg/kg/day)|[?]|1|(mL/min)/kg|CORD BLOOD|6|TREATMENT|2020-12-09|11|2021-01-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|68888445-1819-4f4c-bd0c-a445906476fb|1|V0S|Vol Dist Initial Norm by SA|[?]|NON-COMPARTMENTAL|[?]|mg/mL/(mg/day)|[?]|1|min*pg/mL/(mg/g/day)|LYSATE|3|SCREENING|2021-04-09|95|2021-04-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b2ce31a0-513a-449a-aa2c-7c9668fde275|1|RENALCLD|Renal CL Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|(mL/day)/(mg/m2/day)|[?]|1|h*nmol/L/m2|INFRANATANT, PLEURAL FLUID|5|FOLLOW-UP|2020-07-11|27|2020-09-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6c1d481b-985a-4be0-97ca-ecd06a81b456|1|CMAXB|Max Conc Norm by BMI|[?]|COMPARTMENTAL|[?]|ng/mL/(mg/cm2)|[?]|1|h*umol/L/m2|LAVAGE FLUID|6|TREATMENT|2020-10-07|12|2020-12-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|645a9247-efcb-4641-9514-58d6e28560e0|1|CAVGDW|Average Concentration Norm by Dose/WT|[?]|COMPARTMENTAL|[?]|(mL/h)/(mg/kg/day)|[?]|1|(L/h)/(ug/m2/day)|BREAST MILK|3|TREATMENT|2021-03-16|95|2021-03-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9e2164c8-0f5b-4951-83b8-487ed7b2d0a7|1|ARCMIND|Accum Ratio Cmin norm by dose|[?]|NON-COMPARTMENTAL|[?]|fg/mL/(mg/kg/day)|[?]|1|h*ngEq/mL/mgEq|PLASMA|5|WASHOUT|2020-09-23|18|2020-10-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|05b05951-b1ba-4c51-b50f-9c842532bc4e|1|RAAUCIOD|Ratio AUC Infinity Obs Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|g/mL/ug|[?]|1|min*pmol/L/(mg/g/day)|CELL PELLET|1|TREATMENT|2020-09-08|52|2020-10-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ab38e976-8c2b-48ff-bdba-5a056637ecdd|1|ARAUC|Accumulation Ratio AUCTAU|[?]|NON-COMPARTMENTAL|[?]|pmol/L/(kg/m2)|[?]|1|L/(ug/kg)|LOCHIA|6|FOLLOW-UP|2020-12-18|66|2020-12-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f19cb801-34fc-42fd-8691-ccfb6c5f8bb6|1|CLFOS|Total CL Obs by F Norm by SA|[?]|NON-COMPARTMENTAL|[?]|h2*DNA copies/ug|[?]|1|min*ng/mL/(mg/g/day)|LYMPH|7|WASHOUT|2020-09-09|19|2020-11-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|51a49847-6405-4842-b549-0e2ab99f61b2|1|LAMZNTAU|Number of Points for Lambda z TAU|[?]|COMPARTMENTAL|[?]|fg/mL/(ug/m2)|[?]|1|L/(ug/kg/day)|ARTERIALIZED CAPILLARY BLOOD|7|TREATMENT|2021-02-19|44|2021-03-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|44dcfb9a-c590-4826-a28c-b5e9f83129d5|1|AUMCIFOW|AUMC Infinity Obs Norm by WT|[?]|NON-COMPARTMENTAL|[?]|day*mmol/L/g|[?]|1|/day|SMEGMA|1|WASHOUT|2020-07-04|54|2020-07-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|98166d74-caa7-4693-a817-b2cbae947ff8|1|CLFPB|Total CL Pred by F Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|g/mL/(ug/m2/day)|[?]|1|ng/mL/m2|SUPERNATANT, SERUM|5|SCREENING|2021-02-15|45|2021-01-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|cb07675a-2042-44da-a1f9-8b7783347e88|1|ERINTD|Excret Rate from T1 to T2 Norm by Dose|[?]|COMPARTMENTAL|[?]|L/m2|[?]|1|(mL/h)/(mg/kg/day)|TRANSUDATE|1|FOLLOW-UP|2021-02-05|72|2020-12-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a8a14aa1-4484-4bbc-86bf-c44257146a26|1|VZFPB|Vz Pred by F Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|day*pmol/L/kg|[?]|1|mL/kg|SMEGMA|2|SCREENING|2020-07-25|34|2020-09-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|dfa4c661-9317-4bec-b307-a31eeadcaba6|1|VZTAUB|Vz for Dose Int Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|h*pg/mL/kg|[?]|1|min*mol/L/(mg/g)|BILE|5|WASHOUT|2020-08-04|71|2020-08-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9ed984a9-c153-4729-9dc9-3bb3d9059919|1|RCAMINTW|Amt Rec from T1 to T2 Norm by WT|[?]|COMPARTMENTAL|[?]|IU/mL/mg|[?]|1|IU|PUS|4|FOLLOW-UP|2020-10-23|62|2020-09-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|fb234b67-3c81-4d55-bc63-2389a23d67b2|1|CLSTW|Last Nonzero Conc Norm by WT|[?]|NON-COMPARTMENTAL|[?]|mg/mL/(mg/m2/day)|[?]|1|(L/min)/mg|SERUM OR PLASMA|1|TREATMENT|2021-02-14|44|2021-01-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|84d7ff44-cbe2-446f-b667-5bc539de519b|1|MRAUCIFO|Metabolite Ratio for AUC Infinity Obs|[?]|NON-COMPARTMENTAL|[?]|pmol/L/kg|[?]|1|(mL/day)/(mg/m2/day)|LAVAGE FLUID|6|FOLLOW-UP|2020-07-05|9|2020-07-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c96e4485-4aff-4c18-9c65-5f1a800cc6db|1|VSSOF|Vol Dist Steady State Obs by F|[?]|NON-COMPARTMENTAL|[?]|min*ng/mL/(kg/m2)|[?]|1|day*pmol/L/kg|MUCUS|3|FOLLOW-UP|2020-12-21|98|2020-10-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|955188f1-b434-40ab-94c8-0c0fb7f23e84|1|LAMZUTAU|Lambda z Upper Limit TAU|[?]|COMPARTMENTAL|[?]|min*mmol/L/(kg/m2)|[?]|1|fg/mL/(ug/m2/day)|HAIR|1|TREATMENT|2021-01-14|41|2021-02-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5a384b5e-954c-4af9-bd60-96aadc72ca44|1|AUCLSTDW|AUCLST Norm by Dose/WT|[?]|NON-COMPARTMENTAL|[?]|day*ug/mL/m2|[?]|1|mmol/h|CERUMEN|2|TREATMENT|2020-10-24|25|2021-01-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2c2d4104-35dd-4f81-ac31-ab1f84c2bc35|1|TMAX|Time of CMAX|[?]|NON-COMPARTMENTAL|[?]|min*mol/L/(mg/g)|[?]|1|min*umol/L/(kg/m2)|PLEURAL FLUID|3|TREATMENT|2020-08-25|64|2020-07-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f9432d72-f7d7-4cdf-a173-2e2029258474|1|ERINT|Excret Rate from T1 to T2|[?]|NON-COMPARTMENTAL|[?]|Bq/ug|[?]|1|min*pg/mL|CORD BLOOD|7|TREATMENT|2020-11-28|18|2021-02-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1382c3ff-89fd-48e2-b64d-56c8ca9c71d3|1|MRTEVIFP|MRT Extravasc Infinity Pred|[?]|COMPARTMENTAL|[?]|fg/mL|[?]|1|g/mL/m2|RETICULOCYTES|3|TREATMENT|2021-01-16|38|2021-02-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0fc0650f-ed95-422d-b407-dcee93178780|1|AUMCLSTD|AUMC to Last Nonzero Conc Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|min*mmol/L/(mg/g)|[?]|1|mIU/mL/kg|TRANSUDATE|7|TREATMENT|2020-09-26|44|2020-11-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3b5e8a1c-1174-4f60-8a95-b2cf413f7e39|1|TROUGHPR|Trough Peak Ratio|[?]|NON-COMPARTMENTAL|[?]|min*umol/L/(kg/m2)|[?]|1|(mL/min)/kg|BILE|5|FOLLOW-UP|2020-07-12|49|2020-06-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a6f48290-787a-46ad-bee1-ae263ad3c121|1|VZOUB|Vz Obs for UB|[?]|COMPARTMENTAL|[?]|mol/L|[?]|1|min*umol/L/(kg/m2)|DERMAL TISSUE|1|WASHOUT|2021-01-30|21|2021-04-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|565e5c83-9c67-4718-bd54-af34be936427|1|AUCLSTB|AUC to Last Nonzero Conc Norm by BMI|[?]|COMPARTMENTAL|[?]|(L/min)/(mg/kg)|[?]|1|mol/L/(ug/kg)|ERYTHROCYTES|7|TREATMENT|2020-07-04|35|2020-07-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b238304c-15ef-4c6e-a32c-9cd583a233a9|1|RCAMINTB|Amt Rec from T1 to T2 Norm by BMI|[?]|COMPARTMENTAL|[?]|min*mol/L/(mg/g/day)|[?]|1|h*pmol/L/g|EPIDERMAL TISSUE|2|TREATMENT|2021-02-22|56|2021-03-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c273f039-bca9-4d55-8620-5c5db32a6c4b|1|AUMCLSTD|AUMC to Last Nonzero Conc Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|L|[?]|1|day*ug/mL/kg|MUSCLE TISSUE|6|TREATMENT|2020-09-24|11|2020-11-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2cdb5053-2108-4f50-8906-8afabc855a36|1|MRCMAX|Metabolite Ratio for Max Conc|[?]|COMPARTMENTAL|[?]|(h*Bq/g)/(kBq/kg)|[?]|1|(L/h)/ug|PLEURAL FLUID|3|TREATMENT|2020-11-13|87|2020-08-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|fce7149a-503e-4209-8c62-8044a2ad1c1c|1|AUCPBEP|AUC %Back Extrapolation Pred|[?]|NON-COMPARTMENTAL|[?]|fraction of 1|[?]|1|min*ng/mL/(mg/g/day)|SMOOTH MUSCLE TISSUE|6|TREATMENT|2020-10-23|88|2020-09-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c8aad550-11a1-4473-8b35-79b7dfb08122|1|CLFTAUS|Total CL by F for Dose Int Norm by SA|[?]|NON-COMPARTMENTAL|[?]|day*mmol/L/m2|[?]|1|h*ng/mL/mg|FLUID|6|TREATMENT|2020-07-16|47|2020-07-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f1967c6e-c520-4482-be7e-01ada4380d87|1|AUMCIFOD|AUMC Infinity Obs Norm by Dose|[?]|COMPARTMENTAL|[?]|h*g/mL/g|[?]|1|mmol/L/m2|SEBUM|2|TREATMENT|2021-02-12|48|2020-12-31|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2a5a1c03-f54e-47da-8dda-2104c9423e94|1|AURCINTS|AURC from T1 to T2 Norm by SA|[?]|NON-COMPARTMENTAL|[?]|IU/mL/(mg/m2/day)|[?]|1|h|CAPILLARY PLASMA|1|TREATMENT|2021-03-08|76|2021-02-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8f98bac3-8010-4902-8ae1-783dc5fea72d|1|AUCINTW|AUC from T1 to T2 Norm by WT|[?]|COMPARTMENTAL|[?]|h*mg/mL/m2|[?]|1|Bq/kg|SWABBED MATERIAL|3|TREATMENT|2020-08-21|63|2020-09-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0fd7cece-4d9d-4d8c-82e0-df0c75613888|1|CHTMAX|Concentration at Half Tmax|[?]|NON-COMPARTMENTAL|[?]|nmol|[?]|1|IU/mL/(ug/day)|LAVAGE FLUID|5|FOLLOW-UP|2021-01-24|54|2020-12-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1ade93f5-35f2-4bcc-9b9b-519c3f13baf9|1|ARAUCIPD|Accum Ratio AUCIFP Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|g/mL/mg|[?]|1|h*mmol/L/m2|CORD BLOOD|7|FOLLOW-UP|2020-07-19|46|2020-08-05|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4be1ea69-9baf-45b4-873b-13a879544d9c|1|HDER|Hemodialysis Extraction Ratio|[?]|NON-COMPARTMENTAL|[?]|RATIO|[?]|1|g/mL/(mg/m2/day)|URINE SEDIMENT|3|WASHOUT|2021-02-15|30|2021-04-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7480ca7e-bffc-455b-a08e-c732ac6c8b4e|1|VZTAUS|Vz for Dose Int Norm by SA|[?]|COMPARTMENTAL|[?]|min*pmol/L/(mg/g)|[?]|1|pg/mL/m2|GASTRIC FLUID|5|WASHOUT|2020-11-10|22|2021-01-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|16720f71-55b5-478f-b041-00b61ae19ac9|1|CLPD|Total CL Pred Norm by Dose|[?]|COMPARTMENTAL|[?]|day*umol/L/g|[?]|1|min*mg/mL/(mg/g)|ALVEOLAR AIR|3|FOLLOW-UP|2021-01-30|30|2021-02-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4349f45e-f18b-4606-9a72-fd45e64e17dc|1|CLFO|Total CL Obs by F|[?]|NON-COMPARTMENTAL|[?]|h*fg/mL/(mg/g)|[?]|1|/day|ALVEOLAR AIR|3|TREATMENT|2021-02-01|31|2021-02-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|32e36ec1-6895-42ff-bf33-52977e72b338|1|CLP|Total CL Pred|[?]|COMPARTMENTAL|[?]|min*g/mL/g|[?]|1|mL/(mg/m2)|AMNIOTIC FLUID|4|TREATMENT|2020-11-09|75|2020-11-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e546f2d8-baea-4a6e-93cb-c7ec7292b423|1|RCPCIFOS|Pct Rec Infinity Obs Norm by SA|[?]|NON-COMPARTMENTAL|[?]|IU/min|[?]|1|L/m2|MUSCLE TISSUE|2|WASHOUT|2020-10-23|8|2020-11-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0329de16-fc7a-4941-900c-b390dac637aa|1|RCPCTAUS|Pct Rec Over Dosing Interval Norm by SA|[?]|COMPARTMENTAL|[?]|mg/kg/day|[?]|1|g/day|WHITE MATTER TISSUE|5|TREATMENT|2020-12-04|78|2020-11-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|89d364c9-1338-472b-af0b-19280e45508b|1|RAAUCALL|Ratio AUC All|[?]|NON-COMPARTMENTAL|[?]|pmol/L/(kg/m2)|[?]|1|h*ng/mL/(mg/g)|CAPILLARY PLASMA|2|FOLLOW-UP|2021-01-07|94|2020-12-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ecd8ff7b-9c30-4b74-ad95-f8555c59ab5e|1|TAU|Dosing Interval|[?]|NON-COMPARTMENTAL|[?]|Bq|[?]|1|min*ng/mL/m2|SPUTUM|1|TREATMENT|2020-06-22|36|2020-06-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f53c6f33-e2a6-4153-b1d6-9073f4ddefd1|1|CLTAUW|Total CL for Dose Int Norm by WT|[?]|COMPARTMENTAL|[?]|(L/day)/(mg/kg)|[?]|1|(L/h)/kg|ADIPOSE TISSUE|4|TREATMENT|2020-12-30|89|2020-11-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0c103005-efae-48ed-91e3-35d38fa1d359|1|AURCLSTD|AURC Dosing to Last Conc Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|(L/h)/(ug/day)|[?]|1|min*mg/mL/(kg/m2)|ARTERIAL BLOOD|3|WASHOUT|2020-08-14|88|2020-06-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c9808184-3432-448c-a5e5-50176715effa|1|CMAXB|Max Conc Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|pg/h|[?]|1|h*mol/L/(mg/g)|MUSCLE TISSUE|6|TREATMENT|2021-03-11|82|2021-03-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c3d7d293-975f-44de-bd35-0168eec40ac9|1|ERLSTB|Last Meas Excretion Rate Norm by BMI|[?]|COMPARTMENTAL|[?]|umol/L/m2|[?]|1|pmol/L/(kg/m2)|BONE MARROW|5|TREATMENT|2021-02-11|48|2021-03-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2db1f07d-a7db-4cc3-8943-536e24378f08|1|ERINTD|Excret Rate from T1 to T2 Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|day*umol/L|[?]|1|nmol/L/(ug/day)|SMOOTH MUSCLE TISSUE|3|TREATMENT|2020-07-14|42|2020-07-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c343ba98-87d7-40bc-b0e8-b866e42d3a21|1|CTROUGHS|Conc Trough by SA|[?]|COMPARTMENTAL|[?]|min*g/mL|[?]|1|g/mL/(ug/m2)|VENOUS PLASMA|4|FOLLOW-UP|2021-02-09|66|2020-12-31|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d2b31ba9-9718-43ce-82ca-3276c28ac42a|1|AUCPBEO|AUC %Back Extrapolation Obs|[?]|NON-COMPARTMENTAL|[?]|h2*pg/mL|[?]|1|Bq/mL|EPITHELIAL CELL|1|SCREENING|2021-02-13|81|2021-01-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4aa77a8a-bbbe-4b7f-91fb-1edb3b61b711|1|AUCIFP|AUC Infinity Pred|[?]|COMPARTMENTAL|[?]|nmol/L|[?]|1|ng/min|ARTERIALIZED CAPILLARY BLOOD|7|WASHOUT|2020-08-15|33|2020-09-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0a42f96a-49c3-492f-a272-bf9989e53e9d|1|VZFPUB|Vz Pred by F for UB|[?]|COMPARTMENTAL|[?]|min*fg/mL/g|[?]|1|g/mL/(mg/m2/day)|CARDIAC MUSCLE TISSUE|1|TREATMENT|2021-02-20|35|2021-03-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a78e7287-581c-4bf2-b3ca-ad2476c010cd|1|RCPCINTW|Pct Rec from T1 to T2 Norm by WT|[?]|NON-COMPARTMENTAL|[?]|IU/mL/(mg/m2)|[?]|1|min*fg/mL/kg|URINE|7|TREATMENT|2021-01-23|25|2021-01-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d3651e5f-bc38-4c96-afbf-5a65873ff306|1|VZTAUD|Vz for Dose Int Norm by Dose|[?]|COMPARTMENTAL|[?]|ng/kg/min|[?]|1|(L/day)/(mg/m2)|SYNOVIAL FLUID|4|SCREENING|2020-08-28|41|2020-09-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4dca1d91-f6fe-4ee7-b4c3-062972eb5f37|1|CTROUGH|Conc Trough|[?]|NON-COMPARTMENTAL|[?]|(L/h)/(kg/m2)|[?]|1|(mL/min)/(mg/kg)|BILE|2|TREATMENT|2020-06-10|9|2020-07-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f50537d2-e098-4dae-8f91-16f2357d709c|1|RENALCLB|Renal CL Norm by BMI|[?]|COMPARTMENTAL|[?]|IU|[?]|1|min*fg/mL/(mg/g)|PLEURAL FLUID|7|TREATMENT|2021-01-31|65|2021-01-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7fedb0fd-d2ff-434c-9208-ffabb26d1a98|1|AUCIFOD|AUC Infinity Obs Norm by Dose|[?]|COMPARTMENTAL|[?]|mg/h|[?]|1|h*mg/mL/(mg/g/day)|HAIR|7|SCREENING|2020-08-21|43|2020-07-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|489870ed-9da5-4df6-a5ef-17821c449c84|1|MAT|Mean Absorption Time|[?]|COMPARTMENTAL|[?]|(L/h)/(mg/kg)|[?]|1|min*mg/mL|LYSATE|7|TREATMENT|2020-08-21|32|2020-10-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|90fe992f-5a11-4829-b3b0-1c8314f53012|1|AUCLSTB|AUC to Last Nonzero Conc Norm by BMI|[?]|COMPARTMENTAL|[?]|(mL/day)/(mg/kg)|[?]|1|min*umol/L/(kg/m2)|STRIATED MUSCLE TISSUE|5|TREATMENT|2020-10-24|41|2020-10-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|74be8de0-3307-4cc3-9044-05068b60f7e0|1|FLUCP|Fluctuation%|[?]|COMPARTMENTAL|[?]|(L/h)/(mg/m2)|[?]|1|(L/min)/(ug/m2/day)|ENDOTRACHEAL FLUID|5|TREATMENT|2020-11-10|31|2020-12-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b95317e6-0acc-4be7-9525-4f6ca6cfe0fc|1|RCPCIFO|Pct Rec Infinity Obs|[?]|NON-COMPARTMENTAL|[?]|fg/mL/ug|[?]|1|mL/(mg/day)|COLOSTRUM|3|WASHOUT|2020-08-06|66|2020-07-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8825b806-fa76-49d7-b281-d36fc42fee1e|1|CMINB|Min Conc Norm by BMI|[?]|COMPARTMENTAL|[?]|mIU/mL/(mg/kg)|[?]|1|ng/mL|REFLEX TEAR|1|WASHOUT|2020-10-31|73|2020-10-31|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c075ec99-ae16-4a7d-b5da-d0f1db78bbac|1|AURCALL|AURC All|[?]|NON-COMPARTMENTAL|[?]|g|[?]|1|g/mL/(mg/kg/day)|PERSPIRATION|5|SCREENING|2020-05-18|9|2020-07-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|def2ec82-35be-4ef5-a1fd-a7212b2d1a1e|1|FREL|Relative Bioavailability|[?]|COMPARTMENTAL|[?]|g/mL/(mg/kg/day)|[?]|1|h*ug/mL/(mg/kg/day)|LUNG SURFACTANT|7|TREATMENT|2021-02-19|46|2021-01-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b36220d8-c129-48bf-8c41-542a954b819a|1|ERMAXB|Max Excretion Rate Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|h*ngEq/mL|[?]|1|(L/day)/(ug/day)|PLASMA|5|TREATMENT|2020-08-14|92|2020-07-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|92d3477b-7460-4ce8-b237-38ca4c55fc91|1|ARAUCIPD|Accum Ratio AUCIFP Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|h*g/mL|[?]|1|min*mmol/L/(kg/m2)|MENSTRUAL BLOOD|6|FOLLOW-UP|2020-10-30|87|2020-09-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|62b4fc8f-517b-4fa2-ac96-2420934bfd7d|1|EFFHL|Effective Half-Life|[?]|NON-COMPARTMENTAL|[?]|uIU/mL/kg|[?]|1|h*umol/L/(kg/m2)|SUPERNATANT, PLASMA|5|SCREENING|2020-12-29|23|2021-01-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|db13afe0-14f6-445b-869a-b0d9fe87e5b9|1|ERMAXS|Max Excretion Rate Norm by SA|[?]|COMPARTMENTAL|[?]|(L/day)/m2|[?]|1|pg/mL/m2|SERUM OR PLASMA OR BLOOD|1|WASHOUT|2020-08-20|8|2020-11-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3f75a463-1348-4c7f-8b29-7472d29628c8|1|HTMAX|Half Tmax|[?]|COMPARTMENTAL|[?]|fg/mL/(mg/kg/day)|[?]|1|(mL/day)/(mg/day)|CERUMEN|2|SCREENING|2020-07-05|3|2020-08-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d1644413-1ed4-4ac9-b68f-f7ccb3cf6e42|1|VSSPB|Vol Dist Steady State Pred Norm by BMI|[?]|COMPARTMENTAL|[?]|nmol/L/m2|[?]|1|day*fg/mL/(mg/g/day)|MIXED VENOUS BLOOD|7|TREATMENT|2021-04-09|79|2021-04-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4b00b9ef-ddc3-4669-8a73-f69c73743bce|1|RNCLTAUW|Renal CL for Dose Int Norm by WT|[?]|COMPARTMENTAL|[?]|pgEq/mL|[?]|1|h*nmol/L|ENDOTRACHEAL FLUID|4|WASHOUT|2020-09-20|69|2020-09-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a125efdf-aec8-47a1-b492-cdaf8b619a78|1|VZFTAUB|Vz for Dose Int by F Norm by BMI|[?]|COMPARTMENTAL|[?]|(L/h)/(mg/day)|[?]|1|Bq/g|RETICULOCYTES|1|TREATMENT|2020-09-27|7|2020-12-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9171362e-0166-46f2-ab2d-2748d8c291d5|1|CLPS|Total CL Pred Norm by SA|[?]|NON-COMPARTMENTAL|[?]|min*pmol/L/(kg/m2)|[?]|1|ng/mL/(mg/m2)|EXHALED BREATH CONDENSATE|3|TREATMENT|2021-03-07|64|2021-04-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9b150e38-dc85-4a28-aad3-43f7620be460|1|AURCALLD|AURC All Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|day*fg/mL/(mg/g/day)|[?]|1|L|PLEURAL FLUID|4|WASHOUT|2020-07-24|12|2020-07-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2a595fc0-7621-4ec9-bd77-74444886052e|1|FB|Fraction Bound|[?]|COMPARTMENTAL|[?]|nmol/min|[?]|1|day*mol/L/m2|SEBUM|2|TREATMENT|2020-12-03|49|2020-11-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0bab89c8-cf57-4d19-9b95-884a2e9da523|1|CLPB|Total CL Pred Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|IU/mL/mg|[?]|1|GBq/nL|EPIDERMAL TISSUE|2|TREATMENT|2020-12-20|10|2021-02-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|84edaa9d-ce48-4866-ab43-af91bee126ae|1|LAMZSPN|Lambda z Span|[?]|NON-COMPARTMENTAL|[?]|IU/mL/(mg/day)|[?]|1|h*ng/mL/kg|ADIPOSE TISSUE|1|FOLLOW-UP|2020-06-21|51|2020-08-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0a955f0d-058a-49ac-bc7f-4f8ef9690f5a|1|VZFOB|Vz Obs by F Norm by BMI|[?]|COMPARTMENTAL|[?]|min*g/mL/g|[?]|1|mg/min|HAIR FOLLICLE|6|SCREENING|2020-09-23|61|2020-08-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9734ec2a-d06b-43e1-82a5-37764af17890|1|CMIN|Min Conc|[?]|COMPARTMENTAL|[?]|mmol/L/ug|[?]|1|min*ng/mL/m2|CORD BLOOD|6|SCREENING|2020-10-02|13|2020-10-31|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9a0ce525-7f10-4651-885a-f64bd9c8925e|1|RCAMTAU|Amt Rec Over Dosing Interval|[?]|NON-COMPARTMENTAL|[?]|day*fg/mL/(mg/g)|[?]|1|L/(ug/m2/day)|PLASMA ULTRAFILTRATE|3|TREATMENT|2020-12-28|40|2021-01-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f2cd01c4-b765-4ac5-8e8d-c9fef7366720|1|VSSOW|Vol Dist Steady State Obs Norm by WT|[?]|NON-COMPARTMENTAL|[?]|day*ug/mL|[?]|1|(mL/h)/(mg/day)|COLOSTRUM|2|TREATMENT|2020-09-27|84|2020-08-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4ba88073-0003-461a-a950-4504ef7680e7|1|RACMIN|Ratio Min Conc|[?]|COMPARTMENTAL|[?]|(L/h)/(ug/kg/day)|[?]|1|day*pmol/L/kg|EPIDERMAL TISSUE|3|TREATMENT|2020-09-09|17|2020-10-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a0079507-0ad8-45e3-94f9-bfe0a80c7c4d|1|EFFHL|Effective Half-Life|[?]|NON-COMPARTMENTAL|[?]|mmol/L/(ug/m2/day)|[?]|1|(L/day)/(mg/m2/day)|ISOLATE|3|FOLLOW-UP|2020-09-05|14|2020-10-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f552fa78-d78f-44c5-9590-30a737e6652d|1|SRAUC|Stationarity Ratio AUC|[?]|NON-COMPARTMENTAL|[?]|uIU/mL/(mg/kg)|[?]|1|mL/h|WHITE MATTER TISSUE|2|TREATMENT|2020-10-08|13|2020-10-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|38d83f86-d8ce-461a-a288-95aebe498d22|1|RCPCINTB|Pct Rec from T1 to T2 Norm by BMI|[?]|COMPARTMENTAL|[?]|day*umol/L/(mg/g)|[?]|1|(mL/day)/(mg/kg/day)|ENDOMETRIAL TISSUE|2|FOLLOW-UP|2020-09-16|32|2020-09-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b31e8820-cc17-4ce5-af30-358dbeb12ba2|1|CLST|Last Nonzero Conc|[?]|COMPARTMENTAL|[?]|fg/mL/(ug/m2)|[?]|1|ngEq/g|ARTERIALIZED CAPILLARY BLOOD|6|TREATMENT|2020-08-22|19|2020-10-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|cf39d5bd-7682-4546-8495-5bcf48600a69|1|AUCTAUB|AUC Over Dosing Interval Norm by BMI|[?]|COMPARTMENTAL|[?]|(L/h)/(kg/m2)|[?]|1|day*fg/mL|SPERMATOZOON|7|TREATMENT|2021-01-28|18|2021-04-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|84c17e7b-8d56-4726-96a5-9ca41fb9d894|1|AUMCTAUW|AUMC Over Dosing Interval Norm by WT|[?]|COMPARTMENTAL|[?]|mgEq|[?]|1|g/mL/(mg/day)|PUS|5|FOLLOW-UP|2021-02-19|97|2021-01-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6e557fd7-efaf-4c86-806d-9bd66c7de7da|1|AURCIFOW|AURC Infinity Obs Norm by WT|[?]|COMPARTMENTAL|[?]|(L/day)/g|[?]|1|(mL/day)/(mg/kg/day)|VITREOUS HUMOR|3|WASHOUT|2021-02-18|32|2021-04-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2b25e1f9-929c-4bdc-8758-79f33b832026|1|AURCINTB|AURC from T1 to T2 Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|(L/min)/(ug/m2)|[?]|1|fg/mL/(mg/m2)|PUS|6|SCREENING|2020-11-09|31|2020-11-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d02c7553-17f5-44ec-8c24-469234d080e8|1|RENALCLB|Renal CL Norm by BMI|[?]|COMPARTMENTAL|[?]|day*mol/L/g|[?]|1|min*g/mL/(mg/g/day)|SUPERNATANT, PLEURAL FLUID|7|TREATMENT|2021-01-21|5|2021-04-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e819939e-548d-4e05-83e3-7976790de7e1|1|ERINT|Excret Rate from T1 to T2|[?]|COMPARTMENTAL|[?]|h*mol/L/(mg/g)|[?]|1|nmol/L/m2|INTERSTITIAL FLUID|7|TREATMENT|2020-11-02|66|2020-09-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3b35f16c-38c8-45a2-8872-fe0f0f30b0d9|1|AUCALLW|AUC All Norm by WT|[?]|NON-COMPARTMENTAL|[?]|day*ng/mL/m2|[?]|1|min*mg/mL/m2|PLASMA|1|TREATMENT|2020-09-25|48|2020-10-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ea5229ad-6469-4147-be40-546d27c04c4c|1|TLST|Time of Last Nonzero Conc|[?]|COMPARTMENTAL|[?]|uIU/mL/(mg/kg/day)|[?]|1|mg/mL/(kg/m2)|HAIR FOLLICLE|7|SCREENING|2020-07-19|50|2020-07-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0a566742-0f71-4603-85f0-875e2c3395e7|1|AUCIFPUB|AUC Infinity Pred, Unbound Drug|[?]|COMPARTMENTAL|[?]|ng/min|[?]|1|nmol/L/(kg/m2)|VENOUS BLOOD|6|TREATMENT|2021-02-26|59|2021-01-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|fdcd8f25-f7bd-477e-a7f6-4a279380d98f|1|C0|Initial Conc|[?]|NON-COMPARTMENTAL|[?]|fg/mL/kg|[?]|1|(L/day)/(ug/day)|SYNOVIAL FLUID|2|TREATMENT|2020-07-06|63|2020-05-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|48103500-0f3d-4108-9167-6afee1098773|1|V0B|Vol Dist Initial Norm by BMI|[?]|COMPARTMENTAL|[?]|L|[?]|1|min*pg/mL|SMOOTH MUSCLE TISSUE|4|WASHOUT|2020-07-06|62|2020-05-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9855fc59-f162-48ba-8c51-e8c6c54b72f3|1|VSSPD|Vol Dist Steady State Pred Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|h*ng/mL/(mg/kg)|[?]|1|ng/mL/kg|SERUM OR PLASMA OR BLOOD|3|TREATMENT|2020-07-27|12|2020-07-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ceab42b0-3a7e-4aad-b599-5da311398148|1|AURCALLS|AURC All Norm by SA|[?]|COMPARTMENTAL|[?]|day*ng/mL/kg|[?]|1|day*nmol/L/(mg/g/day)|ALVEOLAR AIR|1|FOLLOW-UP|2020-07-17|36|2020-07-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c6fed210-d4a7-41f9-b3ff-ece262a91a5f|1|AUMCIFPS|AUMC Infinity Pred Norm by SA|[?]|COMPARTMENTAL|[?]|(L/h)/(mg/day)|[?]|1|IU/day|MENSTRUAL BLOOD|4|TREATMENT|2020-09-20|83|2020-09-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6fdbc6f3-431d-48ca-b51b-992f2340b9f5|1|CONCD|Conc by Dose|[?]|COMPARTMENTAL|[?]|day*mg/mL/m2|[?]|1|g/mL/(ug/day)|MIXED VENOUS BLOOD|7|FOLLOW-UP|2020-07-27|27|2020-09-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|36a54b72-6368-460e-ab4c-952923e0fd14|1|VSSOBD|Vol Dist Steady State Obs by B|[?]|NON-COMPARTMENTAL|[?]|min*g/mL|[?]|1|ng/mL/(mg/kg/day)|URINE SEDIMENT|6|TREATMENT|2020-07-04|60|2020-06-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|84e56692-9a33-472a-9ddc-545d3342da34|1|V0W|Vol Dist Initial Norm by WT|[?]|COMPARTMENTAL|[?]|fg/mL/(mg/kg/day)|[?]|1|Bq/ug|SERUM OR PLASMA OR BLOOD|6|TREATMENT|2020-12-15|6|2021-01-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d917a86c-f13b-4ed8-aa0a-cc36ac57647e|1|CMINDW|Min Conc Norm by Dose/WT|[?]|NON-COMPARTMENTAL|[?]|h*ng/mL/(mg/g)|[?]|1|(L/h)/kg|PROSTATIC FLUID|6|WASHOUT|2020-08-27|98|2020-07-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|917f909f-fd5d-47ad-9e2a-f7c6953cfbd1|1|ARCTROUG|Accumulation Ratio Ctrough|[?]|COMPARTMENTAL|[?]|(mL/min)/(mg/m2)|[?]|1|mIU/mL/kg|EMOTIONAL TEAR|2|TREATMENT|2020-07-31|61|2020-09-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ae0e05c1-3953-4406-bfae-299295c1fa4c|1|CMINW|Min Conc Norm by WT|[?]|COMPARTMENTAL|[?]|ng/mL/(mg/kg/day)|[?]|1|pmol/L/(kg/m2)|PLEURAL FLUID|1|FOLLOW-UP|2021-03-27|84|2021-02-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7bbe20e7-3dcc-41ea-bba8-fc03ff83a28b|1|AURCPEP|AURC % Extrapolation Pred|[?]|NON-COMPARTMENTAL|[?]|uIU/mL/(mg/day)|[?]|1|h*mmol/L/m2|SUPERNATANT, PLASMA|2|WASHOUT|2021-02-11|36|2021-04-07|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ab09e76d-8bbf-4126-a60d-08d6b5292836|1|MAT|Mean Absorption Time|[?]|NON-COMPARTMENTAL|[?]|uIU/mL/(mg/m2/day)|[?]|1|min*mg/mL|URINE|7|FOLLOW-UP|2021-02-12|59|2020-12-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8b7e3909-4115-4736-b07a-e0b6c382aa7e|1|HDCL|Hemodialysis Clearance|[?]|NON-COMPARTMENTAL|[?]|umol/h|[?]|1|nmol/g|EPIDERMAL TISSUE|1|TREATMENT|2020-07-06|5|2020-08-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|187b2279-526f-4978-89d4-d2da56cc2257|1|VSSPF|Vol Dist Steady State Pred by F|[?]|COMPARTMENTAL|[?]|h*fg/mL/(mg/g)|[?]|1|(mL/h)/(mg/m2)|SERUM OR PLASMA OR BLOOD|7|FOLLOW-UP|2020-07-24|43|2020-07-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|53506a04-dedb-495b-8e35-0576cdf1b323|1|RARECINT|Ratio Amt Rec from T1 to T2|[?]|NON-COMPARTMENTAL|[?]|uIU/mL/kg|[?]|1|h*mg/mL|RETICULOCYTES|5|TREATMENT|2020-10-30|2|2020-12-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|defa600c-4205-476e-a40c-690cb16769b3|1|RACTRGH|Ratio Conc Trough|[?]|NON-COMPARTMENTAL|[?]|uIU/mL/(kg/m2)|[?]|1|(mL/min)/(mg/m2/day)|SUPERNATANT, SERUM|7|TREATMENT|2021-04-16|92|2021-01-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e5092583-4259-40ba-a6a2-eeef6607263b|1|RCAMIFOS|Amt Rec Infinity Obs Norm by SA|[?]|NON-COMPARTMENTAL|[?]|h*g/mL/m2|[?]|1|IU/min|VENOUS CORD BLOOD|1|TREATMENT|2020-09-11|5|2020-09-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|461196d1-1213-4e5f-9bac-71f097b6cfdb|1|RAAUC|Ratio AUC|[?]|COMPARTMENTAL|[?]|h2*mmol/L|[?]|1|g/mL/(ug/kg/day)|ENDOMETRIAL TISSUE|7|TREATMENT|2020-11-27|24|2021-01-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4c82922a-55d0-45b9-a7bb-4edac32b0f68|1|MRCMAX|Metabolite Ratio for Max Conc|[?]|COMPARTMENTAL|[?]|DNA copies/ug|[?]|1|day*ng/mL/(mg/g)|INFRANATANT, PLEURAL FLUID|5|SCREENING|2021-03-05|96|2021-01-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|57971bdc-14df-4d9e-a59a-2665703c12ab|1|MRAUCINT|Metabolite Ratio AUC from T1 to T2|[?]|COMPARTMENTAL|[?]|nmol/g|[?]|1|h*mg/mL/(mg/kg)|PLASMA|1|FOLLOW-UP|2020-07-20|61|2020-08-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|dacea2da-9101-41e9-97aa-1cb8445b1320|1|CLOW|Total CL Obs Norm by WT|[?]|COMPARTMENTAL|[?]|mg/mL/(mg/kg)|[?]|1|ng/mL/(mg/kg/day)|KERATINOCYTE|2|SCREENING|2020-10-12|13|2020-10-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|cbf5d05e-e934-4946-b991-5fef63a01888|1|ERLSTB|Last Meas Excretion Rate Norm by BMI|[?]|COMPARTMENTAL|[?]|mol/L|[?]|1|umol/L/(kg/m2)|SERUM|2|SCREENING|2020-11-07|11|2020-11-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|be18633c-0ff9-4775-9737-dc8a9524fd2c|1|AURCPEO|AURC % Extrapolation Obs|[?]|NON-COMPARTMENTAL|[?]|h*ug/mL/(mg/kg)|[?]|1|min*ug/mL/(mg/g)|SYNOVIAL FLUID|2|SCREENING|2020-10-18|10|2020-11-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f7eba9b8-94fb-46b8-842a-0322eb68a355|1|AUCINTB|AUC from T1 to T2 Norm by BMI|[?]|COMPARTMENTAL|[?]|pg/h|[?]|1|IU/day|AMNIOTIC FLUID|2|WASHOUT|2020-08-06|96|2020-07-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|903199e2-56e1-41e4-8904-d33cc6846ee3|1|MRAUCTAU|Metabolite Ratio for AUC Dosing Interval|[?]|COMPARTMENTAL|[?]|min*pmol/L/(kg/m2)|[?]|1|min*umol/L/g|CELL PELLET|3|SCREENING|2021-01-22|14|2021-04-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|32567f8d-e746-44e1-a269-d95ba3bb0b11|1|AUMCPEO|AUMC % Extrapolation Obs|[?]|NON-COMPARTMENTAL|[?]|day*mol/L/(mg/g)|[?]|1|GBq/uL|MECONIUM|1|TREATMENT|2021-01-20|89|2020-11-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ecdc54eb-c02f-4112-8e85-8a3352470b3b|1|RENALCLW|Renal CL Norm by WT|[?]|NON-COMPARTMENTAL|[?]|ugEq/mL/mgEq|[?]|1|(L/h)/(mg/kg/day)|SKELETAL MUSCLE TISSUE|6|TREATMENT|2021-01-28|88|2021-01-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6885a3d0-5bd9-4f2f-a126-35b8030ad1b8|1|ERMAXB|Max Excretion Rate Norm by BMI|[?]|COMPARTMENTAL|[?]|L/(mg/m2/day)|[?]|1|day*g/mL/m2|EXHALED BREATH CONDENSATE|3|SCREENING|2020-07-23|24|2020-07-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5d7241ec-120d-486d-ab39-b9e14ab4ce90|1|RCPCIFO|Pct Rec Infinity Obs|[?]|COMPARTMENTAL|[?]|nmol/L/(mg/day)|[?]|1|h*mmol/L/m2|SALIVA|7|TREATMENT|2020-08-03|12|2020-09-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|17fdb337-01e4-42ce-b3f0-1f4beeafc26c|1|VSSOS|Vol Dist Steady State Obs Norm by SA|[?]|NON-COMPARTMENTAL|[?]|day*fg/mL/(kg/m2)|[?]|1|min*mol/L/g|INTERSTITIAL FLUID|5|TREATMENT|2020-06-27|36|2020-07-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8efc2f2c-fa89-4ceb-a43c-c77bc2ff6319|1|MRCMAX|Metabolite Ratio for Max Conc|[?]|NON-COMPARTMENTAL|[?]|(L/day)/(kg/m2)|[?]|1|nmol/min|PLATELET|5|WASHOUT|2020-07-06|12|2020-07-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a69c6182-9c35-4365-b732-b238e0584ba7|1|VZOB|Vz Obs Norm by BMI|[?]|COMPARTMENTAL|[?]|mol/L/(ug/m2/day)|[?]|1|mmol/L/(mg/kg/day)|PLATELET POOR PLASMA|5|SCREENING|2020-11-04|99|2020-09-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1b9896cf-160e-4a56-8737-9759cd83e784|1|MRAUCIFO|Metabolite Ratio for AUC Infinity Obs|[?]|NON-COMPARTMENTAL|[?]|h*ug/mL/(kg/m2)|[?]|1|min*pmol/L/kg|PERIPHERAL BLOOD MONONUCLEAR CELL|4|SCREENING|2020-12-12|11|2020-12-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ea87b553-e331-40cf-bd86-d2bd22694476|1|VZTAUW|Vz for Dose Int Norm by WT|[?]|COMPARTMENTAL|[?]|min*ug/mL/g|[?]|1|mol/L/(ug/m2)|MIXED VENOUS BLOOD|3|TREATMENT|2020-08-17|22|2020-07-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7aebcf72-ac09-4814-ade2-0c0b2add2d8c|1|CLFPB|Total CL Pred by F Norm by BMI|[?]|COMPARTMENTAL|[?]|mg/day|[?]|1|L/mg|STRIATED MUSCLE TISSUE|2|TREATMENT|2020-09-18|60|2020-07-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|051dc064-be6f-43eb-aa51-7ed8634d6e23|1|AUCIFOD|AUC Infinity Obs Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|h*g/mL/g|[?]|1|h2*mg/mL|COLOSTRUM|6|SCREENING|2020-08-18|51|2020-07-05|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9d85acbf-5a26-4bcd-aee8-e1ab2834a2f9|1|CLOB|Total CL Obs Norm by BMI|[?]|COMPARTMENTAL|[?]|ug/mL/mg|[?]|1|pgEq/g|ERYTHROCYTES|6|TREATMENT|2020-07-19|56|2020-06-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7a17fe21-b640-4bc5-bf19-b1bceb393dab|1|LAMZTAU|Lambda z TAU|[?]|COMPARTMENTAL|[?]|ugEq/mL/mgEq|[?]|1|h*umol/L/(mg/g)|GASTRIC FLUID|2|TREATMENT|2020-09-09|17|2020-10-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d2080dd2-03ad-4c43-be69-eeb8151cc9b5|1|CAVGINTW|Average Conc from T1 to T2 Norm by WT|[?]|COMPARTMENTAL|[?]|(mL/min)/kg|[?]|1|ngEq/mL/mgEq|CIRCULATING TUMOR CELL|4|TREATMENT|2021-04-15|95|2021-02-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f1d0daec-aa97-4838-9c53-e16dae3e17b2|1|RCAMIFO|Amt Rec Infinity Obs|[?]|COMPARTMENTAL|[?]|h2*pg/mL|[?]|1|uIU/mL|CEREBROSPINAL FLUID|2|TREATMENT|2020-08-27|75|2020-09-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|835594ab-e93c-402b-8129-6af659be5ae1|1|AURCLSTB|AURC Dosing to Last Conc Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|h2*pmol/L|[?]|1|day*pg/mL/(mg/g)|HAIR|1|TREATMENT|2020-12-10|49|2021-01-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|c3c85786-d24b-4620-9ee0-c13b1cc4f951|1|ERINT|Excret Rate from T1 to T2|[?]|COMPARTMENTAL|[?]|nmol/L/(mg/kg)|[?]|1|h*nmol/L/m2|SMEGMA|2|WASHOUT|2020-10-25|28|2020-11-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5354e3c4-4106-4e4c-85c3-2dbbd001688c|1|R2|R Squared|[?]|NON-COMPARTMENTAL|[?]|GBq/nL|[?]|1|day*fg/mL/(mg/g)|MONOCYTE|5|SCREENING|2020-12-12|37|2020-12-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f10e9188-ef7b-46f9-a80a-0669436eb4dd|1|ERLSTW|Last Meas Excretion Rate Norm by WT|[?]|NON-COMPARTMENTAL|[?]|pg/mL/(kg/m2)|[?]|1|ugEq/mL|SMEGMA|3|SCREENING|2020-06-28|14|2020-06-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f5c49bb8-c1c4-42fc-a5a0-4a39d95604eb|1|TAUHL|Half-Life TAU|[?]|NON-COMPARTMENTAL|[?]|h2*mmol/L|[?]|1|mIU/mL|NAIL|2|TREATMENT|2020-08-19|16|2020-10-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|000b5b99-a92d-4c84-9edc-ee08930d8a2e|1|AUCINT|AUC from T1 to T2|[?]|NON-COMPARTMENTAL|[?]|(L/day)/(ug/kg/day)|[?]|1|pgEq/mL|PUS|7|WASHOUT|2020-12-17|73|2020-12-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4f919ad0-fdb4-49d8-ba63-bb9e1680bca5|1|VZFPB|Vz Pred by F Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|IU/mL/ug|[?]|1|nmol/L/kg|PROSTATIC FLUID|3|FOLLOW-UP|2020-08-21|91|2020-07-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|11b2b359-d4a1-411d-a676-075b26e1453c|1|AURCALL|AURC All|[?]|COMPARTMENTAL|[?]|mL/(kg/m2)|[?]|1|uIU/mL/(kg/m2)|ADIPOSE TISSUE|3|TREATMENT|2020-09-24|14|2020-12-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|293f673d-af6a-473e-8bce-118bb85bbd9e|1|AUCIFPB|AUC Infinity Pred Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|mL|[?]|1|min*g/mL/(mg/g/day)|CERVICOVAGINAL SECRETION|1|SCREENING|2020-10-27|18|2020-10-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0f60ab31-ee13-4846-93d2-6bcac139006f|1|RNCLTAUW|Renal CL for Dose Int Norm by WT|[?]|NON-COMPARTMENTAL|[?]|mmol/L/(mg/day)|[?]|1|mL/h|EMOTIONAL TEAR|6|TREATMENT|2020-09-20|90|2020-08-31|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d49f37ce-2d6e-4ebb-91af-7ed32322f824|1|R2|R Squared|[?]|NON-COMPARTMENTAL|[?]|(L/h)/(mg/kg)|[?]|1|ng/mL/(mg/kg)|CORD SERUM|4|WASHOUT|2020-10-10|50|2020-10-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|76dd2fe2-bc9e-48e4-870c-af7ece70009a|1|AUCLSTD|AUC to Last Nonzero Conc Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|(L/min)/m2|[?]|1|day*mol/L/m2|PLEURAL FLUID|1|TREATMENT|2020-07-27|31|2020-08-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5ac0fe16-cde1-41ea-9948-0b79e72fd8ad|1|AUMCPEP|AUMC % Extrapolation Pred|[?]|COMPARTMENTAL|[?]|(L/h)/(ug/m2/day)|[?]|1|ng/kg/min|SUPERNATANT, PLASMA|1|SCREENING|2021-02-05|83|2020-12-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|78778706-6b5b-4ad8-90af-f56d602863ae|1|VZFPW|Vz Pred by F Norm by WT|[?]|NON-COMPARTMENTAL|[?]|umol/day|[?]|1|min*pg/mL/(mg/g)|INTERSTITIAL FLUID|7|TREATMENT|2020-07-25|83|2020-05-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a6954aa1-4860-412a-b988-7f708aca2ab2|1|VZTAU|Vz for Dose Int|[?]|NON-COMPARTMENTAL|[?]|day*mol/L/g|[?]|1|h*pg/mL/(mg/g)|INFRANATANT, PLEURAL FLUID|7|TREATMENT|2020-11-25|79|2020-09-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0a970eb4-f958-42ad-ad8b-60bb427c9cba|1|NRENALCL|Nonrenal CL|[?]|NON-COMPARTMENTAL|[?]|fg/mL/(ug/day)|[?]|1|day*ug/mL/g|SEBUM|1|TREATMENT|2020-07-26|83|2020-08-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|dd6179f5-d2f5-4258-ac74-cf8e7a2d8673|1|AURCLST|AURC to Last Nonzero Rate|[?]|NON-COMPARTMENTAL|[?]|L/(ug/m2/day)|[?]|1|mg/kg/day|KERATINOCYTE|7|TREATMENT|2021-03-08|51|2021-01-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|fae58cd9-1ff0-47dc-9ecb-916fb9f4187b|1|CLOW|Total CL Obs Norm by WT|[?]|COMPARTMENTAL|[?]|h*pmol/L/(mg/g/day)|[?]|1|(mL/h)/m2|CAPILLARY PLASMA|6|TREATMENT|2020-11-20|98|2020-08-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9b268a13-dc40-4eb6-8729-c131ac302dd3|1|CMIND|Min Conc Norm by Dose|[?]|COMPARTMENTAL|[?]|h*mg/mL/(mg/kg/day)|[?]|1|(mL/min)/(mg/m2)|SMEGMA|3|TREATMENT|2020-05-07|2|2020-06-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|fa11534a-92f9-4887-828b-25b7637b8f57|1|ARAUCINT|Accumulation Ratio AUC from T1 to T2|[?]|NON-COMPARTMENTAL|[?]|fg/mL/(mg/kg)|[?]|1|h*mmol/L/(mg/g)|DERMAL TISSUE|6|SCREENING|2021-03-07|94|2021-03-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f305f7a3-8c8b-4eca-afb2-4a376f811170|1|ARCTROUD|Accum Ratio Ctrough norm by dose|[?]|NON-COMPARTMENTAL|[?]|mol/L/m2|[?]|1|min*mmol/L/(mg/g)|PLATELET POOR PLASMA|2|TREATMENT|2020-10-21|27|2020-10-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6e4ed6b3-e419-464c-a40e-f100a6894baa|1|RCAMIFP|Amt Rec Infinity Pred|[?]|COMPARTMENTAL|[?]|mmol|[?]|1|pmol/L/kg|CARDIAC MUSCLE TISSUE|5|FOLLOW-UP|2020-08-17|81|2020-06-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1e5e6ccc-a4b2-4aec-8048-988d1708caf0|1|AUCPEP|AUC %Extrapolation Pred|[?]|COMPARTMENTAL|[?]|fg/mL/(mg/m2)|[?]|1|mol/L|BASAL TEAR|4|SCREENING|2020-09-30|63|2020-08-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5d25ac6d-428d-41eb-9549-c23df035a54e|1|AUCINT|AUC from T1 to T2|[?]|COMPARTMENTAL|[?]|h*g/mL/g|[?]|1|h*ug/mL/(kg/m2)|MECONIUM|1|TREATMENT|2020-05-10|7|2020-06-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7d7dde17-c060-4ad3-9821-6faa49ddd1b2|1|RCPCTAUS|Pct Rec Over Dosing Interval Norm by SA|[?]|COMPARTMENTAL|[?]|(mL/min)/(mg/m2)|[?]|1|h*mg/mL/(mg/g)|MUSCLE TISSUE|4|SCREENING|2020-11-20|31|2020-12-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|173aea61-964d-4f4a-8d48-56a1a58de6d8|1|CLSTD|Last Nonzero Conc Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|mIU/mL/(mg/kg/day)|[?]|1|/day|STRIATED MUSCLE TISSUE|5|TREATMENT|2020-10-15|12|2021-01-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|45d1adb8-9b3b-4f06-87cb-740205448680|1|ERLSTS|Last Meas Excretion Rate Norm by SA|[?]|COMPARTMENTAL|[?]|(mL/day)/(mg/m2)|[?]|1|day*mol/L/(kg/m2)|BLOOD|3|TREATMENT|2020-09-08|63|2020-08-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7403ad67-7ed5-4716-a874-c360429845bc|1|HDER|Hemodialysis Extraction Ratio|[?]|COMPARTMENTAL|[?]|pmol/L/(mg/day)|[?]|1|ug/mL/m2|ALVEOLAR AIR|4|TREATMENT|2020-06-22|33|2020-06-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8be919ce-34da-4e49-ac7a-3679c7af632d|1|VZTAUW|Vz for Dose Int Norm by WT|[?]|COMPARTMENTAL|[?]|mmol/L/(mg/m2/day)|[?]|1|day*g/mL|ADIPOSE TISSUE|2|TREATMENT|2021-01-20|17|2021-03-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9c44967b-914e-43d5-be1e-6829804e04ab|1|AURCALLS|AURC All Norm by SA|[?]|NON-COMPARTMENTAL|[?]|pmol/L/(mg/m2)|[?]|1|IU/mL/(mg/m2/day)|INFRANATANT, PLEURAL FLUID|4|SCREENING|2021-02-10|27|2021-03-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|36b6c36e-3cba-4d15-85e2-9f9bfc4c05e1|1|CLSTW|Last Nonzero Conc Norm by WT|[?]|NON-COMPARTMENTAL|[?]|DNA copies/ug|[?]|1|fg/mL/(mg/day)|INFRANATANT, SERUM|2|TREATMENT|2020-10-28|99|2020-08-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|cad8c553-739f-4046-a898-d939eb286dba|1|FREXINT|Fract Excr from T1 to T2|[?]|COMPARTMENTAL|[?]|(L/day)/(ug/kg/day)|[?]|1|h*pmol/L/(mg/kg)|DISCHARGE|7|TREATMENT|2020-07-20|74|2020-08-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0bd95d1b-a993-4ae6-9ed0-3e3256ee1648|1|AUMCIFOW|AUMC Infinity Obs Norm by WT|[?]|COMPARTMENTAL|[?]|min*nmol/L/(kg/m2)|[?]|1|day*mmol/L/(mg/g/day)|SEMINAL FLUID|7|FOLLOW-UP|2020-10-18|47|2020-11-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|81e934f8-7bcc-48d2-8d15-5270e51f2870|1|HDCL|Hemodialysis Clearance|[?]|COMPARTMENTAL|[?]|L/(mg/m2)|[?]|1|mL/(ug/kg)|EPITHELIAL CELL|2|SCREENING|2021-03-14|59|2021-02-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5713cabe-4d79-4f77-8ddc-daad1242a837|1|ARCMIND|Accum Ratio Cmin norm by dose|[?]|NON-COMPARTMENTAL|[?]|(L/min)/(ug/m2/day)|[?]|1|mmol/L/ug|DERMAL TISSUE|1|TREATMENT|2020-11-06|68|2020-11-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|414d20c7-8dc8-49ad-8ae9-f113b9610109|1|ERLSTB|Last Meas Excretion Rate Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|L/(mg/kg/day)|[?]|1|umol|CARDIAC MUSCLE TISSUE|3|WASHOUT|2020-07-10|10|2020-07-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|21e16094-23bd-4d20-b5f8-10d45858160e|1|CLFP|Total CL Pred by F|[?]|NON-COMPARTMENTAL|[?]|uIU/mL/(mg/m2/day)|[?]|1|pmol/L|BONE|5|TREATMENT|2020-09-19|12|2020-11-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2346613e-6734-476a-a414-511606c2d753|1|LAMZUL|Lambda z Upper Limit|[?]|COMPARTMENTAL|[?]|h*mol/L/(mg/g)|[?]|1|(mL/day)/(kg/m2)|INFRANATANT, PLASMA|6|FOLLOW-UP|2020-12-01|80|2020-11-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6a8bda83-1b5a-481e-af4f-77fe74bc37be|1|AURCLST|AURC to Last Nonzero Rate|[?]|NON-COMPARTMENTAL|[?]|mol/L/(ug/day)|[?]|1|umol|MIXED VENOUS BLOOD|7|TREATMENT|2020-12-18|32|2020-12-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|748ef401-3def-4674-8d5e-4a198709d672|1|VSSPUB|Vol Dist Steady State Pred by UB|[?]|COMPARTMENTAL|[?]|L/ug|[?]|1|min*umol/L/(kg/m2)|ARTERIALIZED CAPILLARY BLOOD|2|TREATMENT|2020-08-29|92|2020-09-05|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|03c399c1-77b9-4879-a6e8-42ba58ca68d4|1|VSSOUB|Vol Dist Steady State Obs by UB|[?]|COMPARTMENTAL|[?]|ng/mL/(mg/m2/day)|[?]|1|day*mg/mL/(kg/m2)|INFRANATANT, PLEURAL FLUID|6|WASHOUT|2020-07-15|10|2020-08-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b8afdaf1-5c4d-408f-b8ba-381461f15bde|1|AUCTAUW|AUC Over Dosing Interval Norm by WT|[?]|COMPARTMENTAL|[?]|fg/mL/(mg/m2/day)|[?]|1|h*g/mL|VENOUS BLOOD|2|SCREENING|2020-11-14|11|2020-11-08|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8115d6e8-0908-4491-a82a-08f43ccf1f0d|1|VZFPUB|Vz Pred by F for UB|[?]|NON-COMPARTMENTAL|[?]|mL/min|[?]|1|h*fg/mL/(mg/g)|WHITE MATTER TISSUE|3|TREATMENT|2021-02-23|97|2021-01-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|fbd7ecb2-905f-40a9-babc-ebaf310cc372|1|V0|Vol Dist Initial|[?]|NON-COMPARTMENTAL|[?]|IU/mL/(ug/day)|[?]|1|(mL/min)/(mg/kg)|TISSUE|4|WASHOUT|2020-07-22|32|2020-08-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1a0e1a66-82dd-4945-9c9f-179fba9d781e|1|CONCB|Conc by BMI|[?]|NON-COMPARTMENTAL|[?]|day*pmol/L/(mg/g)|[?]|1|day*ug/mL/kg|CIRCULATING TUMOR CELL|4|WASHOUT|2021-01-03|35|2021-03-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b3ab1879-3dc7-41fa-be53-f4484af21fbd|1|LAMZTAU|Lambda z TAU|[?]|COMPARTMENTAL|[?]|mg/mL/(mg/m2)|[?]|1|L/(ug/m2/day)|FLUID|3|FOLLOW-UP|2021-02-13|96|2021-02-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|bc71ddfa-c71c-447b-9684-005e4c112172|1|CONC|Concentration|[?]|COMPARTMENTAL|[?]|(L/day)/(ug/kg)|[?]|1|min*nmol/L/m2|TISSUE|1|WASHOUT|2020-07-20|19|2020-07-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ed3ae3f4-892a-4e68-9f3d-e81b2f2e09c0|1|CAVGW|Average Conc Norm by WT|[?]|NON-COMPARTMENTAL|[?]|day*umol/L/kg|[?]|1|/day|NAIL|4|TREATMENT|2020-12-10|11|2021-03-06|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|88d03ea3-dc55-4fb5-9296-3b94037a1aa6|1|TLAG|Time Until First Nonzero Conc|[?]|NON-COMPARTMENTAL|[?]|uIU/mL/(mg/m2/day)|[?]|1|h*umol/L/(mg/g)|SERUM OR PLASMA|1|FOLLOW-UP|2020-10-31|65|2020-09-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b1b3e113-8c73-4446-8095-3341f8912bd7|1|RCPCIFOW|Pct Rec Infinity Obs Norm by WT|[?]|NON-COMPARTMENTAL|[?]|min*umol/L/(kg/m2)|[?]|1|h*pmol/L/(kg/m2)|KERATINOCYTE|4|TREATMENT|2021-02-22|36|2021-02-09|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|caed12ff-3dfa-42cd-95e8-9a3dfd10184d|1|RCPCINTS|Pct Rec from T1 to T2 Norm by SA|[?]|NON-COMPARTMENTAL|[?]|h*pg/mL/kg|[?]|1|mmol/L/(ug/kg/day)|CAPILLARY PLASMA|7|FOLLOW-UP|2020-12-10|28|2020-12-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8ef3d6ea-49e3-4646-90ba-4b8b5b65e799|1|VSSOD|Vol Dist Steady State Obs Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|min*mg/mL/(mg/g)|[?]|1|min*mmol/L/g|DERMAL TISSUE|6|TREATMENT|2020-08-01|5|2020-10-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|3b83c7a0-e22b-45b1-b065-71971f014039|1|VZFPS|Vz Pred by F Norm by SA|[?]|NON-COMPARTMENTAL|[?]|h*mol/L/g|[?]|1|Bq/g|DERMAL TISSUE|5|WASHOUT|2020-11-13|83|2020-11-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|92c849ce-12b8-4c38-baab-f91c44a007b9|1|CONCDW|Concentration Norm by Dose/WT|[?]|NON-COMPARTMENTAL|[?]|min*fg/mL/(mg/g/day)|[?]|1|umol/L/m2|EMESIS|3|SCREENING|2020-11-13|11|2020-12-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f2101018-c983-435e-a453-148f182388f7|1|VZFP|Vz Pred by F|[?]|NON-COMPARTMENTAL|[?]|h*mmol/L/g|[?]|1|nmol/L/(ug/m2/day)|PERSPIRATION|3|TREATMENT|2020-09-18|27|2020-09-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|613284eb-edbe-446b-b4fe-f96f1510e626|1|ERLST|Last Meas Excretion Rate|[?]|NON-COMPARTMENTAL|[?]|IU/h|[?]|1|h*fg/mL/(kg/m2)|SERUM OR PLASMA|1|FOLLOW-UP|2021-01-25|89|2021-01-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|65e8391b-0c34-4687-a0ab-cb291a4cdf36|1|AURCIFO|AURC Infinity Obs|[?]|NON-COMPARTMENTAL|[?]|uIU/mL/(mg/kg/day)|[?]|1|g/mL/(mg/kg)|AMNIOTIC FLUID|6|TREATMENT|2020-09-07|64|2020-08-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2350438a-0bc8-4da5-b6c9-99a6c012b454|1|RCAMLST|Amt Rec to Last Nonzero Conc|[?]|COMPARTMENTAL|[?]|(L/day)/(ug/kg)|[?]|1|nmol/L/(mg/kg)|BLOOD|1|SCREENING|2020-11-05|86|2020-10-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ddfe1ae3-a8d4-4011-b2d0-753ef49d0bb8|1|MRTEVIFP|MRT Extravasc Infinity Pred|[?]|COMPARTMENTAL|[?]|mL/h|[?]|1|IU/day|MUSCLE TISSUE|2|TREATMENT|2021-01-15|70|2021-01-31|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|416fe99b-1258-4e72-b1df-48b989f8f8ed|1|AUMCIFPD|AUMC Infinity Pred Norm by Dose|[?]|COMPARTMENTAL|[?]|L/(mg/m2)|[?]|1|day*ug/mL/m2|DIALYSIS FLUID, PERITONEAL|5|WASHOUT|2020-11-24|98|2020-10-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|16a9e070-3e5d-444c-9ac1-6a1abfac0370|1|RCPCIFOB|Pct Rec Infinity Obs Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|nmol/L/(mg/kg/day)|[?]|1|min*fg/mL/m2|PROSTATIC FLUID|6|WASHOUT|2020-05-19|3|2020-08-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|1497a00d-55b1-4e02-a957-cf15e3d15512|1|AUCLSTB|AUC to Last Nonzero Conc Norm by BMI|[?]|COMPARTMENTAL|[?]|day*ug/mL/m2|[?]|1|(mL/min)/(mg/m2/day)|BREAST MILK|5|FOLLOW-UP|2021-04-15|90|2021-02-22|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9c188f41-b137-4d5a-bfbf-1783b1e0d3df|1|SRAUC|Stationarity Ratio AUC|[?]|COMPARTMENTAL|[?]|(mL/min)/(mg/kg/day)|[?]|1|MBq/uL|PROSTATIC FLUID|2|FOLLOW-UP|2020-09-10|61|2020-08-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b5e44703-e5e2-43b8-af6b-b74af0ae3ede|1|AURCALLS|AURC All Norm by SA|[?]|NON-COMPARTMENTAL|[?]|ug/min|[?]|1|(mL/day)/(mg/m2/day)|VENOUS PLASMA|2|TREATMENT|2021-01-10|42|2021-03-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|80f006d0-1a4f-4ee7-9492-3ab1f6d7caef|1|TROUGHPR|Trough Peak Ratio|[?]|NON-COMPARTMENTAL|[?]|h*ngEq/mL/mgEq|[?]|1|(L/day)/(mg/m2/day)|BUFFY COAT|1|TREATMENT|2020-11-25|30|2020-12-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8aa15baf-9164-4dc8-b7c2-30e435b9e6bd|1|VZFTAU|Vz for Dose Int by F|[?]|COMPARTMENTAL|[?]|h*pgEq/mL|[?]|1|(L/h)/ug|PLEURAL TISSUE|1|TREATMENT|2020-06-23|37|2020-05-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|2216086b-197e-4780-8e10-28123eb090c5|1|C0B|Initial Conc Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|IU/min|[?]|1|L|VENOUS BLOOD|5|TREATMENT|2021-03-10|98|2021-02-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7280f69c-a0f4-48b5-b714-1e272193168c|1|AURCINTD|AURC from T1 to T2 Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|h*pmol/L/g|[?]|1|h*mol/L|STRIATED MUSCLE TISSUE|6|TREATMENT|2020-09-26|48|2020-08-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4ce0546d-d8d9-42cb-bf2a-8e002536dd65|1|AUCIFOUB|AUC Infinity Obs, Unbound Drug|[?]|COMPARTMENTAL|[?]|(mL/h)/(mg/kg)|[?]|1|h*pmol/L/(kg/m2)|PLATELET POOR PLASMA|2|SCREENING|2020-09-21|61|2020-08-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|25c6812b-9200-4dc4-a954-6879183a2c54|1|RAMAXMIN|Ratio of CMAX to CMIN|[?]|NON-COMPARTMENTAL|[?]|(L/day)/ug|[?]|1|h*mg/mL/(mg/g)|SERUM OR PLASMA|7|SCREENING|2021-02-25|73|2021-01-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|10dca475-f364-42f3-9192-faf762832adf|1|VZTAUW|Vz for Dose Int Norm by WT|[?]|NON-COMPARTMENTAL|[?]|nmol/L/(ug/day)|[?]|1|(L/min)/(ug/m2)|GASTRIC CONTENTS|5|TREATMENT|2020-10-31|46|2020-12-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|caf54095-56c3-428f-8342-ce45c6c9a287|1|AURCIFOB|AURC Infinity Obs Norm by BMI|[?]|COMPARTMENTAL|[?]|h*Bq/mL|[?]|1|h2*ng/mL|PROSTATIC FLUID|7|WASHOUT|2021-01-19|40|2020-12-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|f833ca56-d426-420b-a6d3-fedeabc02734|1|CTROUGHB|Conc Trough by BMI|[?]|COMPARTMENTAL|[?]|nmol/L/(ug/day)|[?]|1|mg/mL/(mg/day)|PUS|4|TREATMENT|2020-09-08|90|2020-08-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|03c8e2c7-b70d-4d46-8064-c99370eab232|1|VZTAUB|Vz for Dose Int Norm by BMI|[?]|COMPARTMENTAL|[?]|h*pmol/L/(mg/kg)|[?]|1|pg/mL/(mg/kg)|BILE|3|TREATMENT|2021-01-27|69|2021-01-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|944617c7-c5e6-4e06-b114-499c3020dbbd|1|VZP|Vz Pred|[?]|COMPARTMENTAL|[?]|day*pg/mL/m2|[?]|1|day*umol/L/g|ENDOMETRIAL TISSUE|4|TREATMENT|2021-01-02|82|2020-11-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e4878c66-1e2b-49bb-838e-85139d160dd4|1|AUCIFPUB|AUC Infinity Pred, Unbound Drug|[?]|NON-COMPARTMENTAL|[?]|nmol/L/(kg/m2)|[?]|1|min*mmol/L/(mg/g)|CAPILLARY PLASMA|7|WASHOUT|2020-12-14|64|2020-10-23|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6873e227-baef-4d6e-8600-0bb61d60fe49|1|RAAUCIND|Ratio AUC from T1 to T2 Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|IU/mL/(mg/kg)|[?]|1|mmol/L/(mg/kg)|WHITE MATTER TISSUE|5|SCREENING|2020-08-01|66|2020-06-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|bad01879-9b97-4d9c-9eec-58871168bd57|1|RCAMLST|Amt Rec to Last Nonzero Conc|[?]|COMPARTMENTAL|[?]|nmol/L/(mg/kg)|[?]|1|GBq|SPERMATOZOON|5|SCREENING|2020-10-31|26|2020-12-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|10d97d12-b3e9-4e58-87a2-d0c81ceeac17|1|RNCLTAUD|Renal CL for Dose Int Norm by Dose|[?]|COMPARTMENTAL|[?]|h*ug/mL/(mg/g/day)|[?]|1|g/mL/(kg/m2)|NAIL|5|TREATMENT|2020-12-01|36|2020-11-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0df77775-6e65-4f77-9f8f-7faaa1471141|1|AUCTAUW|AUC Over Dosing Interval Norm by WT|[?]|NON-COMPARTMENTAL|[?]|/day|[?]|1|ug/mL|URINE|4|SCREENING|2020-11-21|99|2020-08-31|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|adc5359a-f1d5-428b-97d8-fce67cfeeaea|1|RCAMIFO|Amt Rec Infinity Obs|[?]|NON-COMPARTMENTAL|[?]|mg/mL/(kg/m2)|[?]|1|h*umol/L/(kg/m2)|KERATINOCYTE|6|TREATMENT|2020-08-15|3|2020-11-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|cd68296c-95d4-489e-8b64-b2404f16316c|1|RCAMTAUB|Amt Rec Over Dosing Interval Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|min*fg/mL|[?]|1|IU/mL/(mg/m2/day)|PLEURAL TISSUE|6|TREATMENT|2021-03-16|96|2021-03-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|fe137506-d1ce-4b08-a043-9366d86c421e|1|RAMAXMIN|Ratio of CMAX to CMIN|[?]|NON-COMPARTMENTAL|[?]|(mL/h)/(mg/kg/day)|[?]|1|mmol|SOFT TISSUE|5|TREATMENT|2020-07-16|23|2020-09-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b112c524-42c8-4e9e-8699-209e739972a7|1|CMIN|Min Conc|[?]|COMPARTMENTAL|[?]|h*fg/mL/m2|[?]|1|day*pmol/L/(mg/g)|CARDIAC MUSCLE TISSUE|4|TREATMENT|2021-02-20|58|2021-02-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e6e32df8-8b66-49a5-a626-fd385297dd6f|1|CLFOD|Total CL Obs by F Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|L/(ug/day)|[?]|1|kBq/uL|MIXED VENOUS BLOOD|4|WASHOUT|2020-11-30|99|2020-09-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4dbfcc27-dc5a-4f04-a104-0eeb83561ab9|1|V0D|Vol Dist Initial Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|g/mL/(mg/m2)|[?]|1|min*fg/mL/(mg/g)|ARTERIALIZED CAPILLARY BLOOD|7|TREATMENT|2020-09-27|19|2020-11-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5002de57-45df-4525-a6b7-b6cc33c22229|1|VZTAUB|Vz for Dose Int Norm by BMI|[?]|COMPARTMENTAL|[?]|min*umol/L/kg|[?]|1|h*mmol/L/kg|DIALYSIS FLUID|6|TREATMENT|2021-02-02|31|2021-03-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|298f2081-bb11-4856-9e88-4be3b9b2250d|1|AUCINTB|AUC from T1 to T2 Norm by BMI|[?]|COMPARTMENTAL|[?]|h*pg/mL/(mg/kg)|[?]|1|mol/L/(ug/kg)|SPERMATOZOON|2|SCREENING|2020-09-27|2|2020-12-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7c864bb9-ff9d-4e5f-ae93-6e32ad859ac2|1|AUCIFPB|AUC Infinity Pred Norm by BMI|[?]|COMPARTMENTAL|[?]|ng/kg/min|[?]|1|mmol/L/g|BREAST MILK|7|WASHOUT|2020-12-25|6|2021-03-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a9e7f609-df5e-4a99-bf27-2a90cb7deebb|1|RENALCLB|Renal CL Norm by BMI|[?]|NON-COMPARTMENTAL|[?]|(L/h)/(ug/kg/day)|[?]|1|(mL/min)/(mg/day)|BREAST MILK|2|TREATMENT|2020-07-27|86|2020-05-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|18c21176-db5e-4650-a1af-beb2042c31d8|1|EFFHL|Effective Half-Life|[?]|COMPARTMENTAL|[?]|L/(mg/kg/day)|[?]|1|IU/mL/kg|ARTERIAL CORD BLOOD|1|FOLLOW-UP|2020-09-20|31|2020-11-16|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|7808abd1-7d6f-4090-aa08-916a804c95f5|1|CMINW|Min Conc Norm by WT|[?]|NON-COMPARTMENTAL|[?]|IU/mL/kg|[?]|1|fg/mL|SEMEN|5|TREATMENT|2020-08-15|66|2020-06-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|57553b78-e761-4577-aae2-5c693a2dc303|1|CLFOS|Total CL Obs by F Norm by SA|[?]|COMPARTMENTAL|[?]|mmol/min|[?]|1|min*ug/mL/m2|VITREOUS HUMOR|2|TREATMENT|2021-03-30|98|2021-03-03|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|40883550-4627-4f92-974a-7eeb5bde74c5|1|AUCALLB|AUC All Norm by BMI|[?]|COMPARTMENTAL|[?]|min*nmol/L/m2|[?]|1|fg/mL/ug|SEBUM|1|TREATMENT|2020-10-06|3|2020-11-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|4199b549-d021-4bfd-97e6-95630d407183|1|CMINS|Min Conc Norm by SA|[?]|NON-COMPARTMENTAL|[?]|nmol/min|[?]|1|mgEq|PROSTATIC FLUID|7|TREATMENT|2021-01-13|52|2021-02-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6366647f-62fa-48dc-9d77-1677fce62fc7|1|AUMCTAUD|AUMC Over Dosing Interval Norm by Dose|[?]|COMPARTMENTAL|[?]|mmol/L/(mg/kg)|[?]|1|min*umol/L/m2|CARDIAC MUSCLE TISSUE|2|WASHOUT|2020-09-16|74|2020-08-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|29fe31ae-bf22-4cfb-bdd3-f35ddf68cbc8|1|CMINB|Min Conc Norm by BMI|[?]|COMPARTMENTAL|[?]|ug/min|[?]|1|mg/mL/(kg/m2)|PLEURAL TISSUE|7|TREATMENT|2020-07-01|59|2020-06-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|637d7d5f-78d3-47fb-b6dc-d877d92b9001|1|RAMAXMIN|Ratio of CMAX to CMIN|[?]|NON-COMPARTMENTAL|[?]|min*mg/mL/m2|[?]|1|mL|GASTRIC CONTENTS|3|WASHOUT|2020-07-09|46|2020-06-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|696cd04a-cde7-4481-b5e2-fad1877ec284|1|CLSTD|Last Nonzero Conc Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|day*mg/mL/m2|[?]|1|min*ng/mL/kg|MUSCLE TISSUE|1|TREATMENT|2020-09-27|37|2020-09-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ce4699cb-66f1-4c13-8428-84064255b765|1|VZPUB|Vz Pred for UB|[?]|COMPARTMENTAL|[?]|(Bq/g)/(kBq/kg)|[?]|1|h*g/mL/(mg/g)|PLASMA|6|TREATMENT|2021-01-27|66|2021-02-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|015b391b-23c7-478d-b9d1-226d3cb9edcf|1|AURCIFPD|AURC Infinity Pred Norm by Dose|[?]|COMPARTMENTAL|[?]|h*Bq/g|[?]|1|h*pg/mL/(mg/kg/day)|SUPERNATANT, SERUM OR PLASMA|3|TREATMENT|2021-01-16|58|2021-01-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b510a277-c5ee-4a32-b111-b2dbc72c8a27|1|DISTHL|Half-Life Distribution|[?]|COMPARTMENTAL|[?]|day*ug/mL/kg|[?]|1|IU/mL/(ug/m2)|SMOOTH MUSCLE TISSUE|2|TREATMENT|2020-08-11|75|2020-08-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9e9acf6b-d29a-4c11-96d6-b580c721f462|1|TAU|Dosing Interval|[?]|NON-COMPARTMENTAL|[?]|nmol/kg|[?]|1|uIU/mL/(kg/m2)|DIALYSIS FLUID|3|FOLLOW-UP|2020-11-14|96|2020-09-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|da69b157-7dab-49c5-b8fb-bd312a21fcf0|1|RACAVG|Ratio Average Concentration|[?]|COMPARTMENTAL|[?]|mIU/mL/(kg/m2)|[?]|1|h*g/mL/(mg/g)|MENSTRUAL BLOOD|5|WASHOUT|2020-08-02|25|2020-07-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|0e94ec23-3ef8-4a1f-b6e0-72ce49abba5d|1|AUCIFPD|AUC Infinity Pred Norm by Dose|[?]|COMPARTMENTAL|[?]|h*ngEq/mL|[?]|1|(L/h)/(mg/m2)|INTERSTITIAL FLUID|1|FOLLOW-UP|2020-08-04|77|2020-06-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|77c97d1e-e223-4485-b2de-59daa4e5b01f|1|AURCIFOW|AURC Infinity Obs Norm by WT|[?]|NON-COMPARTMENTAL|[?]|fg/mL/g|[?]|1|day*g/mL/g|VENOUS CORD BLOOD|3|TREATMENT|2020-07-04|25|2020-08-14|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9ea26788-8e26-4cbf-9a5a-58cb49686fc6|1|AUCALLS|AUC All Norm by SA|[?]|NON-COMPARTMENTAL|[?]|h*ug/g|[?]|1|fg/mL/m2|PLATELET|5|FOLLOW-UP|2020-10-12|8|2020-10-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|af049bb3-79a3-4a4c-8c2c-05d5b8c82967|1|PTROUGHR|Peak Trough Ratio|[?]|NON-COMPARTMENTAL|[?]|RATIO|[?]|1|mg/kg/day|EMOTIONAL TEAR|4|SCREENING|2021-01-11|81|2020-12-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|9eb6e591-d266-4e05-85b6-230e8a02d494|1|RCPCTAU|Pct Rec Over Dosing Interval|[?]|NON-COMPARTMENTAL|[?]|(L/day)/(mg/kg/day)|[?]|1|ng/mL/(mg/m2/day)|CIRCULATING TUMOR CELL|2|FOLLOW-UP|2020-07-07|19|2020-07-12|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6a6e040d-6a09-4004-9fab-f4f82ba00eae|1|CONCDW|Concentration Norm by Dose/WT|[?]|COMPARTMENTAL|[?]|L/(ug/kg/day)|[?]|1|fg/mL/(mg/kg/day)|EXUDATE|3|TREATMENT|2020-09-25|97|2020-08-20|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5d4845ae-b8b5-4a5d-91b9-bfd391e7829e|1|RAMAXMIN|Ratio of CMAX to CMIN|[?]|COMPARTMENTAL|[?]|IU/mL/(ug/m2/day)|[?]|1|min*mg/mL|CARDIAC MUSCLE TISSUE|7|TREATMENT|2020-08-18|11|2020-08-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|6c7d2865-ecfa-40fc-aae1-3d1083bc7e40|1|RENALCLD|Renal CL Norm by Dose|[?]|COMPARTMENTAL|[?]|ngEq/g|[?]|1|h*mg/mL/(mg/g/day)|TISSUE|7|TREATMENT|2021-03-29|79|2021-01-29|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|81eefadb-c9b5-49c5-8bc0-3d243fc67e23|1|TROUGHPR|Trough Peak Ratio|[?]|COMPARTMENTAL|[?]|day*g/mL|[?]|1|(mL/min)/(mg/day)|LYMPH|1|TREATMENT|2020-05-28|26|2020-06-02|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|ba99022a-d398-4c60-828c-876f119459e1|1|RCAMTAUB|Amt Rec Over Dosing Interval Norm by BMI|[?]|COMPARTMENTAL|[?]|min*pg/mL/(mg/g)|[?]|1|ng/mL/(mg/m2)|BILE|6|TREATMENT|2021-01-06|46|2020-12-26|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d713869e-061c-4e95-8a50-da2e1ec47b3c|1|VZTAU|Vz for Dose Int|[?]|NON-COMPARTMENTAL|[?]|ugEq/g|[?]|1|h*nmol/L/(kg/m2)|PROSTATIC FLUID|6|SCREENING|2020-09-03|99|2020-07-10|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|fcebb64c-e0e6-4f29-9c52-15fa91f60018|1|RCPCTAU|Pct Rec Over Dosing Interval|[?]|COMPARTMENTAL|[?]|mg/mL/(mg/m2/day)|[?]|1|mIU/mL/kg|LUNG SURFACTANT|1|SCREENING|2020-09-08|69|2020-10-01|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e443f82e-43a8-4710-bff4-fd2b2f4d512f|1|RAAUC|Ratio AUC|[?]|NON-COMPARTMENTAL|[?]|min*umol/L/kg|[?]|1|min*ng/mL/kg|SUPERNATANT, CEREBROSPINAL FLUID|2|TREATMENT|2020-12-31|9|2021-01-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|d9f6cfa7-1321-4e08-bf1c-8a4cba4fc57d|1|RAMAXMIN|Ratio of CMAX to CMIN|[?]|COMPARTMENTAL|[?]|h*ug/mL|[?]|1|pg/mL|SEMEN|5|FOLLOW-UP|2020-09-01|81|2020-08-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8a2147b1-2deb-410e-a298-d028a5efc555|1|RCAMIFP|Amt Rec Infinity Pred|[?]|NON-COMPARTMENTAL|[?]|mg/min|[?]|1|h*mmol/L/g|LYSATE|6|SCREENING|2020-12-07|48|2020-12-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|033db3bf-17fb-4872-afdb-1eea3dac6d85|1|VZPD|Vz Pred Norm by Dose|[?]|NON-COMPARTMENTAL|[?]|min*g/mL/(kg/m2)|[?]|1|day*mmol/L/(mg/g/day)|SWABBED MATERIAL|2|TREATMENT|2020-07-19|24|2020-09-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e6bd8fdb-3af0-41c3-a23a-912ccd0cfce5|1|VZFP|Vz Pred by F|[?]|NON-COMPARTMENTAL|[?]|fg/mL/(mg/kg/day)|[?]|1|min*umol/L|MENSTRUAL BLOOD|2|SCREENING|2020-07-09|30|2020-07-24|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8dd493b7-a892-4cab-8f69-701471c51d99|1|MRAUCIFP|Metabolite Ratio for AUC Infinity Pred|[?]|NON-COMPARTMENTAL|[?]|mIU/mL/(mg/m2/day)|[?]|1|Bq/mL|CERUMEN|7|SCREENING|2021-01-14|12|2021-02-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a13bbcb3-2c6d-4de3-a3ee-f5651042a9fa|1|AURCLSTB|AURC Dosing to Last Conc Norm by BMI|[?]|COMPARTMENTAL|[?]|min*umol/L|[?]|1|umol/L/(kg/m2)|EMESIS|5|TREATMENT|2020-12-14|47|2021-01-27|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|a77d90cb-2f8e-49c7-aa09-ed432432ecc9|1|FREXINT|Fract Excr from T1 to T2|[?]|COMPARTMENTAL|[?]|(mL/min)/kg|[?]|1|uIU/mL/m2|SEMEN|2|WASHOUT|2020-09-02|8|2020-10-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|40319f6b-5d5f-41d2-b96e-6bc8443b85e3|1|RNCLUB|Renal CL for Unbound Drug|[?]|COMPARTMENTAL|[?]|g/mL/(ug/m2)|[?]|1|min*ng/mL/(mg/g)|PLEURAL TISSUE|7|SCREENING|2021-01-16|67|2020-11-30|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|b49ef90c-a17e-4554-9fa6-af72b4d56a06|1|AURCIFPW|AURC Infinity Pred Norm by WT|[?]|NON-COMPARTMENTAL|[?]|(L/day)/(mg/m2/day)|[?]|1|h*ng/mL/(mg/m2)|CORD SERUM|5|TREATMENT|2021-02-21|57|2021-01-04|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|df041193-ee4e-4835-8db9-5be9b832ded0|1|RNCLUB|Renal CL for Unbound Drug|[?]|NON-COMPARTMENTAL|[?]|umol/L|[?]|1|h*umol/L|LEUKOCYTE|7|TREATMENT|2021-01-30|76|2021-01-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e41a4505-a5aa-4cac-895b-04fe85737ca9|1|VZTAUW|Vz for Dose Int Norm by WT|[?]|NON-COMPARTMENTAL|[?]|mIU/mL/(kg/m2)|[?]|1|nmol|SERUM OR PLASMA OR BLOOD|4|SCREENING|2021-01-14|11|2021-02-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|64424aa7-ac36-4c85-bf35-44f8dca3ec4d|1|AURCLSTB|AURC Dosing to Last Conc Norm by BMI|[?]|COMPARTMENTAL|[?]|(L/h)/(kg/m2)|[?]|1|h2*ug/mL|EXPIRED AIR|7|SCREENING|2021-01-19|14|2021-03-19|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|8d572dcc-917b-463d-b8f6-2e3e888c5fb6|1|ARCTROUG|Accumulation Ratio Ctrough|[?]|NON-COMPARTMENTAL|[?]|(L/h)/(mg/m2)|[?]|1|(L/day)/(mg/m2)|DERMAL TISSUE|2|TREATMENT|2021-03-10|98|2021-01-13|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|5abbbb78-2eeb-4d21-85ac-f5d18294c603|1|AUMCIFPD|AUMC Infinity Pred Norm by Dose|[?]|COMPARTMENTAL|[?]|day*ng/mL/kg|[?]|1|(L/day)/(mg/day)|EPITHELIAL CELL|7|TREATMENT|2021-04-16|91|2021-04-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|109fe46d-ac1f-47fe-8ecb-6049a577d38c|1|FABS|Absolute Bioavailability|[?]|NON-COMPARTMENTAL|[?]|min*fg/mL/(mg/g/day)|[?]|1|uIU/mL/(mg/kg/day)|AMNIOTIC FLUID|5|WASHOUT|2020-06-03|24|2020-06-18|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|cdb18d0a-5fca-4437-9b6e-0e46b0930521|1|CLOUB|Total CL Obs for Unbound Drug|[?]|COMPARTMENTAL|[?]|min*pmol/L/(mg/g/day)|[?]|1|day*fg/mL/(kg/m2)|PLEURAL FLUID|3|TREATMENT|2020-10-03|40|2020-11-15|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e515b916-5d28-4236-8835-2ff43b498ab3|1|ERINTS|Excret Rate from T1 to T2 Norm by SA|[?]|COMPARTMENTAL|[?]|umol/day|[?]|1|day*pg/mL|TISSUE|4|WASHOUT|2020-08-19|98|2020-08-11|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|158af2a8-d447-45e5-8c58-3b950f1bd889|1|CONCS|Conc by SA|[?]|NON-COMPARTMENTAL|[?]|IU/mL/(ug/kg/day)|[?]|1|min*pmol/L/kg|SPERMATOZOON|2|FOLLOW-UP|2020-05-30|10|2020-07-28|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e9a930d5-ca57-4069-8251-c164273df082|1|AUCIFOLN|AUC Infinity Obs LN Transformed|[?]|NON-COMPARTMENTAL|[?]|(L/min)/kg|[?]|1|g/h|ISOLATE|5|WASHOUT|2020-06-17|37|2020-07-17|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|e654e37e-1c95-4f25-83b1-9233186626c6|1|CAVGDW|Average Concentration Norm by Dose/WT|[?]|NON-COMPARTMENTAL|[?]|ng/mL/(kg/m2)|[?]|1|min*pmol/L/(mg/g)|INFRANATANT, SERUM|6|TREATMENT|2020-08-25|31|2020-08-21|P1Y2M10DT2H30M|P1Y2M10DT2H30M
e|PP|808ee0ac-e668-4e8e-aa0a-889476cbe631|1|VOLPK|Sum of Urine Vol|[?]|COMPARTMENTAL|[?]|h2*ug/mL|[?]|1|h*umol/L/(mg/g)|RETICULOCYTES|4|TREATMENT|2020-07-25|46|2020-06-25|P1Y2M10DT2H30M|P1Y2M10DT2H30M
